id	sid	tid	token	lemma	pos
ajlm-100	1	1	article	article	PROPN
ajlm-100	1	2	information	information	NOUN
ajlm-100	1	3	authors	author	NOUN
ajlm-100	1	4	:	:	PUNCT
ajlm-100	1	5	maxwell	maxwell	PROPN
ajlm-100	1	6	waema1	waema1	PROPN
ajlm-100	1	7	naomi	naomi	PROPN
ajlm-100	1	8	maina2	maina2	PROPN
ajlm-100	2	1	simon	simon	PROPN
ajlm-100	2	2	karanja1	karanja1	PROPN
ajlm-100	2	3	beatrice	beatrice	PROPN
ajlm-100	2	4	gachie2	gachie2	PROPN
ajlm-100	2	5	maina	maina	PROPN
ajlm-100	2	6	ngotho3	ngotho3	PROPN
ajlm-100	2	7	john	john	PROPN
ajlm-100	2	8	kagira4	kagira4	PROPN
ajlm-100	2	9	affiliations	affiliation	NOUN
ajlm-100	2	10	:	:	PUNCT
ajlm-100	2	11	1institute	1institute	NUM
ajlm-100	2	12	of	of	ADP
ajlm-100	2	13	tropical	tropical	ADJ
ajlm-100	2	14	medicine	medicine	NOUN
ajlm-100	2	15	and	and	CCONJ
ajlm-100	2	16	infectious	infectious	ADJ
ajlm-100	2	17	diseases	disease	NOUN
ajlm-100	2	18	,	,	PUNCT
ajlm-100	2	19	jomo	jomo	PROPN
ajlm-100	2	20	kenyatta	kenyatta	PROPN
ajlm-100	2	21	university	university	PROPN
ajlm-100	2	22	of	of	ADP
ajlm-100	2	23	agriculture	agriculture	NOUN
ajlm-100	2	24	and	and	CCONJ
ajlm-100	2	25	technology	technology	NOUN
ajlm-100	2	26	,	,	PUNCT
ajlm-100	2	27	kenya2biochemistry	kenya2biochemistry	PROPN
ajlm-100	2	28	department	department	PROPN
ajlm-100	2	29	,	,	PUNCT
ajlm-100	2	30	jomo	jomo	PROPN
ajlm-100	2	31	kenyatta	kenyatta	PROPN
ajlm-100	2	32	university	university	PROPN
ajlm-100	2	33	of	of	ADP
ajlm-100	2	34	agriculture	agriculture	NOUN
ajlm-100	2	35	and	and	CCONJ
ajlm-100	2	36	technology	technology	NOUN
ajlm-100	2	37	,	,	PUNCT
ajlm-100	2	38	kenya	kenya	NOUN
ajlm-100	2	39	3animal	3animal	NUM
ajlm-100	2	40	science	science	NOUN
ajlm-100	2	41	department	department	NOUN
ajlm-100	2	42	,	,	PUNCT
ajlm-100	2	43	institute	institute	NOUN
ajlm-100	2	44	of	of	ADP
ajlm-100	2	45	primate	primate	PROPN
ajlm-100	2	46	research	research	NOUN
ajlm-100	2	47	,	,	PUNCT
ajlm-100	2	48	kenya	kenya	PROPN
ajlm-100	2	49	4department	4department	NUM
ajlm-100	2	50	of	of	ADP
ajlm-100	2	51	land	land	NOUN
ajlm-100	2	52	resources	resource	NOUN
ajlm-100	2	53	planning	planning	NOUN
ajlm-100	2	54	management	management	NOUN
ajlm-100	2	55	,	,	PUNCT
ajlm-100	2	56	jomo	jomo	PROPN
ajlm-100	2	57	kenyatta	kenyatta	PROPN
ajlm-100	2	58	university	university	PROPN
ajlm-100	2	59	of	of	ADP
ajlm-100	2	60	agriculture	agriculture	NOUN
ajlm-100	2	61	and	and	CCONJ
ajlm-100	2	62	technology	technology	NOUN
ajlm-100	2	63	,	,	PUNCT
ajlm-100	2	64	kenya	kenya	PROPN
ajlm-100	2	65	correspondence	correspondence	NOUN
ajlm-100	2	66	to	to	ADP
ajlm-100	2	67	:	:	PUNCT
ajlm-100	2	68	john	john	PROPN
ajlm-100	2	69	kagira	kagira	PROPN
ajlm-100	2	70	postal	postal	PROPN
ajlm-100	2	71	address	address	PROPN
ajlm-100	2	72	:	:	PUNCT
ajlm-100	2	73	jomo	jomo	PROPN
ajlm-100	2	74	kenyatta	kenyatta	PROPN
ajlm-100	2	75	university	university	PROPN
ajlm-100	2	76	of	of	ADP
ajlm-100	2	77	agriculture	agriculture	PROPN
ajlm-100	2	78	and	and	CCONJ
ajlm-100	2	79	technology	technology	NOUN
ajlm-100	2	80	,	,	PUNCT
ajlm-100	2	81	po	po	PROPN
ajlm-100	2	82	box	box	PROPN
ajlm-100	2	83	62000	62000	NUM
ajlm-100	2	84	–	–	PUNCT
ajlm-100	2	85	00200	00200	NUM
ajlm-100	2	86	nairobi	nairobi	PROPN
ajlm-100	2	87	,	,	PUNCT
ajlm-100	2	88	kenya	kenya	PROPN
ajlm-100	2	89	dates	date	NOUN
ajlm-100	2	90	:	:	PUNCT
ajlm-100	2	91	received	receive	VERB
ajlm-100	2	92	:	:	PUNCT
ajlm-100	2	93	01	01	NUM
ajlm-100	2	94	mar	mar	PROPN
ajlm-100	2	95	.	.	PROPN
ajlm-100	2	96	2013	2013	NUM
ajlm-100	2	97	accepted	accept	VERB
ajlm-100	2	98	:	:	PUNCT
ajlm-100	2	99	23	23	NUM
ajlm-100	2	100	oct	oct	PROPN
ajlm-100	2	101	.	.	PROPN
ajlm-100	2	102	2013	2013	NUM
ajlm-100	2	103	published	publish	VERB
ajlm-100	2	104	:	:	PUNCT
ajlm-100	2	105	29	29	NUM
ajlm-100	2	106	oct	oct	PROPN
ajlm-100	2	107	.	.	PROPN
ajlm-100	2	108	2014	2014	NUM
ajlm-100	2	109	how	how	SCONJ
ajlm-100	2	110	to	to	PART
ajlm-100	2	111	cite	cite	VERB
ajlm-100	2	112	this	this	DET
ajlm-100	2	113	article	article	NOUN
ajlm-100	2	114	:	:	PUNCT
ajlm-100	2	115	waema	waema	PROPN
ajlm-100	2	116	m	m	PROPN
ajlm-100	2	117	,	,	PUNCT
ajlm-100	2	118	maina	maina	PROPN
ajlm-100	2	119	m	m	PROPN
ajlm-100	2	120	,	,	PUNCT
ajlm-100	2	121	karanja	karanja	PROPN
ajlm-100	2	122	s	s	PROPN
ajlm-100	2	123	,	,	PUNCT
ajlm-100	2	124	gachie	gachie	PROPN
ajlm-100	2	125	b	b	PROPN
ajlm-100	2	126	,	,	PUNCT
ajlm-100	2	127	ngotho	ngotho	PROPN
ajlm-100	2	128	m	m	PROPN
ajlm-100	2	129	,	,	PUNCT
ajlm-100	2	130	kagira	kagira	PROPN
ajlm-100	2	131	j.	j.	PROPN
ajlm-100	2	132	development	development	PROPN
ajlm-100	2	133	of	of	ADP
ajlm-100	2	134	a	a	DET
ajlm-100	2	135	safer	safe	ADJ
ajlm-100	2	136	laboratory	laboratory	NOUN
ajlm-100	2	137	vervet	vervet	NOUN
ajlm-100	2	138	monkey	monkey	NOUN
ajlm-100	2	139	model	model	NOUN
ajlm-100	2	140	for	for	ADP
ajlm-100	2	141	the	the	DET
ajlm-100	2	142	study	study	NOUN
ajlm-100	2	143	of	of	ADP
ajlm-100	2	144	human	human	ADJ
ajlm-100	2	145	african	african	ADJ
ajlm-100	2	146	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	2	147	.	.	PUNCT
ajlm-100	3	1	afr	afr	PROPN
ajlm-100	3	2	j	j	PROPN
ajlm-100	3	3	lab	lab	PROPN
ajlm-100	3	4	med	med	PROPN
ajlm-100	3	5	.	.	PUNCT
ajlm-100	4	1	2013;3(1	2013;3(1	NUM
ajlm-100	4	2	)	)	PUNCT
ajlm-100	4	3	,	,	PUNCT
ajlm-100	4	4	art	art	NOUN
ajlm-100	4	5	.	.	PUNCT
ajlm-100	5	1	#	#	SYM
ajlm-100	5	2	100	100	NUM
ajlm-100	5	3	,	,	PUNCT
ajlm-100	5	4	6	6	NUM
ajlm-100	5	5	pages	page	NOUN
ajlm-100	5	6	.	.	PUNCT
ajlm-100	6	1	http://dx.doi.org/10.4102/	http://dx.doi.org/10.4102/	NUM
ajlm-100	6	2	ajlm.v3i1.100	ajlm.v3i1.100	PROPN
ajlm-100	6	3	copyright	copyright	NOUN
ajlm-100	6	4	notice	notice	NOUN
ajlm-100	6	5	:	:	PUNCT
ajlm-100	6	6	©	©	PROPN
ajlm-100	6	7	2014	2014	NUM
ajlm-100	6	8	.	.	PUNCT
ajlm-100	7	1	the	the	DET
ajlm-100	7	2	authors	author	NOUN
ajlm-100	7	3	.	.	PUNCT
ajlm-100	8	1	licensee	licensee	NOUN
ajlm-100	8	2	:	:	PUNCT
ajlm-100	8	3	aosis	aosis	NOUN
ajlm-100	8	4	openjournals	openjournal	NOUN
ajlm-100	8	5	.	.	PUNCT
ajlm-100	9	1	this	this	PRON
ajlm-100	9	2	is	be	AUX
ajlm-100	9	3	an	an	DET
ajlm-100	9	4	open	open	ADJ
ajlm-100	9	5	access	access	NOUN
ajlm-100	9	6	article	article	NOUN
ajlm-100	9	7	distributed	distribute	VERB
ajlm-100	9	8	under	under	ADP
ajlm-100	9	9	the	the	DET
ajlm-100	9	10	terms	term	NOUN
ajlm-100	9	11	of	of	ADP
ajlm-100	9	12	the	the	DET
ajlm-100	9	13	creative	creative	ADJ
ajlm-100	9	14	commons	common	NOUN
ajlm-100	9	15	attribution	attribution	NOUN
ajlm-100	9	16	license	license	NOUN
ajlm-100	9	17	,	,	PUNCT
ajlm-100	9	18	which	which	PRON
ajlm-100	9	19	permits	permit	VERB
ajlm-100	9	20	unrestricted	unrestricted	ADJ
ajlm-100	9	21	use	use	NOUN
ajlm-100	9	22	,	,	PUNCT
ajlm-100	9	23	distribution	distribution	NOUN
ajlm-100	9	24	,	,	PUNCT
ajlm-100	9	25	and	and	CCONJ
ajlm-100	9	26	reproduction	reproduction	NOUN
ajlm-100	9	27	in	in	ADP
ajlm-100	9	28	any	any	DET
ajlm-100	9	29	medium	medium	NOUN
ajlm-100	9	30	,	,	PUNCT
ajlm-100	9	31	provided	provide	VERB
ajlm-100	9	32	the	the	DET
ajlm-100	9	33	original	original	ADJ
ajlm-100	9	34	work	work	NOUN
ajlm-100	9	35	is	be	AUX
ajlm-100	9	36	properly	properly	ADV
ajlm-100	9	37	cited	cite	VERB
ajlm-100	9	38	.	.	PUNCT
ajlm-100	10	1	development	development	NOUN
ajlm-100	10	2	of	of	ADP
ajlm-100	10	3	a	a	DET
ajlm-100	10	4	safer	safe	ADJ
ajlm-100	10	5	laboratory	laboratory	NOUN
ajlm-100	10	6	vervet	vervet	NOUN
ajlm-100	10	7	monkey	monkey	NOUN
ajlm-100	10	8	model	model	NOUN
ajlm-100	10	9	for	for	ADP
ajlm-100	10	10	the	the	DET
ajlm-100	10	11	study	study	NOUN
ajlm-100	10	12	of	of	ADP
ajlm-100	10	13	human	human	ADJ
ajlm-100	10	14	african	african	ADJ
ajlm-100	10	15	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	10	16	in	in	ADP
ajlm-100	10	17	this	this	DET
ajlm-100	10	18	original	original	ADJ
ajlm-100	10	19	research	research	NOUN
ajlm-100	10	20	...	...	PUNCT
ajlm-100	10	21	open	open	ADJ
ajlm-100	10	22	access	access	NOUN
ajlm-100	10	23	•	•	ADP
ajlm-100	10	24	abstract	abstract	ADJ
ajlm-100	10	25	•	•	NUM
ajlm-100	10	26	introduction	introduction	NOUN
ajlm-100	10	27	•	•	NOUN
ajlm-100	10	28	research	research	NOUN
ajlm-100	10	29	methods	method	NOUN
ajlm-100	10	30	and	and	CCONJ
ajlm-100	10	31	design	design	NOUN
ajlm-100	10	32	   	   	SPACE
ajlm-100	10	33	•	•	ADP
ajlm-100	10	34	trypanosomes	trypanosome	NOUN
ajlm-100	10	35	   	   	SPACE
ajlm-100	10	36	•	•	NOUN
ajlm-100	10	37	drugs	drug	NOUN
ajlm-100	10	38	   	   	SPACE
ajlm-100	10	39	•	•	NUM
ajlm-100	10	40	experimental	experimental	ADJ
ajlm-100	10	41	animals	animal	NOUN
ajlm-100	10	42	   	   	SPACE
ajlm-100	10	43	•	•	NUM
ajlm-100	10	44	experimental	experimental	ADJ
ajlm-100	10	45	design	design	NOUN
ajlm-100	10	46	   	   	SPACE
ajlm-100	10	47	•	•	NUM
ajlm-100	10	48	clinical	clinical	ADJ
ajlm-100	10	49	examination	examination	NOUN
ajlm-100	10	50	and	and	CCONJ
ajlm-100	10	51	sample	sample	NOUN
ajlm-100	10	52	collection	collection	NOUN
ajlm-100	10	53	   	   	SPACE
ajlm-100	10	54	•	•	NOUN
ajlm-100	10	55	laboratory	laboratory	NOUN
ajlm-100	10	56	analysis	analysis	NOUN
ajlm-100	10	57	   	   	SPACE
ajlm-100	10	58	•	•	NUM
ajlm-100	10	59	disease	disease	NOUN
ajlm-100	10	60	staging	stage	VERB
ajlm-100	10	61	criteria	criterion	NOUN
ajlm-100	10	62	   	   	SPACE
ajlm-100	10	63	•	•	NUM
ajlm-100	10	64	statistical	statistical	ADJ
ajlm-100	10	65	analysis	analysis	NOUN
ajlm-100	10	66	   	   	SPACE
ajlm-100	10	67	•	•	ADP
ajlm-100	10	68	ethical	ethical	ADJ
ajlm-100	10	69	consideration	consideration	NOUN
ajlm-100	10	70	•	•	NOUN
ajlm-100	10	71	results	result	NOUN
ajlm-100	10	72	   	   	SPACE
ajlm-100	10	73	•	•	NUM
ajlm-100	10	74	clinical	clinical	ADJ
ajlm-100	10	75	signs	sign	NOUN
ajlm-100	10	76	   	   	SPACE
ajlm-100	10	77	•	•	NUM
ajlm-100	10	78	parasitaemia	parasitaemia	NOUN
ajlm-100	10	79	and	and	CCONJ
ajlm-100	10	80	cerebrospinal	cerebrospinal	ADJ
ajlm-100	10	81	fluid	fluid	ADJ
ajlm-100	10	82	parasitosis	parasitosis	NOUN
ajlm-100	10	83	   	   	SPACE
ajlm-100	10	84	•	•	NUM
ajlm-100	10	85	haematology	haematology	NOUN
ajlm-100	10	86	profiles	profile	NOUN
ajlm-100	10	87	      	      	SPACE
ajlm-100	10	88	•	•	NOUN
ajlm-100	10	89	erythrocyte	erythrocyte	NOUN
ajlm-100	10	90	changes	change	NOUN
ajlm-100	10	91	      	      	SPACE
ajlm-100	10	92	•	•	NUM
ajlm-100	10	93	platelets	platelet	NOUN
ajlm-100	10	94	      	      	SPACE
ajlm-100	10	95	•	•	NUM
ajlm-100	10	96	leucocytes	leucocyte	NOUN
ajlm-100	10	97	•	•	PRON
ajlm-100	10	98	trustworthiness	trustworthiness	NOUN
ajlm-100	10	99	   	   	SPACE
ajlm-100	10	100	•	•	NUM
ajlm-100	10	101	reliability	reliability	NOUN
ajlm-100	10	102	and	and	CCONJ
ajlm-100	10	103	validity	validity	NOUN
ajlm-100	10	104	of	of	ADP
ajlm-100	10	105	the	the	DET
ajlm-100	10	106	research	research	NOUN
ajlm-100	10	107	•	•	NOUN
ajlm-100	10	108	discussion	discussion	NOUN
ajlm-100	10	109	•	•	NOUN
ajlm-100	10	110	limitations	limitation	NOUN
ajlm-100	10	111	of	of	ADP
ajlm-100	10	112	the	the	DET
ajlm-100	10	113	study	study	NOUN
ajlm-100	10	114	   	   	SPACE
ajlm-100	10	115	•	•	NUM
ajlm-100	10	116	recommendations	recommendation	NOUN
ajlm-100	10	117	•	•	ADP
ajlm-100	10	118	conclusion	conclusion	NOUN
ajlm-100	10	119	•	•	NUM
ajlm-100	10	120	acknowledgements	acknowledgement	NOUN
ajlm-100	10	121	   	   	SPACE
ajlm-100	10	122	•	•	NOUN
ajlm-100	10	123	competing	compete	VERB
ajlm-100	10	124	interests	interest	NOUN
ajlm-100	10	125	   	   	SPACE
ajlm-100	10	126	•	•	NUM
ajlm-100	10	127	authors	author	NOUN
ajlm-100	10	128	’	'	PUNCT
ajlm-100	10	129	contributions	contribution	NOUN
ajlm-100	10	130	•	•	NUM
ajlm-100	10	131	references	reference	NOUN
ajlm-100	10	132	abstract	abstract	ADJ
ajlm-100	10	133	top	top	PROPN
ajlm-100	10	134	↑	↑	PROPN
ajlm-100	10	135	background	background	NOUN
ajlm-100	10	136	:	:	PUNCT
ajlm-100	10	137	there	there	PRON
ajlm-100	10	138	are	be	VERB
ajlm-100	10	139	three	three	NUM
ajlm-100	10	140	subspecies	subspecie	NOUN
ajlm-100	10	141	of	of	ADP
ajlm-100	10	142	trypanosoma	trypanosoma	PROPN
ajlm-100	10	143	brucei	brucei	PROPN
ajlm-100	10	144	:	:	PUNCT
ajlm-100	10	145	t.	t.	PROPN
ajlm-100	10	146	b.	b.	PROPN
ajlm-100	10	147	gambiense	gambiense	PROPN
ajlm-100	10	148	,	,	PUNCT
ajlm-100	10	149	t.	t.	PROPN
ajlm-100	10	150	b.	b.	PROPN
ajlm-100	10	151	rhodesiense	rhodesiense	PROPN
ajlm-100	10	152	and	and	CCONJ
ajlm-100	10	153	t.	t.	PROPN
ajlm-100	10	154	b.	b.	PROPN
ajlm-100	10	155	brucei	brucei	PROPN
ajlm-100	10	156	.	.	PUNCT
ajlm-100	11	1	the	the	DET
ajlm-100	11	2	first	first	ADJ
ajlm-100	11	3	two	two	NUM
ajlm-100	11	4	are	be	AUX
ajlm-100	11	5	infectious	infectious	ADJ
ajlm-100	11	6	to	to	ADP
ajlm-100	11	7	humans	human	NOUN
ajlm-100	11	8	,	,	PUNCT
ajlm-100	11	9	whilst	whilst	SCONJ
ajlm-100	11	10	t.	t.	PROPN
ajlm-100	11	11	b.	b.	PROPN
ajlm-100	11	12	brucei	brucei	PROPN
ajlm-100	11	13	is	be	AUX
ajlm-100	11	14	not	not	PART
ajlm-100	11	15	.	.	PUNCT
ajlm-100	12	1	identifying	identify	VERB
ajlm-100	12	2	an	an	DET
ajlm-100	12	3	animal	animal	NOUN
ajlm-100	12	4	model	model	NOUN
ajlm-100	12	5	of	of	ADP
ajlm-100	12	6	t.	t.	PROPN
ajlm-100	12	7	b.	b.	PROPN
ajlm-100	12	8	brucei	brucei	PROPN
ajlm-100	12	9	that	that	PRON
ajlm-100	12	10	mimics	mimic	VERB
ajlm-100	12	11	human	human	ADJ
ajlm-100	12	12	african	african	ADJ
ajlm-100	12	13	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	12	14	(	(	PUNCT
ajlm-100	12	15	hat	hat	NOUN
ajlm-100	12	16	)	)	PUNCT
ajlm-100	12	17	would	would	AUX
ajlm-100	12	18	enable	enable	VERB
ajlm-100	12	19	researchers	researcher	NOUN
ajlm-100	12	20	to	to	PART
ajlm-100	12	21	study	study	VERB
ajlm-100	12	22	hat	hat	NOUN
ajlm-100	12	23	without	without	ADP
ajlm-100	12	24	subjecting	subject	VERB
ajlm-100	12	25	themselves	themselves	PRON
ajlm-100	12	26	to	to	ADP
ajlm-100	12	27	undue	undue	ADJ
ajlm-100	12	28	risks	risk	NOUN
ajlm-100	12	29	such	such	ADJ
ajlm-100	12	30	as	as	ADP
ajlm-100	12	31	accidental	accidental	ADJ
ajlm-100	12	32	infection.objectives	infection.objective	NOUN
ajlm-100	12	33	:	:	PUNCT
ajlm-100	12	34	this	this	DET
ajlm-100	12	35	study	study	NOUN
ajlm-100	12	36	assessed	assess	VERB
ajlm-100	12	37	the	the	DET
ajlm-100	12	38	sequential	sequential	ADJ
ajlm-100	12	39	clinical	clinical	ADJ
ajlm-100	12	40	,	,	PUNCT
ajlm-100	12	41	parasitological	parasitological	ADJ
ajlm-100	12	42	and	and	CCONJ
ajlm-100	12	43	haematological	haematological	ADJ
ajlm-100	12	44	changes	change	NOUN
ajlm-100	12	45	in	in	ADP
ajlm-100	12	46	vervet	vervet	NOUN
ajlm-100	12	47	monkeys	monkey	NOUN
ajlm-100	12	48	infected	infect	VERB
ajlm-100	12	49	with	with	ADP
ajlm-100	12	50	t.	t.	PROPN
ajlm-100	12	51	b.	b.	PROPN
ajlm-100	12	52	brucei	brucei	PROPN
ajlm-100	12	53	.	.	PUNCT
ajlm-100	13	1	methods	method	NOUN
ajlm-100	13	2	:	:	PUNCT
ajlm-100	13	3	three	three	NUM
ajlm-100	13	4	vervet	vervet	NOUN
ajlm-100	13	5	monkeys	monkey	NOUN
ajlm-100	13	6	were	be	AUX
ajlm-100	13	7	infected	infect	VERB
ajlm-100	13	8	with	with	ADP
ajlm-100	13	9	a	a	DET
ajlm-100	13	10	104	104	NUM
ajlm-100	13	11	inoculum	inoculum	NOUN
ajlm-100	13	12	of	of	ADP
ajlm-100	13	13	t.	t.	PROPN
ajlm-100	13	14	b.	b.	PROPN
ajlm-100	13	15	brucei	brucei	PROPN
ajlm-100	13	16	(	(	PUNCT
ajlm-100	13	17	isolate	isolate	VERB
ajlm-100	13	18	gutat	gutat	NOUN
ajlm-100	13	19	1	1	NUM
ajlm-100	13	20	)	)	PUNCT
ajlm-100	13	21	.	.	PUNCT
ajlm-100	14	1	late	late	ADJ
ajlm-100	14	2	-	-	PUNCT
ajlm-100	14	3	stage	stage	NOUN
ajlm-100	14	4	disease	disease	NOUN
ajlm-100	14	5	was	be	AUX
ajlm-100	14	6	induced	induce	VERB
ajlm-100	14	7	by	by	ADP
ajlm-100	14	8	subcurative	subcurative	ADJ
ajlm-100	14	9	treatment	treatment	NOUN
ajlm-100	14	10	with	with	ADP
ajlm-100	14	11	diminazene	diminazene	NOUN
ajlm-100	14	12	aceturate	aceturate	VERB
ajlm-100	14	13	28	28	NUM
ajlm-100	14	14	days	day	NOUN
ajlm-100	14	15	post	post	ADJ
ajlm-100	14	16	-	-	NOUN
ajlm-100	14	17	infection	infection	NOUN
ajlm-100	14	18	.	.	PUNCT
ajlm-100	15	1	the	the	DET
ajlm-100	15	2	animals	animal	NOUN
ajlm-100	15	3	were	be	AUX
ajlm-100	15	4	treated	treat	VERB
ajlm-100	15	5	curatively	curatively	ADV
ajlm-100	15	6	with	with	ADP
ajlm-100	15	7	melarsoprol	melarsoprol	NOUN
ajlm-100	15	8	upon	upon	SCONJ
ajlm-100	15	9	relapse	relapse	NOUN
ajlm-100	15	10	.	.	PUNCT
ajlm-100	16	1	parasitaemia	parasitaemia	NOUN
ajlm-100	16	2	and	and	CCONJ
ajlm-100	16	3	clinical	clinical	ADJ
ajlm-100	16	4	signs	sign	NOUN
ajlm-100	16	5	were	be	AUX
ajlm-100	16	6	monitored	monitor	VERB
ajlm-100	16	7	daily	daily	ADV
ajlm-100	16	8	and	and	CCONJ
ajlm-100	16	9	,	,	PUNCT
ajlm-100	16	10	at	at	ADP
ajlm-100	16	11	weekly	weekly	ADJ
ajlm-100	16	12	intervals	interval	NOUN
ajlm-100	16	13	,	,	PUNCT
ajlm-100	16	14	the	the	DET
ajlm-100	16	15	monkeys	monkey	NOUN
ajlm-100	16	16	’	'	PUNCT
ajlm-100	16	17	blood	blood	NOUN
ajlm-100	16	18	and	and	CCONJ
ajlm-100	16	19	cerebrospinal	cerebrospinal	ADJ
ajlm-100	16	20	fluid	fluid	NOUN
ajlm-100	16	21	(	(	PUNCT
ajlm-100	16	22	csf	csf	NOUN
ajlm-100	16	23	)	)	PUNCT
ajlm-100	16	24	were	be	AUX
ajlm-100	16	25	sampled	sample	VERB
ajlm-100	16	26	for	for	ADP
ajlm-100	16	27	haematology	haematology	NOUN
ajlm-100	16	28	and	and	CCONJ
ajlm-100	16	29	parasitosis	parasitosis	NOUN
ajlm-100	16	30	assessments	assessment	NOUN
ajlm-100	16	31	,	,	PUNCT
ajlm-100	16	32	respectively	respectively	ADV
ajlm-100	16	33	.	.	PUNCT
ajlm-100	17	1	results	result	NOUN
ajlm-100	17	2	:	:	PUNCT
ajlm-100	17	3	the	the	DET
ajlm-100	17	4	first	first	ADJ
ajlm-100	17	5	-	-	PUNCT
ajlm-100	17	6	peak	peak	NOUN
ajlm-100	17	7	parasitaemia	parasitaemia	NOUN
ajlm-100	17	8	was	be	AUX
ajlm-100	17	9	observed	observe	VERB
ajlm-100	17	10	between	between	ADP
ajlm-100	17	11	seven	seven	NUM
ajlm-100	17	12	and	and	CCONJ
ajlm-100	17	13	nine	nine	NUM
ajlm-100	17	14	days	day	NOUN
ajlm-100	17	15	post	post	ADJ
ajlm-100	17	16	-	-	NOUN
ajlm-100	17	17	infection	infection	NOUN
ajlm-100	17	18	.	.	PUNCT
ajlm-100	18	1	clinical	clinical	ADJ
ajlm-100	18	2	signs	sign	NOUN
ajlm-100	18	3	associated	associate	VERB
ajlm-100	18	4	with	with	ADP
ajlm-100	18	5	the	the	DET
ajlm-100	18	6	disease	disease	NOUN
ajlm-100	18	7	included	include	VERB
ajlm-100	18	8	fever	fever	NOUN
ajlm-100	18	9	,	,	PUNCT
ajlm-100	18	10	dullness	dullness	NOUN
ajlm-100	18	11	,	,	PUNCT
ajlm-100	18	12	pallor	pallor	NOUN
ajlm-100	18	13	of	of	ADP
ajlm-100	18	14	mucous	mucous	ADJ
ajlm-100	18	15	membranes	membrane	NOUN
ajlm-100	18	16	,	,	PUNCT
ajlm-100	18	17	lymphadenopathy	lymphadenopathy	ADJ
ajlm-100	18	18	,	,	PUNCT
ajlm-100	18	19	splenomegaly	splenomegaly	ADJ
ajlm-100	18	20	and	and	CCONJ
ajlm-100	18	21	oedema	oedema	VERB
ajlm-100	18	22	.	.	PUNCT
ajlm-100	19	1	late	late	ADJ
ajlm-100	19	2	-	-	PUNCT
ajlm-100	19	3	stage	stage	NOUN
ajlm-100	19	4	signs	sign	NOUN
ajlm-100	19	5	included	include	VERB
ajlm-100	19	6	stiffness	stiffness	NOUN
ajlm-100	19	7	of	of	ADP
ajlm-100	19	8	joints	joint	NOUN
ajlm-100	19	9	and	and	CCONJ
ajlm-100	19	10	lethargy	lethargy	NOUN
ajlm-100	19	11	.	.	PUNCT
ajlm-100	20	1	the	the	DET
ajlm-100	20	2	monkeys	monkey	NOUN
ajlm-100	20	3	developed	develop	VERB
ajlm-100	20	4	a	a	DET
ajlm-100	20	5	disease	disease	NOUN
ajlm-100	20	6	associated	associate	VERB
ajlm-100	20	7	with	with	ADP
ajlm-100	20	8	microcytic	microcytic	ADJ
ajlm-100	20	9	hypochromic	hypochromic	ADJ
ajlm-100	20	10	anaemia	anaemia	NOUN
ajlm-100	20	11	.	.	PUNCT
ajlm-100	21	1	there	there	PRON
ajlm-100	21	2	was	be	VERB
ajlm-100	21	3	an	an	DET
ajlm-100	21	4	initial	initial	ADJ
ajlm-100	21	5	decline	decline	NOUN
ajlm-100	21	6	,	,	PUNCT
ajlm-100	21	7	followed	follow	VERB
ajlm-100	21	8	by	by	ADP
ajlm-100	21	9	an	an	DET
ajlm-100	21	10	increase	increase	NOUN
ajlm-100	21	11	,	,	PUNCT
ajlm-100	21	12	in	in	ADP
ajlm-100	21	13	total	total	ADJ
ajlm-100	21	14	white	white	ADJ
ajlm-100	21	15	blood	blood	NOUN
ajlm-100	21	16	cell	cell	NOUN
ajlm-100	21	17	counts	count	NOUN
ajlm-100	21	18	from	from	ADP
ajlm-100	21	19	earlyto	earlyto	ADJ
ajlm-100	21	20	late	late	ADJ
ajlm-100	21	21	-	-	PUNCT
ajlm-100	21	22	stage	stage	NOUN
ajlm-100	21	23	disease	disease	NOUN
ajlm-100	21	24	.	.	PUNCT
ajlm-100	22	1	trypanosomes	trypanosome	NOUN
ajlm-100	22	2	were	be	AUX
ajlm-100	22	3	detected	detect	VERB
ajlm-100	22	4	in	in	ADP
ajlm-100	22	5	the	the	DET
ajlm-100	22	6	csf	csf	NOUN
ajlm-100	22	7	and	and	CCONJ
ajlm-100	22	8	there	there	PRON
ajlm-100	22	9	was	be	VERB
ajlm-100	22	10	a	a	DET
ajlm-100	22	11	significant	significant	ADJ
ajlm-100	22	12	increase	increase	NOUN
ajlm-100	22	13	in	in	ADP
ajlm-100	22	14	white	white	ADJ
ajlm-100	22	15	cell	cell	NOUN
ajlm-100	22	16	counts	count	NOUN
ajlm-100	22	17	in	in	ADP
ajlm-100	22	18	the	the	DET
ajlm-100	22	19	csf	csf	NOUN
ajlm-100	22	20	during	during	ADP
ajlm-100	22	21	late	late	ADJ
ajlm-100	22	22	-	-	PUNCT
ajlm-100	22	23	stage	stage	NOUN
ajlm-100	22	24	disease	disease	NOUN
ajlm-100	22	25	.	.	PUNCT
ajlm-100	23	1	infected	infect	VERB
ajlm-100	23	2	vervet	vervet	NOUN
ajlm-100	23	3	monkeys	monkey	NOUN
ajlm-100	23	4	displayed	display	VERB
ajlm-100	23	5	classical	classical	ADJ
ajlm-100	23	6	clinical	clinical	ADJ
ajlm-100	23	7	symptoms	symptom	NOUN
ajlm-100	23	8	,	,	PUNCT
ajlm-100	23	9	parasitological	parasitological	ADJ
ajlm-100	23	10	and	and	CCONJ
ajlm-100	23	11	haematological	haematological	ADJ
ajlm-100	23	12	trends	trend	NOUN
ajlm-100	23	13	that	that	PRON
ajlm-100	23	14	were	be	AUX
ajlm-100	23	15	similar	similar	ADJ
ajlm-100	23	16	to	to	ADP
ajlm-100	23	17	monkeys	monkey	NOUN
ajlm-100	23	18	infected	infect	VERB
ajlm-100	23	19	with	with	ADP
ajlm-100	23	20	t.b	t.b	PROPN
ajlm-100	23	21	.	.	PROPN
ajlm-100	23	22	rhodesiense	rhodesiense	PROPN
ajlm-100	23	23	.	.	PUNCT
ajlm-100	24	1	conclusion	conclusion	NOUN
ajlm-100	24	2	:	:	PUNCT
ajlm-100	24	3	the	the	DET
ajlm-100	24	4	t.	t.	PROPN
ajlm-100	24	5	b.	b.	PROPN
ajlm-100	24	6	brucei	brucei	PROPN
ajlm-100	24	7	vervet	vervet	PROPN
ajlm-100	24	8	monkey	monkey	NOUN
ajlm-100	24	9	model	model	NOUN
ajlm-100	24	10	can	can	AUX
ajlm-100	24	11	be	be	AUX
ajlm-100	24	12	used	use	VERB
ajlm-100	24	13	for	for	ADP
ajlm-100	24	14	studying	study	VERB
ajlm-100	24	15	hat	hat	NOUN
ajlm-100	24	16	without	without	ADP
ajlm-100	24	17	putting	put	VERB
ajlm-100	24	18	laboratory	laboratory	NOUN
ajlm-100	24	19	technicians	technician	NOUN
ajlm-100	24	20	and	and	CCONJ
ajlm-100	24	21	researchers	researcher	NOUN
ajlm-100	24	22	at	at	ADP
ajlm-100	24	23	high	high	ADJ
ajlm-100	24	24	risk	risk	NOUN
ajlm-100	24	25	of	of	ADP
ajlm-100	24	26	accidental	accidental	ADJ
ajlm-100	24	27	infection	infection	NOUN
ajlm-100	24	28	.	.	PUNCT
ajlm-100	25	1	introduction	introduction	NOUN
ajlm-100	25	2	top	top	PROPN
ajlm-100	25	3	↑	↑	PROPN
ajlm-100	25	4	trypanosoma	trypanosoma	PROPN
ajlm-100	25	5	brucei	brucei	PROPN
ajlm-100	25	6	(	(	PUNCT
ajlm-100	25	7	t.	t.	PROPN
ajlm-100	25	8	brucei	brucei	PROPN
ajlm-100	25	9	)	)	PUNCT
ajlm-100	25	10	is	be	AUX
ajlm-100	25	11	a	a	DET
ajlm-100	25	12	protozoan	protozoan	NOUN
ajlm-100	25	13	parasite	parasite	NOUN
ajlm-100	25	14	,	,	PUNCT
ajlm-100	25	15	of	of	ADP
ajlm-100	25	16	which	which	PRON
ajlm-100	25	17	there	there	PRON
ajlm-100	25	18	are	be	VERB
ajlm-100	25	19	three	three	NUM
ajlm-100	25	20	subspecies	subspecie	NOUN
ajlm-100	25	21	:	:	PUNCT
ajlm-100	25	22	t.	t.	PROPN
ajlm-100	25	23	b.	b.	PROPN
ajlm-100	25	24	gambiense	gambiense	PROPN
ajlm-100	25	25	,	,	PUNCT
ajlm-100	25	26	t.	t.	PROPN
ajlm-100	25	27	b.	b.	PROPN
ajlm-100	25	28	rhodesiense	rhodesiense	PROPN
ajlm-100	25	29	and	and	CCONJ
ajlm-100	25	30	t.	t.	PROPN
ajlm-100	25	31	b.	b.	PROPN
ajlm-100	25	32	brucei	brucei	PROPN
ajlm-100	25	33	.	.	PUNCT
ajlm-100	26	1	the	the	DET
ajlm-100	26	2	first	first	ADJ
ajlm-100	26	3	two	two	NUM
ajlm-100	26	4	subspecies	subspecie	NOUN
ajlm-100	26	5	are	be	AUX
ajlm-100	26	6	infectious	infectious	ADJ
ajlm-100	26	7	to	to	ADP
ajlm-100	26	8	humans	human	NOUN
ajlm-100	26	9	,	,	PUNCT
ajlm-100	26	10	causing	cause	VERB
ajlm-100	26	11	human	human	ADJ
ajlm-100	26	12	african	african	ADJ
ajlm-100	26	13	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	26	14	(	(	PUNCT
ajlm-100	26	15	hat	hat	NOUN
ajlm-100	26	16	)	)	PUNCT
ajlm-100	26	17	(	(	PUNCT
ajlm-100	26	18	also	also	ADV
ajlm-100	26	19	known	know	VERB
ajlm-100	26	20	as	as	ADP
ajlm-100	26	21	sleeping	sleep	VERB
ajlm-100	26	22	sickness),1	sickness),1	X
ajlm-100	26	23	whilst	whilst	SCONJ
ajlm-100	26	24	t.	t.	PROPN
ajlm-100	26	25	b.	b.	PROPN
ajlm-100	26	26	brucei	brucei	PROPN
ajlm-100	26	27	only	only	ADV
ajlm-100	26	28	causes	cause	VERB
ajlm-100	26	29	disease	disease	NOUN
ajlm-100	26	30	in	in	ADP
ajlm-100	26	31	animals	animal	NOUN
ajlm-100	26	32	.	.	PUNCT
ajlm-100	27	1	the	the	DET
ajlm-100	27	2	disease	disease	NOUN
ajlm-100	27	3	has	have	VERB
ajlm-100	27	4	two	two	NUM
ajlm-100	27	5	recognised	recognise	VERB
ajlm-100	27	6	stages	stage	NOUN
ajlm-100	27	7	:	:	PUNCT
ajlm-100	27	8	the	the	DET
ajlm-100	27	9	early	early	ADJ
ajlm-100	27	10	(	(	PUNCT
ajlm-100	27	11	haemolymphatic	haemolymphatic	ADJ
ajlm-100	27	12	)	)	PUNCT
ajlm-100	27	13	stage	stage	NOUN
ajlm-100	27	14	when	when	SCONJ
ajlm-100	27	15	parasites	parasite	NOUN
ajlm-100	27	16	appear	appear	VERB
ajlm-100	27	17	in	in	ADP
ajlm-100	27	18	the	the	DET
ajlm-100	27	19	blood	blood	NOUN
ajlm-100	27	20	and	and	CCONJ
ajlm-100	27	21	the	the	DET
ajlm-100	27	22	late	late	ADJ
ajlm-100	27	23	(	(	PUNCT
ajlm-100	27	24	encephalitic	encephalitic	ADJ
ajlm-100	27	25	)	)	PUNCT
ajlm-100	27	26	stage	stage	NOUN
ajlm-100	27	27	when	when	SCONJ
ajlm-100	27	28	the	the	DET
ajlm-100	27	29	central	central	ADJ
ajlm-100	27	30	nervous	nervous	ADJ
ajlm-100	27	31	system	system	NOUN
ajlm-100	27	32	is	be	AUX
ajlm-100	27	33	involved.t	involved.t	PROPN
ajlm-100	27	34	.	.	PUNCT
ajlm-100	28	1	b.	b.	PROPN
ajlm-100	28	2	rhodesiense	rhodesiense	PROPN
ajlm-100	28	3	is	be	AUX
ajlm-100	28	4	found	find	VERB
ajlm-100	28	5	in	in	ADP
ajlm-100	28	6	eastern	eastern	ADJ
ajlm-100	28	7	and	and	CCONJ
ajlm-100	28	8	southern	southern	ADJ
ajlm-100	28	9	africa	africa	PROPN
ajlm-100	28	10	and	and	CCONJ
ajlm-100	28	11	causes	cause	VERB
ajlm-100	28	12	an	an	DET
ajlm-100	28	13	acute	acute	ADJ
ajlm-100	28	14	infection	infection	NOUN
ajlm-100	28	15	.	.	PUNCT
ajlm-100	29	1	the	the	DET
ajlm-100	29	2	first	first	ADJ
ajlm-100	29	3	clinical	clinical	ADJ
ajlm-100	29	4	symptoms	symptom	NOUN
ajlm-100	29	5	are	be	AUX
ajlm-100	29	6	observed	observe	VERB
ajlm-100	29	7	a	a	DET
ajlm-100	29	8	few	few	ADJ
ajlm-100	29	9	weeks	week	NOUN
ajlm-100	29	10	or	or	CCONJ
ajlm-100	29	11	months	month	NOUN
ajlm-100	29	12	after	after	ADP
ajlm-100	29	13	initial	initial	ADJ
ajlm-100	29	14	infection	infection	NOUN
ajlm-100	29	15	–	–	PUNCT
ajlm-100	29	16	a	a	DET
ajlm-100	29	17	result	result	NOUN
ajlm-100	29	18	of	of	ADP
ajlm-100	29	19	the	the	DET
ajlm-100	29	20	parasite	parasite	NOUN
ajlm-100	29	21	invading	invade	VERB
ajlm-100	29	22	the	the	DET
ajlm-100	29	23	central	central	ADJ
ajlm-100	29	24	nervous	nervous	ADJ
ajlm-100	29	25	system	system	NOUN
ajlm-100	29	26	(	(	PUNCT
ajlm-100	29	27	cns	cns	NOUN
ajlm-100	29	28	)	)	PUNCT
ajlm-100	29	29	.	.	PUNCT
ajlm-100	30	1	t.	t.	PROPN
ajlm-100	30	2	b.	b.	PROPN
ajlm-100	30	3	gambiense	gambiense	PROPN
ajlm-100	30	4	is	be	AUX
ajlm-100	30	5	found	find	VERB
ajlm-100	30	6	in	in	ADP
ajlm-100	30	7	west	west	NOUN
ajlm-100	30	8	and	and	CCONJ
ajlm-100	30	9	central	central	PROPN
ajlm-100	30	10	africa	africa	PROPN
ajlm-100	30	11	and	and	CCONJ
ajlm-100	30	12	causes	cause	VERB
ajlm-100	30	13	a	a	DET
ajlm-100	30	14	chronic	chronic	ADJ
ajlm-100	30	15	infection	infection	NOUN
ajlm-100	30	16	.	.	PUNCT
ajlm-100	31	1	the	the	DET
ajlm-100	31	2	parasite	parasite	NOUN
ajlm-100	31	3	can	can	AUX
ajlm-100	31	4	be	be	AUX
ajlm-100	31	5	present	present	ADJ
ajlm-100	31	6	in	in	ADP
ajlm-100	31	7	the	the	DET
ajlm-100	31	8	body	body	NOUN
ajlm-100	31	9	for	for	ADP
ajlm-100	31	10	months	month	NOUN
ajlm-100	31	11	or	or	CCONJ
ajlm-100	31	12	even	even	ADJ
ajlm-100	31	13	years	year	NOUN
ajlm-100	31	14	without	without	ADP
ajlm-100	31	15	causing	cause	VERB
ajlm-100	31	16	severe	severe	ADJ
ajlm-100	31	17	symptoms	symptom	NOUN
ajlm-100	31	18	.	.	PUNCT
ajlm-100	32	1	for	for	ADP
ajlm-100	32	2	the	the	DET
ajlm-100	32	3	majority	majority	NOUN
ajlm-100	32	4	of	of	ADP
ajlm-100	32	5	patients	patient	NOUN
ajlm-100	32	6	infected	infect	VERB
ajlm-100	32	7	with	with	ADP
ajlm-100	32	8	t.	t.	PROPN
ajlm-100	32	9	b.	b.	PROPN
ajlm-100	32	10	gambiense	gambiense	PROPN
ajlm-100	32	11	,	,	PUNCT
ajlm-100	32	12	the	the	DET
ajlm-100	32	13	disease	disease	NOUN
ajlm-100	32	14	is	be	AUX
ajlm-100	32	15	already	already	ADV
ajlm-100	32	16	in	in	ADP
ajlm-100	32	17	an	an	DET
ajlm-100	32	18	advanced	advanced	ADJ
ajlm-100	32	19	stage	stage	NOUN
ajlm-100	32	20	by	by	ADP
ajlm-100	32	21	the	the	DET
ajlm-100	32	22	time	time	NOUN
ajlm-100	32	23	symptoms	symptom	NOUN
ajlm-100	32	24	emerge	emerge	VERB
ajlm-100	32	25	,	,	PUNCT
ajlm-100	32	26	with	with	ADP
ajlm-100	32	27	parasites	parasite	NOUN
ajlm-100	32	28	having	having	AUX
ajlm-100	32	29	affected	affect	VERB
ajlm-100	32	30	the	the	DET
ajlm-100	32	31	cns.1	cns.1	NOUN
ajlm-100	32	32	hat	hat	NOUN
ajlm-100	32	33	remains	remain	VERB
ajlm-100	32	34	a	a	DET
ajlm-100	32	35	neglected	neglect	VERB
ajlm-100	32	36	disease	disease	NOUN
ajlm-100	32	37	of	of	ADP
ajlm-100	32	38	major	major	ADJ
ajlm-100	32	39	health	health	NOUN
ajlm-100	32	40	and	and	CCONJ
ajlm-100	32	41	socioeconomic	socioeconomic	ADJ
ajlm-100	32	42	consequence	consequence	NOUN
ajlm-100	32	43	in	in	ADP
ajlm-100	32	44	sub	sub	ADJ
ajlm-100	32	45	-	-	ADJ
ajlm-100	32	46	saharan	saharan	ADJ
ajlm-100	32	47	africa,1	africa,1	NOUN
ajlm-100	32	48	with	with	ADP
ajlm-100	32	49	an	an	DET
ajlm-100	32	50	estimated	estimate	VERB
ajlm-100	32	51	60	60	NUM
ajlm-100	32	52	million	million	NUM
ajlm-100	32	53	people	people	NOUN
ajlm-100	32	54	in	in	ADP
ajlm-100	32	55	36	36	NUM
ajlm-100	32	56	countries	country	NOUN
ajlm-100	32	57	at	at	ADP
ajlm-100	32	58	risk.2	risk.2	PROPN
ajlm-100	32	59	the	the	DET
ajlm-100	32	60	management	management	NOUN
ajlm-100	32	61	of	of	ADP
ajlm-100	32	62	the	the	DET
ajlm-100	32	63	disease	disease	NOUN
ajlm-100	32	64	remains	remain	VERB
ajlm-100	32	65	a	a	DET
ajlm-100	32	66	major	major	ADJ
ajlm-100	32	67	challenge	challenge	NOUN
ajlm-100	32	68	due	due	ADP
ajlm-100	32	69	to	to	ADP
ajlm-100	32	70	poor	poor	ADJ
ajlm-100	32	71	diagnostics	diagnostic	NOUN
ajlm-100	32	72	and	and	CCONJ
ajlm-100	32	73	treatment	treatment	NOUN
ajlm-100	32	74	regimens	regimen	NOUN
ajlm-100	32	75	,	,	PUNCT
ajlm-100	32	76	most	most	ADJ
ajlm-100	32	77	of	of	ADP
ajlm-100	32	78	which	which	PRON
ajlm-100	32	79	have	have	AUX
ajlm-100	32	80	been	be	AUX
ajlm-100	32	81	used	use	VERB
ajlm-100	32	82	for	for	ADP
ajlm-100	32	83	decades	decade	NOUN
ajlm-100	32	84	.	.	PUNCT
ajlm-100	33	1	research	research	NOUN
ajlm-100	33	2	and	and	CCONJ
ajlm-100	33	3	development	development	NOUN
ajlm-100	33	4	of	of	ADP
ajlm-100	33	5	diagnostics	diagnostic	NOUN
ajlm-100	33	6	and	and	CCONJ
ajlm-100	33	7	new	new	ADJ
ajlm-100	33	8	drugs	drug	NOUN
ajlm-100	33	9	normally	normally	ADV
ajlm-100	33	10	rely	rely	VERB
ajlm-100	33	11	upon	upon	SCONJ
ajlm-100	33	12	the	the	DET
ajlm-100	33	13	use	use	NOUN
ajlm-100	33	14	of	of	ADP
ajlm-100	33	15	laboratory	laboratory	NOUN
ajlm-100	33	16	animal	animal	NOUN
ajlm-100	33	17	models	model	NOUN
ajlm-100	33	18	,	,	PUNCT
ajlm-100	33	19	principally	principally	ADV
ajlm-100	33	20	mice	mouse	NOUN
ajlm-100	33	21	and	and	CCONJ
ajlm-100	33	22	monkeys	monkey	NOUN
ajlm-100	33	23	,	,	PUNCT
ajlm-100	33	24	which	which	PRON
ajlm-100	33	25	mimic	mimic	VERB
ajlm-100	33	26	human	human	ADJ
ajlm-100	33	27	disease	disease	NOUN
ajlm-100	33	28	.	.	PUNCT
ajlm-100	34	1	six	six	NUM
ajlm-100	34	2	accidental	accidental	ADJ
ajlm-100	34	3	,	,	PUNCT
ajlm-100	34	4	laboratory	laboratory	NOUN
ajlm-100	34	5	-	-	PUNCT
ajlm-100	34	6	acquired	acquire	VERB
ajlm-100	34	7	cases	case	NOUN
ajlm-100	34	8	of	of	ADP
ajlm-100	34	9	t.	t.	PROPN
ajlm-100	34	10	b.	b.	PROPN
ajlm-100	34	11	rhodesiense	rhodesiense	PROPN
ajlm-100	34	12	have	have	AUX
ajlm-100	34	13	been	be	AUX
ajlm-100	34	14	reported.3,4,5	reported.3,4,5	NOUN
ajlm-100	34	15	rather	rather	ADV
ajlm-100	34	16	than	than	ADP
ajlm-100	34	17	identifying	identify	VERB
ajlm-100	34	18	an	an	DET
ajlm-100	34	19	animal	animal	NOUN
ajlm-100	34	20	model	model	NOUN
ajlm-100	34	21	of	of	ADP
ajlm-100	34	22	a	a	DET
ajlm-100	34	23	dangerous	dangerous	ADJ
ajlm-100	34	24	human	human	ADJ
ajlm-100	34	25	pathogen	pathogen	NOUN
ajlm-100	34	26	,	,	PUNCT
ajlm-100	34	27	a	a	DET
ajlm-100	34	28	safer	safe	ADJ
ajlm-100	34	29	option	option	NOUN
ajlm-100	34	30	would	would	AUX
ajlm-100	34	31	be	be	AUX
ajlm-100	34	32	to	to	PART
ajlm-100	34	33	identify	identify	VERB
ajlm-100	34	34	a	a	DET
ajlm-100	34	35	non	non	ADJ
ajlm-100	34	36	-	-	ADJ
ajlm-100	34	37	human	human	ADJ
ajlm-100	34	38	pathogen	pathogen	NOUN
ajlm-100	34	39	that	that	PRON
ajlm-100	34	40	mimics	mimic	VERB
ajlm-100	34	41	hat	hat	NOUN
ajlm-100	34	42	.	.	PUNCT
ajlm-100	35	1	unlike	unlike	ADP
ajlm-100	35	2	t.	t.	PROPN
ajlm-100	35	3	b.	b.	PROPN
ajlm-100	35	4	rhodesiense	rhodesiense	PROPN
ajlm-100	35	5	,	,	PUNCT
ajlm-100	35	6	t.	t.	PROPN
ajlm-100	35	7	b.	b.	PROPN
ajlm-100	35	8	brucei	brucei	PROPN
ajlm-100	35	9	is	be	AUX
ajlm-100	35	10	unable	unable	ADJ
ajlm-100	35	11	to	to	PART
ajlm-100	35	12	infect	infect	VERB
ajlm-100	35	13	humans	human	NOUN
ajlm-100	35	14	,	,	PUNCT
ajlm-100	35	15	but	but	CCONJ
ajlm-100	35	16	mimics	mimic	VERB
ajlm-100	35	17	the	the	DET
ajlm-100	35	18	pathogenesis	pathogenesis	NOUN
ajlm-100	35	19	of	of	ADP
ajlm-100	35	20	human	human	ADJ
ajlm-100	35	21	-	-	PUNCT
ajlm-100	35	22	infective	infective	ADJ
ajlm-100	35	23	t.	t.	PROPN
ajlm-100	35	24	b.	b.	PROPN
ajlm-100	35	25	rhodesiense	rhodesiense	PROPN
ajlm-100	35	26	in	in	ADP
ajlm-100	35	27	infected	infected	ADJ
ajlm-100	35	28	animals.6	animals.6	PROPN
ajlm-100	35	29	thus	thus	ADV
ajlm-100	35	30	,	,	PUNCT
ajlm-100	35	31	an	an	DET
ajlm-100	35	32	animal	animal	NOUN
ajlm-100	35	33	model	model	NOUN
ajlm-100	35	34	of	of	ADP
ajlm-100	35	35	t.	t.	PROPN
ajlm-100	35	36	b.	b.	PROPN
ajlm-100	35	37	brucei	brucei	PROPN
ajlm-100	35	38	that	that	PRON
ajlm-100	35	39	mimics	mimic	VERB
ajlm-100	35	40	hat	hat	NOUN
ajlm-100	35	41	would	would	AUX
ajlm-100	35	42	enable	enable	VERB
ajlm-100	35	43	researchers	researcher	NOUN
ajlm-100	35	44	to	to	PART
ajlm-100	35	45	study	study	VERB
ajlm-100	35	46	the	the	DET
ajlm-100	35	47	disease	disease	NOUN
ajlm-100	35	48	without	without	ADP
ajlm-100	35	49	subjecting	subject	VERB
ajlm-100	35	50	themselves	themselves	PRON
ajlm-100	35	51	to	to	ADP
ajlm-100	35	52	undue	undue	ADJ
ajlm-100	35	53	risks	risk	NOUN
ajlm-100	35	54	.	.	PUNCT
ajlm-100	36	1	given	give	VERB
ajlm-100	36	2	that	that	SCONJ
ajlm-100	36	3	the	the	DET
ajlm-100	36	4	vervet	vervet	PROPN
ajlm-100	36	5	monkey	monkey	NOUN
ajlm-100	36	6	disease	disease	NOUN
ajlm-100	36	7	model	model	NOUN
ajlm-100	36	8	of	of	ADP
ajlm-100	36	9	t.	t.	PROPN
ajlm-100	36	10	b.	b.	PROPN
ajlm-100	36	11	rhodesiense	rhodesiense	PROPN
ajlm-100	36	12	bears	bear	VERB
ajlm-100	36	13	a	a	DET
ajlm-100	36	14	close	close	ADJ
ajlm-100	36	15	relationship	relationship	NOUN
ajlm-100	36	16	to	to	PART
ajlm-100	36	17	hat,7	hat,7	VERB
ajlm-100	36	18	the	the	DET
ajlm-100	36	19	authors	author	NOUN
ajlm-100	36	20	hypothesised	hypothesise	VERB
ajlm-100	36	21	that	that	DET
ajlm-100	36	22	infection	infection	NOUN
ajlm-100	36	23	with	with	ADP
ajlm-100	36	24	t.	t.	PROPN
ajlm-100	36	25	b.	b.	PROPN
ajlm-100	36	26	brucei	brucei	PROPN
ajlm-100	36	27	could	could	AUX
ajlm-100	36	28	provide	provide	VERB
ajlm-100	36	29	similar	similar	ADJ
ajlm-100	36	30	disease	disease	NOUN
ajlm-100	36	31	progression	progression	NOUN
ajlm-100	36	32	.	.	PUNCT
ajlm-100	37	1	these	these	DET
ajlm-100	37	2	monkeys	monkey	NOUN
ajlm-100	37	3	may	may	AUX
ajlm-100	37	4	provide	provide	VERB
ajlm-100	37	5	an	an	DET
ajlm-100	37	6	excellent	excellent	ADJ
ajlm-100	37	7	opportunity	opportunity	NOUN
ajlm-100	37	8	to	to	PART
ajlm-100	37	9	investigate	investigate	VERB
ajlm-100	37	10	controlled	control	VERB
ajlm-100	37	11	laboratory	laboratory	NOUN
ajlm-100	37	12	studies	study	NOUN
ajlm-100	37	13	on	on	ADP
ajlm-100	37	14	serum	serum	NOUN
ajlm-100	37	15	and	and	CCONJ
ajlm-100	37	16	cerebrospinal	cerebrospinal	ADJ
ajlm-100	37	17	fluid	fluid	NOUN
ajlm-100	37	18	(	(	PUNCT
ajlm-100	37	19	csf	csf	NOUN
ajlm-100	37	20	)	)	PUNCT
ajlm-100	37	21	samples	sample	NOUN
ajlm-100	37	22	,	,	PUNCT
ajlm-100	37	23	which	which	PRON
ajlm-100	37	24	would	would	AUX
ajlm-100	37	25	also	also	ADV
ajlm-100	37	26	allow	allow	VERB
ajlm-100	37	27	for	for	ADP
ajlm-100	37	28	identification	identification	NOUN
ajlm-100	37	29	of	of	ADP
ajlm-100	37	30	potential	potential	ADJ
ajlm-100	37	31	biomarkers	biomarker	NOUN
ajlm-100	37	32	of	of	ADP
ajlm-100	37	33	the	the	DET
ajlm-100	37	34	disease	disease	NOUN
ajlm-100	37	35	stages	stage	VERB
ajlm-100	37	36	.	.	PUNCT
ajlm-100	38	1	this	this	DET
ajlm-100	38	2	study	study	NOUN
ajlm-100	38	3	was	be	AUX
ajlm-100	38	4	designed	design	VERB
ajlm-100	38	5	to	to	PART
ajlm-100	38	6	determine	determine	VERB
ajlm-100	38	7	the	the	DET
ajlm-100	38	8	clinical	clinical	ADJ
ajlm-100	38	9	,	,	PUNCT
ajlm-100	38	10	parasitological	parasitological	ADJ
ajlm-100	38	11	and	and	CCONJ
ajlm-100	38	12	haematological	haematological	ADJ
ajlm-100	38	13	profile	profile	NOUN
ajlm-100	38	14	of	of	ADP
ajlm-100	38	15	vervet	vervet	NOUN
ajlm-100	38	16	monkeys	monkey	NOUN
ajlm-100	38	17	infected	infect	VERB
ajlm-100	38	18	with	with	ADP
ajlm-100	38	19	t.	t.	PROPN
ajlm-100	38	20	b.	b.	PROPN
ajlm-100	38	21	brucei	brucei	PROPN
ajlm-100	38	22	and	and	CCONJ
ajlm-100	38	23	to	to	PART
ajlm-100	38	24	determine	determine	VERB
ajlm-100	38	25	whether	whether	SCONJ
ajlm-100	38	26	a	a	DET
ajlm-100	38	27	t.	t.	PROPN
ajlm-100	38	28	b.	b.	PROPN
ajlm-100	38	29	brucei	brucei	PROPN
ajlm-100	38	30	model	model	NOUN
ajlm-100	38	31	would	would	AUX
ajlm-100	38	32	be	be	AUX
ajlm-100	38	33	a	a	DET
ajlm-100	38	34	suitable	suitable	ADJ
ajlm-100	38	35	and	and	CCONJ
ajlm-100	38	36	safer	safe	ADJ
ajlm-100	38	37	alternative	alternative	NOUN
ajlm-100	38	38	to	to	ADP
ajlm-100	38	39	the	the	DET
ajlm-100	38	40	vervet	vervet	NOUN
ajlm-100	38	41	monkey	monkey	NOUN
ajlm-100	38	42	model	model	NOUN
ajlm-100	38	43	of	of	ADP
ajlm-100	38	44	t.	t.	PROPN
ajlm-100	38	45	b.	b.	PROPN
ajlm-100	38	46	rhodesiense	rhodesiense	PROPN
ajlm-100	38	47	.	.	PUNCT
ajlm-100	39	1	research	research	NOUN
ajlm-100	39	2	methods	method	NOUN
ajlm-100	39	3	and	and	CCONJ
ajlm-100	39	4	design	design	VERB
ajlm-100	39	5	top	top	ADJ
ajlm-100	39	6	↑	↑	PROPN
ajlm-100	39	7	trypanosomes	trypanosome	VERB
ajlm-100	39	8	the	the	DET
ajlm-100	39	9	t.	t.	PROPN
ajlm-100	39	10	b.	b.	PROPN
ajlm-100	39	11	brucei	brucei	PROPN
ajlm-100	39	12	gutat	gutat	PROPN
ajlm-100	39	13	1	1	NUM
ajlm-100	39	14	isolate	isolate	NOUN
ajlm-100	39	15	was	be	AUX
ajlm-100	39	16	used	use	VERB
ajlm-100	39	17	.	.	PUNCT
ajlm-100	40	1	the	the	DET
ajlm-100	40	2	isolate	isolate	NOUN
ajlm-100	40	3	was	be	AUX
ajlm-100	40	4	obtained	obtain	VERB
ajlm-100	40	5	from	from	ADP
ajlm-100	40	6	the	the	DET
ajlm-100	40	7	international	international	ADJ
ajlm-100	40	8	livestock	livestock	PROPN
ajlm-100	40	9	research	research	PROPN
ajlm-100	40	10	institute	institute	PROPN
ajlm-100	40	11	biobank	biobank	PROPN
ajlm-100	40	12	,	,	PUNCT
ajlm-100	40	13	passaged	passage	VERB
ajlm-100	40	14	three	three	NUM
ajlm-100	40	15	times	time	NOUN
ajlm-100	40	16	in	in	ADP
ajlm-100	40	17	mice	mouse	NOUN
ajlm-100	40	18	and	and	CCONJ
ajlm-100	40	19	preserved	preserve	VERB
ajlm-100	40	20	at	at	ADP
ajlm-100	40	21	the	the	DET
ajlm-100	40	22	institute	institute	PROPN
ajlm-100	40	23	of	of	ADP
ajlm-100	40	24	primate	primate	PROPN
ajlm-100	40	25	research	research	NOUN
ajlm-100	40	26	’s	’s	PART
ajlm-100	40	27	trypanosomes	trypanosome	NOUN
ajlm-100	40	28	cryobank	cryobank	ADV
ajlm-100	40	29	.	.	PUNCT
ajlm-100	41	1	the	the	DET
ajlm-100	41	2	cryopreserved	cryopreserve	VERB
ajlm-100	41	3	isolate	isolate	NOUN
ajlm-100	41	4	was	be	AUX
ajlm-100	41	5	thawed	thaw	VERB
ajlm-100	41	6	and	and	CCONJ
ajlm-100	41	7	injected	inject	VERB
ajlm-100	41	8	into	into	ADP
ajlm-100	41	9	donor	donor	NOUN
ajlm-100	41	10	swiss	swiss	ADJ
ajlm-100	41	11	white	white	ADJ
ajlm-100	41	12	mice	mouse	NOUN
ajlm-100	41	13	for	for	ADP
ajlm-100	41	14	expansion	expansion	NOUN
ajlm-100	41	15	.	.	PUNCT
ajlm-100	42	1	at	at	ADP
ajlm-100	42	2	peak	peak	PROPN
ajlm-100	42	3	parasitaemia	parasitaemia	NOUN
ajlm-100	42	4	,	,	PUNCT
ajlm-100	42	5	the	the	DET
ajlm-100	42	6	mice	mouse	NOUN
ajlm-100	42	7	were	be	AUX
ajlm-100	42	8	euthanased	euthanase	VERB
ajlm-100	42	9	with	with	ADP
ajlm-100	42	10	co2	co2	NOUN
ajlm-100	42	11	and	and	CCONJ
ajlm-100	42	12	their	their	PRON
ajlm-100	42	13	blood	blood	NOUN
ajlm-100	42	14	was	be	AUX
ajlm-100	42	15	harvested	harvest	VERB
ajlm-100	42	16	by	by	ADP
ajlm-100	42	17	cardiac	cardiac	ADJ
ajlm-100	42	18	puncture	puncture	NOUN
ajlm-100	42	19	.	.	PUNCT
ajlm-100	43	1	the	the	DET
ajlm-100	43	2	blood	blood	NOUN
ajlm-100	43	3	was	be	AUX
ajlm-100	43	4	serially	serially	ADV
ajlm-100	43	5	diluted	dilute	VERB
ajlm-100	43	6	in	in	ADP
ajlm-100	43	7	phosphate	phosphate	ADJ
ajlm-100	43	8	saline	saline	NOUN
ajlm-100	43	9	glucose	glucose	NOUN
ajlm-100	43	10	to	to	ADP
ajlm-100	43	11	a	a	DET
ajlm-100	43	12	final	final	ADJ
ajlm-100	43	13	concentration	concentration	NOUN
ajlm-100	43	14	of	of	ADP
ajlm-100	43	15	104	104	NUM
ajlm-100	43	16	trypanosomes	trypanosome	NOUN
ajlm-100	43	17	/	/	SYM
ajlm-100	43	18	ml	ml	NOUN
ajlm-100	43	19	.	.	PUNCT
ajlm-100	44	1	drugs	drug	NOUN
ajlm-100	44	2	the	the	DET
ajlm-100	44	3	trypanocidal	trypanocidal	ADJ
ajlm-100	44	4	drugs	drug	NOUN
ajlm-100	44	5	used	use	VERB
ajlm-100	44	6	in	in	ADP
ajlm-100	44	7	this	this	DET
ajlm-100	44	8	study	study	NOUN
ajlm-100	44	9	were	be	AUX
ajlm-100	44	10	diminazene	diminazene	NOUN
ajlm-100	44	11	aceturate	aceturate	NOUN
ajlm-100	44	12	(	(	PUNCT
ajlm-100	44	13	pharma	pharma	PROPN
ajlm-100	44	14	links	link	NOUN
ajlm-100	44	15	,	,	PUNCT
ajlm-100	44	16	india	india	PROPN
ajlm-100	44	17	)	)	PUNCT
ajlm-100	44	18	and	and	CCONJ
ajlm-100	44	19	melarsoprol	melarsoprol	PROPN
ajlm-100	44	20	(	(	PUNCT
ajlm-100	44	21	arsobal	arsobal	PROPN
ajlm-100	44	22	®	®	PROPN
ajlm-100	44	23	,	,	PUNCT
ajlm-100	44	24	specia	specia	NOUN
ajlm-100	44	25	,	,	PUNCT
ajlm-100	44	26	france).diminazene	france).diminazene	NOUN
ajlm-100	44	27	aceturate	aceturate	NOUN
ajlm-100	44	28	is	be	AUX
ajlm-100	44	29	an	an	DET
ajlm-100	44	30	aromatic	aromatic	ADJ
ajlm-100	44	31	diamidine	diamidine	NOUN
ajlm-100	44	32	used	use	VERB
ajlm-100	44	33	as	as	ADP
ajlm-100	44	34	treatment	treatment	NOUN
ajlm-100	44	35	for	for	ADP
ajlm-100	44	36	livestock	livestock	NOUN
ajlm-100	44	37	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	44	38	and	and	CCONJ
ajlm-100	44	39	is	be	AUX
ajlm-100	44	40	also	also	ADV
ajlm-100	44	41	effective	effective	ADJ
ajlm-100	44	42	against	against	ADP
ajlm-100	44	43	early	early	ADJ
ajlm-100	44	44	-	-	PUNCT
ajlm-100	44	45	stage	stage	NOUN
ajlm-100	44	46	t.	t.	PROPN
ajlm-100	44	47	b.	b.	PROPN
ajlm-100	44	48	gambiense	gambiense	PROPN
ajlm-100	44	49	and	and	CCONJ
ajlm-100	44	50	t.	t.	PROPN
ajlm-100	44	51	b.	b.	PROPN
ajlm-100	44	52	rhodesiense	rhodesiense	PROPN
ajlm-100	44	53	infection.7	infection.7	PROPN
ajlm-100	44	54	in	in	ADP
ajlm-100	44	55	monkey	monkey	NOUN
ajlm-100	44	56	models	model	NOUN
ajlm-100	44	57	of	of	ADP
ajlm-100	44	58	hat	hat	NOUN
ajlm-100	44	59	,	,	PUNCT
ajlm-100	44	60	the	the	DET
ajlm-100	44	61	drug	drug	NOUN
ajlm-100	44	62	clears	clear	VERB
ajlm-100	44	63	bloodstream	bloodstream	NOUN
ajlm-100	44	64	parasites	parasite	NOUN
ajlm-100	44	65	but	but	CCONJ
ajlm-100	44	66	is	be	AUX
ajlm-100	44	67	unable	unable	ADJ
ajlm-100	44	68	to	to	PART
ajlm-100	44	69	clear	clear	VERB
ajlm-100	44	70	parasites	parasite	NOUN
ajlm-100	44	71	in	in	ADP
ajlm-100	44	72	the	the	DET
ajlm-100	44	73	cns	cns	NOUN
ajlm-100	44	74	since	since	SCONJ
ajlm-100	44	75	it	it	PRON
ajlm-100	44	76	does	do	AUX
ajlm-100	44	77	not	not	PART
ajlm-100	44	78	cross	cross	VERB
ajlm-100	44	79	the	the	DET
ajlm-100	44	80	blood	blood	NOUN
ajlm-100	44	81	-	-	PUNCT
ajlm-100	44	82	brain	brain	NOUN
ajlm-100	44	83	barrier	barrier	NOUN
ajlm-100	44	84	.	.	PUNCT
ajlm-100	45	1	its	its	PRON
ajlm-100	45	2	mode	mode	NOUN
ajlm-100	45	3	of	of	ADP
ajlm-100	45	4	action	action	NOUN
ajlm-100	45	5	involves	involve	VERB
ajlm-100	45	6	interference	interference	NOUN
ajlm-100	45	7	with	with	ADP
ajlm-100	45	8	rna	rna	NOUN
ajlm-100	45	9	editing	editing	NOUN
ajlm-100	45	10	and	and	CCONJ
ajlm-100	45	11	trans	tran	NOUN
ajlm-100	45	12	-	-	ADJ
ajlm-100	45	13	splicing	splice	VERB
ajlm-100	46	1	and	and	CCONJ
ajlm-100	46	2	it	it	PRON
ajlm-100	46	3	inhibits	inhibit	VERB
ajlm-100	46	4	adomet	adomet	NOUN
ajlm-100	46	5	decarboxylase	decarboxylase	PROPN
ajlm-100	46	6	in	in	ADP
ajlm-100	46	7	trypanosomes	trypanosome	NOUN
ajlm-100	46	8	,	,	PUNCT
ajlm-100	46	9	resulting	result	VERB
ajlm-100	46	10	in	in	ADP
ajlm-100	46	11	the	the	DET
ajlm-100	46	12	reduction	reduction	NOUN
ajlm-100	46	13	of	of	ADP
ajlm-100	46	14	spermidine	spermidine	NOUN
ajlm-100	46	15	content	content	NOUN
ajlm-100	46	16	and	and	CCONJ
ajlm-100	46	17	the	the	DET
ajlm-100	46	18	elevation	elevation	NOUN
ajlm-100	46	19	of	of	ADP
ajlm-100	46	20	putrescine	putrescine	NOUN
ajlm-100	46	21	levels	level	NOUN
ajlm-100	46	22	in	in	ADP
ajlm-100	46	23	the	the	DET
ajlm-100	46	24	parasite	parasite	NOUN
ajlm-100	46	25	.	.	PUNCT
ajlm-100	47	1	melarsoprol	melarsoprol	PROPN
ajlm-100	47	2	is	be	AUX
ajlm-100	47	3	a	a	DET
ajlm-100	47	4	trivalent	trivalent	NOUN
ajlm-100	47	5	arsenical	arsenical	ADJ
ajlm-100	47	6	compound	compound	NOUN
ajlm-100	47	7	used	use	VERB
ajlm-100	47	8	for	for	ADP
ajlm-100	47	9	the	the	DET
ajlm-100	47	10	treatment	treatment	NOUN
ajlm-100	47	11	of	of	ADP
ajlm-100	47	12	late	late	ADJ
ajlm-100	47	13	-	-	PUNCT
ajlm-100	47	14	stage	stage	NOUN
ajlm-100	47	15	sleeping	sleep	VERB
ajlm-100	47	16	sickness	sickness	NOUN
ajlm-100	47	17	.	.	PUNCT
ajlm-100	48	1	the	the	DET
ajlm-100	48	2	mode	mode	NOUN
ajlm-100	48	3	of	of	ADP
ajlm-100	48	4	action	action	NOUN
ajlm-100	48	5	involves	involve	VERB
ajlm-100	48	6	inhibition	inhibition	NOUN
ajlm-100	48	7	of	of	ADP
ajlm-100	48	8	trypanothione	trypanothione	ADJ
ajlm-100	48	9	reductase	reductase	NOUN
ajlm-100	48	10	in	in	ADP
ajlm-100	48	11	trypanosomes	trypanosome	NOUN
ajlm-100	48	12	.	.	PUNCT
ajlm-100	49	1	melarsoprol	melarsoprol	PROPN
ajlm-100	49	2	can	can	AUX
ajlm-100	49	3	cross	cross	VERB
ajlm-100	49	4	the	the	DET
ajlm-100	49	5	blood	blood	NOUN
ajlm-100	49	6	-	-	PUNCT
ajlm-100	49	7	brain	brain	NOUN
ajlm-100	49	8	barrier	barrier	NOUN
ajlm-100	49	9	and	and	CCONJ
ajlm-100	49	10	can	can	AUX
ajlm-100	49	11	thus	thus	ADV
ajlm-100	49	12	clear	clear	VERB
ajlm-100	49	13	trypanosomes	trypanosome	NOUN
ajlm-100	49	14	that	that	PRON
ajlm-100	49	15	have	have	AUX
ajlm-100	49	16	crossed	cross	VERB
ajlm-100	49	17	into	into	ADP
ajlm-100	49	18	the	the	DET
ajlm-100	49	19	brain	brain	NOUN
ajlm-100	49	20	parenchyma	parenchyma	NOUN
ajlm-100	49	21	.	.	PUNCT
ajlm-100	50	1	in	in	ADP
ajlm-100	50	2	hat	hat	NOUN
ajlm-100	50	3	monkey	monkey	NOUN
ajlm-100	50	4	models	model	NOUN
ajlm-100	50	5	,	,	PUNCT
ajlm-100	50	6	melarsoprol	melarsoprol	NOUN
ajlm-100	50	7	is	be	AUX
ajlm-100	50	8	used	use	VERB
ajlm-100	50	9	for	for	ADP
ajlm-100	50	10	curative	curative	ADJ
ajlm-100	50	11	treatment	treatment	NOUN
ajlm-100	50	12	in	in	ADP
ajlm-100	50	13	late	late	ADJ
ajlm-100	50	14	-	-	PUNCT
ajlm-100	50	15	stage	stage	NOUN
ajlm-100	50	16	disease.8	disease.8	NOUN
ajlm-100	50	17	experimental	experimental	ADJ
ajlm-100	50	18	animals	animal	NOUN
ajlm-100	50	19	five	five	NUM
ajlm-100	50	20	wild	wild	ADV
ajlm-100	50	21	-	-	PUNCT
ajlm-100	50	22	caught	catch	VERB
ajlm-100	50	23	vervet	vervet	NOUN
ajlm-100	50	24	monkeys	monkey	NOUN
ajlm-100	50	25	,	,	PUNCT
ajlm-100	50	26	each	each	PRON
ajlm-100	50	27	weighing	weigh	VERB
ajlm-100	50	28	2–4	2–4	PROPN
ajlm-100	50	29	kg	kg	NOUN
ajlm-100	50	30	,	,	PUNCT
ajlm-100	50	31	were	be	AUX
ajlm-100	50	32	obtained	obtain	VERB
ajlm-100	50	33	from	from	ADP
ajlm-100	50	34	the	the	DET
ajlm-100	50	35	animal	animal	NOUN
ajlm-100	50	36	unit	unit	NOUN
ajlm-100	50	37	colony	colony	NOUN
ajlm-100	50	38	of	of	ADP
ajlm-100	50	39	the	the	DET
ajlm-100	50	40	institute	institute	PROPN
ajlm-100	50	41	of	of	ADP
ajlm-100	50	42	primate	primate	PROPN
ajlm-100	50	43	research	research	NOUN
ajlm-100	50	44	.	.	PUNCT
ajlm-100	51	1	prior	prior	ADV
ajlm-100	51	2	to	to	ADP
ajlm-100	51	3	experimentation	experimentation	NOUN
ajlm-100	51	4	,	,	PUNCT
ajlm-100	51	5	the	the	DET
ajlm-100	51	6	monkeys	monkey	NOUN
ajlm-100	51	7	underwent	undergo	VERB
ajlm-100	51	8	quarantine	quarantine	NOUN
ajlm-100	51	9	for	for	ADP
ajlm-100	51	10	90	90	NUM
ajlm-100	51	11	days	day	NOUN
ajlm-100	51	12	,	,	PUNCT
ajlm-100	51	13	during	during	ADP
ajlm-100	51	14	which	which	DET
ajlm-100	51	15	time	time	NOUN
ajlm-100	51	16	they	they	PRON
ajlm-100	51	17	were	be	AUX
ajlm-100	51	18	screened	screen	VERB
ajlm-100	51	19	for	for	ADP
ajlm-100	51	20	zoonotic	zoonotic	ADJ
ajlm-100	51	21	diseases	disease	NOUN
ajlm-100	51	22	as	as	ADV
ajlm-100	51	23	well	well	ADV
ajlm-100	51	24	as	as	ADP
ajlm-100	51	25	ectoand	ectoand	ADJ
ajlm-100	51	26	endoparasites	endoparasite	NOUN
ajlm-100	51	27	.	.	PUNCT
ajlm-100	52	1	because	because	SCONJ
ajlm-100	52	2	of	of	ADP
ajlm-100	52	3	the	the	DET
ajlm-100	52	4	evidence	evidence	NOUN
ajlm-100	52	5	of	of	ADP
ajlm-100	52	6	minor	minor	ADJ
ajlm-100	52	7	strongyle	strongyle	NOUN
ajlm-100	52	8	infections	infection	NOUN
ajlm-100	52	9	and	and	CCONJ
ajlm-100	52	10	mange	mange	NOUN
ajlm-100	52	11	infestations	infestation	NOUN
ajlm-100	52	12	,	,	PUNCT
ajlm-100	52	13	they	they	PRON
ajlm-100	52	14	were	be	AUX
ajlm-100	52	15	treated	treat	VERB
ajlm-100	52	16	with	with	ADP
ajlm-100	52	17	subcutaneous	subcutaneous	ADJ
ajlm-100	52	18	injections	injection	NOUN
ajlm-100	52	19	of	of	ADP
ajlm-100	52	20	ivermectin	ivermectin	NOUN
ajlm-100	52	21	at	at	ADP
ajlm-100	52	22	dosages	dosage	NOUN
ajlm-100	52	23	of	of	ADP
ajlm-100	52	24	300	300	NUM
ajlm-100	52	25	μg	μg	NOUN
ajlm-100	52	26	/	/	SYM
ajlm-100	52	27	kg	kg	PROPN
ajlm-100	52	28	for	for	ADP
ajlm-100	52	29	three	three	NUM
ajlm-100	52	30	days	day	NOUN
ajlm-100	52	31	.	.	PUNCT
ajlm-100	53	1	the	the	DET
ajlm-100	53	2	monkeys	monkey	NOUN
ajlm-100	53	3	were	be	AUX
ajlm-100	53	4	housed	house	VERB
ajlm-100	53	5	in	in	ADP
ajlm-100	53	6	single	single	ADJ
ajlm-100	53	7	90	90	NUM
ajlm-100	53	8	x	x	SYM
ajlm-100	53	9	60	60	NUM
ajlm-100	53	10	x	x	SYM
ajlm-100	53	11	60	60	NUM
ajlm-100	53	12	cm	cm	NOUN
ajlm-100	53	13	stainless	stainless	ADJ
ajlm-100	53	14	-	-	PUNCT
ajlm-100	53	15	steel	steel	NOUN
ajlm-100	53	16	cages	cage	NOUN
ajlm-100	53	17	in	in	ADP
ajlm-100	53	18	a	a	DET
ajlm-100	53	19	room	room	NOUN
ajlm-100	53	20	maintained	maintain	VERB
ajlm-100	53	21	at	at	ADP
ajlm-100	53	22	temperatures	temperature	NOUN
ajlm-100	53	23	in	in	ADP
ajlm-100	53	24	the	the	DET
ajlm-100	53	25	range	range	NOUN
ajlm-100	53	26	of	of	ADP
ajlm-100	53	27	23–25	23–25	NUM
ajlm-100	53	28	°	°	NOUN
ajlm-100	53	29	c	c	NOUN
ajlm-100	53	30	.	.	PUNCT
ajlm-100	54	1	they	they	PRON
ajlm-100	54	2	were	be	AUX
ajlm-100	54	3	fed	feed	VERB
ajlm-100	54	4	twice	twice	ADV
ajlm-100	54	5	daily	daily	ADV
ajlm-100	54	6	with	with	ADP
ajlm-100	54	7	monkey	monkey	NOUN
ajlm-100	54	8	cubes	cube	NOUN
ajlm-100	54	9	(	(	PUNCT
ajlm-100	54	10	goldstar	goldstar	NOUN
ajlm-100	54	11	feeds	feed	VERB
ajlm-100	54	12	®	®	PROPN
ajlm-100	54	13	ltd	ltd	PROPN
ajlm-100	54	14	.	.	PROPN
ajlm-100	54	15	,	,	PUNCT
ajlm-100	54	16	nairobi	nairobi	PROPN
ajlm-100	54	17	,	,	PUNCT
ajlm-100	54	18	kenya	kenya	PROPN
ajlm-100	54	19	)	)	PUNCT
ajlm-100	54	20	,	,	PUNCT
ajlm-100	54	21	vegetables	vegetable	NOUN
ajlm-100	54	22	,	,	PUNCT
ajlm-100	54	23	green	green	ADJ
ajlm-100	54	24	maize	maize	NOUN
ajlm-100	54	25	and	and	CCONJ
ajlm-100	54	26	bananas	banana	NOUN
ajlm-100	54	27	;	;	PUNCT
ajlm-100	54	28	water	water	NOUN
ajlm-100	54	29	was	be	AUX
ajlm-100	54	30	provided	provide	VERB
ajlm-100	54	31	ad	ad	NOUN
ajlm-100	54	32	libitum	libitum	X
ajlm-100	54	33	.	.	PUNCT
ajlm-100	55	1	experimental	experimental	ADJ
ajlm-100	55	2	design	design	NOUN
ajlm-100	55	3	three	three	NUM
ajlm-100	55	4	monkeys	monkey	NOUN
ajlm-100	55	5	were	be	AUX
ajlm-100	55	6	infected	infect	VERB
ajlm-100	55	7	intravenously	intravenously	ADV
ajlm-100	55	8	with	with	ADP
ajlm-100	55	9	1	1	NUM
ajlm-100	55	10	ml	ml	NOUN
ajlm-100	55	11	of	of	ADP
ajlm-100	55	12	the	the	DET
ajlm-100	55	13	suspension	suspension	NOUN
ajlm-100	55	14	containing	contain	VERB
ajlm-100	55	15	104	104	NUM
ajlm-100	55	16	trypanosomes	trypanosome	NOUN
ajlm-100	55	17	of	of	ADP
ajlm-100	55	18	t.	t.	PROPN
ajlm-100	55	19	b.	b.	PROPN
ajlm-100	55	20	brucei	brucei	PROPN
ajlm-100	55	21	(	(	PUNCT
ajlm-100	55	22	gutat	gutat	NOUN
ajlm-100	55	23	1	1	NUM
ajlm-100	55	24	)	)	PUNCT
ajlm-100	55	25	,	,	PUNCT
ajlm-100	55	26	whilst	whilst	SCONJ
ajlm-100	55	27	the	the	DET
ajlm-100	55	28	remaining	remain	VERB
ajlm-100	55	29	two	two	NUM
ajlm-100	55	30	monkeys	monkey	NOUN
ajlm-100	55	31	were	be	AUX
ajlm-100	55	32	kept	keep	VERB
ajlm-100	55	33	as	as	ADP
ajlm-100	55	34	non	non	ADJ
ajlm-100	55	35	-	-	ADJ
ajlm-100	55	36	infected	infected	ADJ
ajlm-100	55	37	controls	control	NOUN
ajlm-100	55	38	.	.	PUNCT
ajlm-100	56	1	the	the	DET
ajlm-100	56	2	infected	infect	VERB
ajlm-100	56	3	monkeys	monkey	NOUN
ajlm-100	56	4	were	be	AUX
ajlm-100	56	5	monitored	monitor	VERB
ajlm-100	56	6	daily	daily	ADV
ajlm-100	56	7	for	for	ADP
ajlm-100	56	8	parasitaemia	parasitaemia	NOUN
ajlm-100	56	9	as	as	SCONJ
ajlm-100	56	10	described	describe	VERB
ajlm-100	56	11	in	in	ADP
ajlm-100	56	12	previous	previous	ADJ
ajlm-100	56	13	studies.7	studies.7	NOUN
ajlm-100	56	14	at	at	ADP
ajlm-100	56	15	28	28	NUM
ajlm-100	56	16	days	day	NOUN
ajlm-100	56	17	post	post	ADJ
ajlm-100	56	18	-	-	ADJ
ajlm-100	56	19	infection	infection	ADJ
ajlm-100	56	20	(	(	PUNCT
ajlm-100	56	21	dpi	dpi	PROPN
ajlm-100	56	22	)	)	PUNCT
ajlm-100	56	23	the	the	DET
ajlm-100	56	24	monkeys	monkey	NOUN
ajlm-100	56	25	were	be	AUX
ajlm-100	56	26	treated	treat	VERB
ajlm-100	56	27	subcuratively	subcuratively	ADV
ajlm-100	56	28	for	for	ADP
ajlm-100	56	29	three	three	NUM
ajlm-100	56	30	consecutive	consecutive	ADJ
ajlm-100	56	31	days	day	NOUN
ajlm-100	56	32	using	use	VERB
ajlm-100	56	33	intramuscular	intramuscular	ADJ
ajlm-100	56	34	diminazene	diminazene	NOUN
ajlm-100	56	35	aceturate	aceturate	NOUN
ajlm-100	56	36	at	at	ADP
ajlm-100	56	37	a	a	DET
ajlm-100	56	38	dose	dose	NOUN
ajlm-100	56	39	rate	rate	NOUN
ajlm-100	56	40	of	of	ADP
ajlm-100	56	41	5	5	NUM
ajlm-100	56	42	mg	mg	PROPN
ajlm-100	56	43	/	/	SYM
ajlm-100	56	44	kg	kg	PROPN
ajlm-100	56	45	body	body	NOUN
ajlm-100	56	46	weight	weight	NOUN
ajlm-100	56	47	.	.	PUNCT
ajlm-100	57	1	the	the	DET
ajlm-100	57	2	monkeys	monkey	NOUN
ajlm-100	57	3	were	be	AUX
ajlm-100	57	4	then	then	ADV
ajlm-100	57	5	monitored	monitor	VERB
ajlm-100	57	6	for	for	ADP
ajlm-100	57	7	parasitaemia	parasitaemia	NOUN
ajlm-100	57	8	and	and	CCONJ
ajlm-100	57	9	,	,	PUNCT
ajlm-100	57	10	on	on	ADP
ajlm-100	57	11	relapse	relapse	NOUN
ajlm-100	57	12	(	(	PUNCT
ajlm-100	57	13	114	114	NUM
ajlm-100	57	14	dpi	dpi	NOUN
ajlm-100	57	15	)	)	PUNCT
ajlm-100	57	16	,	,	PUNCT
ajlm-100	57	17	were	be	AUX
ajlm-100	57	18	treated	treat	VERB
ajlm-100	57	19	curatively	curatively	ADV
ajlm-100	57	20	for	for	ADP
ajlm-100	57	21	four	four	NUM
ajlm-100	57	22	consecutive	consecutive	ADJ
ajlm-100	57	23	days	day	NOUN
ajlm-100	57	24	with	with	ADP
ajlm-100	57	25	intravenous	intravenous	ADJ
ajlm-100	57	26	melarsoprol	melarsoprol	NOUN
ajlm-100	57	27	at	at	ADP
ajlm-100	57	28	a	a	DET
ajlm-100	57	29	dose	dose	NOUN
ajlm-100	57	30	rate	rate	NOUN
ajlm-100	57	31	of	of	ADP
ajlm-100	57	32	3.6	3.6	NUM
ajlm-100	57	33	mg	mg	PROPN
ajlm-100	57	34	/	/	SYM
ajlm-100	57	35	kg	kg	PROPN
ajlm-100	57	36	body	body	NOUN
ajlm-100	57	37	weight	weight	NOUN
ajlm-100	57	38	.	.	PUNCT
ajlm-100	58	1	after	after	ADP
ajlm-100	58	2	180	180	NUM
ajlm-100	58	3	days	day	NOUN
ajlm-100	58	4	of	of	ADP
ajlm-100	58	5	monitoring	monitoring	NOUN
ajlm-100	58	6	,	,	PUNCT
ajlm-100	58	7	the	the	DET
ajlm-100	58	8	monkeys	monkey	NOUN
ajlm-100	58	9	were	be	AUX
ajlm-100	58	10	euthanased	euthanase	VERB
ajlm-100	58	11	using	use	VERB
ajlm-100	58	12	euthatal	euthatal	PROPN
ajlm-100	58	13	(	(	PUNCT
ajlm-100	58	14	20	20	NUM
ajlm-100	58	15	%	%	NOUN
ajlm-100	58	16	sodium	sodium	NOUN
ajlm-100	58	17	pentobarbitone	pentobarbitone	NOUN
ajlm-100	58	18	)	)	PUNCT
ajlm-100	58	19	.	.	PUNCT
ajlm-100	59	1	clinical	clinical	ADJ
ajlm-100	59	2	examination	examination	NOUN
ajlm-100	59	3	and	and	CCONJ
ajlm-100	59	4	sample	sample	NOUN
ajlm-100	59	5	collection	collection	NOUN
ajlm-100	59	6	the	the	DET
ajlm-100	59	7	clinical	clinical	ADJ
ajlm-100	59	8	status	status	NOUN
ajlm-100	59	9	of	of	ADP
ajlm-100	59	10	the	the	DET
ajlm-100	59	11	monkeys	monkey	NOUN
ajlm-100	59	12	was	be	AUX
ajlm-100	59	13	monitored	monitor	VERB
ajlm-100	59	14	daily	daily	ADV
ajlm-100	59	15	.	.	PUNCT
ajlm-100	60	1	at	at	ADP
ajlm-100	60	2	weekly	weekly	ADJ
ajlm-100	60	3	intervals	interval	NOUN
ajlm-100	60	4	,	,	PUNCT
ajlm-100	60	5	the	the	DET
ajlm-100	60	6	monkeys	monkey	NOUN
ajlm-100	60	7	were	be	AUX
ajlm-100	60	8	anaesthetised	anaesthetise	VERB
ajlm-100	60	9	with	with	ADP
ajlm-100	60	10	intramuscular	intramuscular	ADJ
ajlm-100	60	11	injections	injection	NOUN
ajlm-100	60	12	of	of	ADP
ajlm-100	60	13	ketamine	ketamine	PROPN
ajlm-100	60	14	hydrochloride	hydrochloride	NOUN
ajlm-100	60	15	(	(	PUNCT
ajlm-100	60	16	ketamine	ketamine	PROPN
ajlm-100	60	17	®	®	PROPN
ajlm-100	60	18	,	,	PUNCT
ajlm-100	60	19	rotexmedica	rotexmedica	PROPN
ajlm-100	60	20	,	,	PUNCT
ajlm-100	60	21	trittau	trittau	PROPN
ajlm-100	60	22	,	,	PUNCT
ajlm-100	60	23	germany	germany	PROPN
ajlm-100	60	24	)	)	PUNCT
ajlm-100	60	25	at	at	ADP
ajlm-100	60	26	dosages	dosage	NOUN
ajlm-100	60	27	of	of	ADP
ajlm-100	60	28	10	10	NUM
ajlm-100	60	29	mg	mg	NUM
ajlm-100	60	30	/	/	SYM
ajlm-100	60	31	kg	kg	PROPN
ajlm-100	60	32	body	body	NOUN
ajlm-100	60	33	weight	weight	NOUN
ajlm-100	60	34	and	and	CCONJ
ajlm-100	60	35	full	full	ADJ
ajlm-100	60	36	physical	physical	ADJ
ajlm-100	60	37	examinations	examination	NOUN
ajlm-100	60	38	were	be	AUX
ajlm-100	60	39	conducted	conduct	VERB
ajlm-100	60	40	.	.	PUNCT
ajlm-100	61	1	furthermore	furthermore	ADV
ajlm-100	61	2	,	,	PUNCT
ajlm-100	61	3	2	2	NUM
ajlm-100	61	4	ml	ml	NOUN
ajlm-100	61	5	of	of	ADP
ajlm-100	61	6	blood	blood	NOUN
ajlm-100	61	7	were	be	AUX
ajlm-100	61	8	collected	collect	VERB
ajlm-100	61	9	weekly	weekly	ADV
ajlm-100	61	10	by	by	ADP
ajlm-100	61	11	venepuncture	venepuncture	NOUN
ajlm-100	61	12	of	of	ADP
ajlm-100	61	13	the	the	DET
ajlm-100	61	14	femoral	femoral	ADJ
ajlm-100	61	15	vein	vein	NOUN
ajlm-100	61	16	and	and	CCONJ
ajlm-100	61	17	placed	place	VERB
ajlm-100	61	18	in	in	ADP
ajlm-100	61	19	tubes	tube	NOUN
ajlm-100	61	20	containing	contain	VERB
ajlm-100	61	21	ethylenediaminetetraacetic	ethylenediaminetetraacetic	ADJ
ajlm-100	61	22	acid	acid	NOUN
ajlm-100	61	23	(	(	PUNCT
ajlm-100	61	24	edta	edta	NOUN
ajlm-100	61	25	)	)	PUNCT
ajlm-100	61	26	.	.	PUNCT
ajlm-100	62	1	csf	csf	PROPN
ajlm-100	62	2	was	be	AUX
ajlm-100	62	3	collected	collect	VERB
ajlm-100	62	4	weekly	weekly	ADV
ajlm-100	62	5	by	by	ADP
ajlm-100	62	6	lumbar	lumbar	NOUN
ajlm-100	62	7	puncture	puncture	NOUN
ajlm-100	62	8	.	.	PUNCT
ajlm-100	63	1	laboratory	laboratory	NOUN
ajlm-100	63	2	analysis	analysis	NOUN
ajlm-100	63	3	immediately	immediately	ADV
ajlm-100	63	4	after	after	ADP
ajlm-100	63	5	blood	blood	NOUN
ajlm-100	63	6	collection	collection	NOUN
ajlm-100	63	7	,	,	PUNCT
ajlm-100	63	8	the	the	DET
ajlm-100	63	9	haematological	haematological	ADJ
ajlm-100	63	10	assays	assay	NOUN
ajlm-100	63	11	were	be	AUX
ajlm-100	63	12	performed	perform	VERB
ajlm-100	63	13	using	use	VERB
ajlm-100	63	14	an	an	DET
ajlm-100	63	15	ac3diff	ac3diff	PROPN
ajlm-100	63	16	t	t	PROPN
ajlm-100	63	17	coulter	coulter	PROPN
ajlm-100	63	18	counter	counter	PROPN
ajlm-100	63	19	(	(	PUNCT
ajlm-100	63	20	miami	miami	PROPN
ajlm-100	63	21	,	,	PUNCT
ajlm-100	63	22	florida	florida	PROPN
ajlm-100	63	23	,	,	PUNCT
ajlm-100	63	24	usa	usa	PROPN
ajlm-100	63	25	)	)	PUNCT
ajlm-100	63	26	.	.	PUNCT
ajlm-100	64	1	parasitaemia	parasitaemia	PROPN
ajlm-100	64	2	was	be	AUX
ajlm-100	64	3	scored	score	VERB
ajlm-100	64	4	using	use	VERB
ajlm-100	64	5	the	the	DET
ajlm-100	64	6	method	method	NOUN
ajlm-100	64	7	described	describe	VERB
ajlm-100	64	8	by	by	ADP
ajlm-100	64	9	herbert	herbert	PROPN
ajlm-100	64	10	and	and	CCONJ
ajlm-100	64	11	lumsden,8	lumsden,8	NOUN
ajlm-100	64	12	which	which	PRON
ajlm-100	64	13	included	include	VERB
ajlm-100	64	14	the	the	DET
ajlm-100	64	15	daily	daily	ADJ
ajlm-100	64	16	use	use	NOUN
ajlm-100	64	17	of	of	ADP
ajlm-100	64	18	wet	wet	ADJ
ajlm-100	64	19	smear	smear	NOUN
ajlm-100	64	20	detection	detection	NOUN
ajlm-100	64	21	of	of	ADP
ajlm-100	64	22	microscopic	microscopic	ADJ
ajlm-100	64	23	parasites	parasite	NOUN
ajlm-100	64	24	using	use	VERB
ajlm-100	64	25	the	the	DET
ajlm-100	64	26	rapid	rapid	ADJ
ajlm-100	64	27	matching	matching	NOUN
ajlm-100	64	28	method	method	NOUN
ajlm-100	64	29	.	.	PUNCT
ajlm-100	65	1	to	to	PART
ajlm-100	65	2	determine	determine	VERB
ajlm-100	65	3	pathological	pathological	ADJ
ajlm-100	65	4	effects	effect	NOUN
ajlm-100	65	5	,	,	PUNCT
ajlm-100	65	6	baseline	baseline	ADJ
ajlm-100	65	7	biochemical	biochemical	ADJ
ajlm-100	65	8	values	value	NOUN
ajlm-100	65	9	were	be	AUX
ajlm-100	65	10	compared	compare	VERB
ajlm-100	65	11	to	to	ADP
ajlm-100	65	12	those	those	DET
ajlm-100	65	13	post	post	ADJ
ajlm-100	65	14	-	-	NOUN
ajlm-100	65	15	infection	infection	NOUN
ajlm-100	65	16	.	.	PUNCT
ajlm-100	66	1	normal	normal	ADJ
ajlm-100	66	2	ranges	range	NOUN
ajlm-100	66	3	are	be	AUX
ajlm-100	66	4	not	not	PART
ajlm-100	66	5	generally	generally	ADV
ajlm-100	66	6	used	use	VERB
ajlm-100	66	7	because	because	SCONJ
ajlm-100	66	8	of	of	ADP
ajlm-100	66	9	the	the	DET
ajlm-100	66	10	variation	variation	NOUN
ajlm-100	66	11	found	find	VERB
ajlm-100	66	12	amongst	amongst	ADP
ajlm-100	66	13	vervet	vervet	NOUN
ajlm-100	66	14	monkeys.10	monkeys.10	PROPN
ajlm-100	66	15	disease	disease	NOUN
ajlm-100	66	16	staging	staging	NOUN
ajlm-100	66	17	criteria	criterion	NOUN
ajlm-100	66	18	the	the	DET
ajlm-100	66	19	stage	stage	NOUN
ajlm-100	66	20	of	of	ADP
ajlm-100	66	21	trypanosome	trypanosome	NOUN
ajlm-100	66	22	infection	infection	NOUN
ajlm-100	66	23	was	be	AUX
ajlm-100	66	24	determined	determine	VERB
ajlm-100	66	25	in	in	ADP
ajlm-100	66	26	accordance	accordance	NOUN
ajlm-100	66	27	with	with	ADP
ajlm-100	66	28	world	world	NOUN
ajlm-100	66	29	health	health	NOUN
ajlm-100	66	30	organization	organization	NOUN
ajlm-100	66	31	criteria	criterion	NOUN
ajlm-100	66	32	and	and	CCONJ
ajlm-100	66	33	as	as	ADP
ajlm-100	66	34	previously	previously	ADV
ajlm-100	66	35	described.9,11	described.9,11	VERB
ajlm-100	66	36	csf	csf	PROPN
ajlm-100	66	37	was	be	AUX
ajlm-100	66	38	collected	collect	VERB
ajlm-100	66	39	by	by	ADP
ajlm-100	66	40	lumbar	lumbar	NOUN
ajlm-100	66	41	puncture	puncture	NOUN
ajlm-100	66	42	and	and	CCONJ
ajlm-100	66	43	examined	examine	VERB
ajlm-100	66	44	for	for	ADP
ajlm-100	66	45	the	the	DET
ajlm-100	66	46	presence	presence	NOUN
ajlm-100	66	47	of	of	ADP
ajlm-100	66	48	trypanosomes	trypanosome	NOUN
ajlm-100	66	49	and	and	CCONJ
ajlm-100	66	50	the	the	DET
ajlm-100	66	51	number	number	NOUN
ajlm-100	66	52	of	of	ADP
ajlm-100	66	53	white	white	ADJ
ajlm-100	66	54	blood	blood	NOUN
ajlm-100	66	55	cells	cell	NOUN
ajlm-100	66	56	(	(	PUNCT
ajlm-100	66	57	wbcs	wbcs	PROPN
ajlm-100	66	58	)	)	PUNCT
ajlm-100	66	59	.	.	PUNCT
ajlm-100	67	1	the	the	DET
ajlm-100	67	2	wbcs	wbc	NOUN
ajlm-100	67	3	were	be	AUX
ajlm-100	67	4	estimated	estimate	VERB
ajlm-100	67	5	by	by	ADP
ajlm-100	67	6	counting	count	VERB
ajlm-100	67	7	in	in	ADP
ajlm-100	67	8	a	a	DET
ajlm-100	67	9	neubauer	neubauer	PROPN
ajlm-100	67	10	cell	cell	NOUN
ajlm-100	67	11	chamber	chamber	PROPN
ajlm-100	67	12	.	.	PUNCT
ajlm-100	68	1	when	when	SCONJ
ajlm-100	68	2	cells	cell	NOUN
ajlm-100	68	3	were	be	AUX
ajlm-100	68	4	<	<	X
ajlm-100	68	5	5	5	NUM
ajlm-100	68	6	cells/µl	cells/µl	NOUN
ajlm-100	68	7	,	,	PUNCT
ajlm-100	68	8	infection	infection	NOUN
ajlm-100	68	9	was	be	AUX
ajlm-100	68	10	classified	classify	VERB
ajlm-100	68	11	as	as	ADP
ajlm-100	68	12	first	first	ADJ
ajlm-100	68	13	stage	stage	NOUN
ajlm-100	68	14	.	.	PUNCT
ajlm-100	69	1	late	late	ADJ
ajlm-100	69	2	-	-	PUNCT
ajlm-100	69	3	stage	stage	NOUN
ajlm-100	69	4	infection	infection	NOUN
ajlm-100	69	5	was	be	AUX
ajlm-100	69	6	diagnosed	diagnose	VERB
ajlm-100	69	7	when	when	SCONJ
ajlm-100	69	8	trypanosomes	trypanosome	NOUN
ajlm-100	69	9	were	be	AUX
ajlm-100	69	10	detected	detect	VERB
ajlm-100	69	11	in	in	ADP
ajlm-100	69	12	the	the	DET
ajlm-100	69	13	csf	csf	NOUN
ajlm-100	69	14	and	and	CCONJ
ajlm-100	69	15	the	the	DET
ajlm-100	69	16	wbc	wbc	PROPN
ajlm-100	69	17	count	count	NOUN
ajlm-100	69	18	of	of	ADP
ajlm-100	69	19	the	the	DET
ajlm-100	69	20	csf	csf	NOUN
ajlm-100	69	21	was	be	AUX
ajlm-100	69	22	>	>	X
ajlm-100	69	23	5	5	NUM
ajlm-100	69	24	cells/µl.12	cells/µl.12	NOUN
ajlm-100	69	25	statistical	statistical	ADJ
ajlm-100	69	26	analysis	analysis	NOUN
ajlm-100	69	27	data	datum	NOUN
ajlm-100	69	28	were	be	AUX
ajlm-100	69	29	managed	manage	VERB
ajlm-100	69	30	using	use	VERB
ajlm-100	69	31	microsoft	microsoft	PROPN
ajlm-100	69	32	excel	excel	PROPN
ajlm-100	69	33	(	(	PUNCT
ajlm-100	69	34	microsoft	microsoft	PROPN
ajlm-100	69	35	us	us	PROPN
ajlm-100	69	36	,	,	PUNCT
ajlm-100	69	37	version	version	NOUN
ajlm-100	69	38	2007	2007	NUM
ajlm-100	69	39	)	)	PUNCT
ajlm-100	69	40	.	.	PUNCT
ajlm-100	70	1	descriptive	descriptive	ADJ
ajlm-100	70	2	statistics	statistic	NOUN
ajlm-100	70	3	and	and	CCONJ
ajlm-100	70	4	summary	summary	NOUN
ajlm-100	70	5	tables	table	NOUN
ajlm-100	70	6	were	be	AUX
ajlm-100	70	7	employed	employ	VERB
ajlm-100	70	8	for	for	ADP
ajlm-100	70	9	the	the	DET
ajlm-100	70	10	initial	initial	ADJ
ajlm-100	70	11	description	description	NOUN
ajlm-100	70	12	of	of	ADP
ajlm-100	70	13	the	the	DET
ajlm-100	70	14	data	datum	NOUN
ajlm-100	70	15	and	and	CCONJ
ajlm-100	70	16	the	the	DET
ajlm-100	70	17	results	result	NOUN
ajlm-100	70	18	were	be	AUX
ajlm-100	70	19	displayed	display	VERB
ajlm-100	70	20	in	in	ADP
ajlm-100	70	21	excel	excel	PROPN
ajlm-100	70	22	charts	chart	NOUN
ajlm-100	70	23	.	.	PUNCT
ajlm-100	71	1	differences	difference	NOUN
ajlm-100	71	2	between	between	ADP
ajlm-100	71	3	the	the	DET
ajlm-100	71	4	means	mean	NOUN
ajlm-100	71	5	were	be	AUX
ajlm-100	71	6	compared	compare	VERB
ajlm-100	71	7	using	use	VERB
ajlm-100	71	8	the	the	DET
ajlm-100	71	9	student	student	NOUN
ajlm-100	71	10	’s	’s	PART
ajlm-100	71	11	t	t	PROPN
ajlm-100	71	12	-	-	PUNCT
ajlm-100	71	13	test	test	NOUN
ajlm-100	71	14	and	and	CCONJ
ajlm-100	71	15	were	be	AUX
ajlm-100	71	16	deemed	deem	VERB
ajlm-100	71	17	to	to	PART
ajlm-100	71	18	have	have	VERB
ajlm-100	71	19	statistical	statistical	ADJ
ajlm-100	71	20	significance	significance	NOUN
ajlm-100	71	21	at	at	ADP
ajlm-100	71	22	p	p	NOUN
ajlm-100	71	23	<	<	X
ajlm-100	71	24	0.05	0.05	NUM
ajlm-100	71	25	.	.	PUNCT
ajlm-100	72	1	ethical	ethical	ADJ
ajlm-100	72	2	consideration	consideration	NOUN
ajlm-100	72	3	prior	prior	ADV
ajlm-100	72	4	to	to	ADP
ajlm-100	72	5	commencement	commencement	NOUN
ajlm-100	72	6	of	of	ADP
ajlm-100	72	7	the	the	DET
ajlm-100	72	8	study	study	NOUN
ajlm-100	72	9	,	,	PUNCT
ajlm-100	72	10	all	all	DET
ajlm-100	72	11	protocols	protocol	NOUN
ajlm-100	72	12	and	and	CCONJ
ajlm-100	72	13	procedures	procedure	NOUN
ajlm-100	72	14	used	use	VERB
ajlm-100	72	15	were	be	AUX
ajlm-100	72	16	reviewed	review	VERB
ajlm-100	72	17	and	and	CCONJ
ajlm-100	72	18	approved	approve	VERB
ajlm-100	72	19	by	by	ADP
ajlm-100	72	20	the	the	DET
ajlm-100	72	21	institute	institute	PROPN
ajlm-100	72	22	of	of	ADP
ajlm-100	72	23	primate	primate	PROPN
ajlm-100	72	24	research	research	NOUN
ajlm-100	72	25	institutional	institutional	ADJ
ajlm-100	72	26	animal	animal	NOUN
ajlm-100	72	27	care	care	NOUN
ajlm-100	72	28	and	and	CCONJ
ajlm-100	72	29	use	use	VERB
ajlm-100	72	30	committee	committee	NOUN
ajlm-100	72	31	(	(	PUNCT
ajlm-100	72	32	irc/19/10	irc/19/10	PROPN
ajlm-100	72	33	)	)	PUNCT
ajlm-100	72	34	.	.	PUNCT
ajlm-100	73	1	results	result	VERB
ajlm-100	73	2	top	top	ADJ
ajlm-100	73	3	↑	↑	PROPN
ajlm-100	73	4	clinical	clinical	ADJ
ajlm-100	73	5	signs	sign	NOUN
ajlm-100	73	6	all	all	DET
ajlm-100	73	7	the	the	DET
ajlm-100	73	8	infected	infected	ADJ
ajlm-100	73	9	animals	animal	NOUN
ajlm-100	73	10	developed	develop	VERB
ajlm-100	73	11	acute	acute	ADJ
ajlm-100	73	12	symptoms	symptom	NOUN
ajlm-100	73	13	characteristic	characteristic	ADJ
ajlm-100	73	14	of	of	ADP
ajlm-100	73	15	rhodesian	rhodesian	ADJ
ajlm-100	73	16	hat	hat	NOUN
ajlm-100	73	17	,	,	PUNCT
ajlm-100	73	18	including	include	VERB
ajlm-100	73	19	fever	fever	NOUN
ajlm-100	73	20	with	with	ADP
ajlm-100	73	21	a	a	DET
ajlm-100	73	22	mean	mean	ADJ
ajlm-100	73	23	temperature	temperature	NOUN
ajlm-100	73	24	of	of	ADP
ajlm-100	73	25	40	40	NUM
ajlm-100	73	26	°	°	NOUN
ajlm-100	73	27	c	c	NOUN
ajlm-100	73	28	,	,	PUNCT
ajlm-100	73	29	dullness	dullness	NOUN
ajlm-100	73	30	,	,	PUNCT
ajlm-100	73	31	increased	increase	VERB
ajlm-100	73	32	pulse	pulse	NOUN
ajlm-100	73	33	and	and	CCONJ
ajlm-100	73	34	respiratory	respiratory	ADJ
ajlm-100	73	35	rates	rate	NOUN
ajlm-100	73	36	,	,	PUNCT
ajlm-100	73	37	pallor	pallor	NOUN
ajlm-100	73	38	of	of	ADP
ajlm-100	73	39	the	the	DET
ajlm-100	73	40	mucous	mucous	ADJ
ajlm-100	73	41	membranes	membrane	NOUN
ajlm-100	73	42	,	,	PUNCT
ajlm-100	73	43	enlarged	enlarge	VERB
ajlm-100	73	44	superficial	superficial	ADJ
ajlm-100	73	45	lymph	lymph	NOUN
ajlm-100	73	46	nodes	node	NOUN
ajlm-100	73	47	and	and	CCONJ
ajlm-100	73	48	spleen	spleen	NOUN
ajlm-100	73	49	,	,	PUNCT
ajlm-100	73	50	raised	raise	VERB
ajlm-100	73	51	hair	hair	NOUN
ajlm-100	73	52	coat	coat	NOUN
ajlm-100	73	53	,	,	PUNCT
ajlm-100	73	54	peri	peri	NOUN
ajlm-100	73	55	-	-	PUNCT
ajlm-100	73	56	orbital	orbital	ADJ
ajlm-100	73	57	oedema	oedema	NOUN
ajlm-100	73	58	and	and	CCONJ
ajlm-100	73	59	stiffness	stiffness	NOUN
ajlm-100	73	60	of	of	ADP
ajlm-100	73	61	joints	joint	NOUN
ajlm-100	73	62	.	.	PUNCT
ajlm-100	74	1	upon	upon	SCONJ
ajlm-100	74	2	subcurative	subcurative	ADJ
ajlm-100	74	3	treatment	treatment	NOUN
ajlm-100	74	4	with	with	ADP
ajlm-100	74	5	diminazene	diminazene	NOUN
ajlm-100	74	6	aceturate	aceturate	VERB
ajlm-100	74	7	,	,	PUNCT
ajlm-100	74	8	most	most	ADJ
ajlm-100	74	9	of	of	ADP
ajlm-100	74	10	the	the	DET
ajlm-100	74	11	clinical	clinical	ADJ
ajlm-100	74	12	signs	sign	NOUN
ajlm-100	74	13	of	of	ADP
ajlm-100	74	14	disease	disease	NOUN
ajlm-100	74	15	disappeared	disappear	VERB
ajlm-100	74	16	within	within	ADP
ajlm-100	74	17	14	14	NUM
ajlm-100	74	18	days	day	NOUN
ajlm-100	74	19	.	.	PUNCT
ajlm-100	75	1	however	however	ADV
ajlm-100	75	2	,	,	PUNCT
ajlm-100	75	3	starting	start	VERB
ajlm-100	75	4	at	at	ADP
ajlm-100	75	5	42	42	NUM
ajlm-100	75	6	dpi	dpi	NOUN
ajlm-100	75	7	,	,	PUNCT
ajlm-100	75	8	one	one	NUM
ajlm-100	75	9	monkey	monkey	NOUN
ajlm-100	75	10	exhibited	exhibit	VERB
ajlm-100	75	11	a	a	DET
ajlm-100	75	12	general	general	ADJ
ajlm-100	75	13	body	body	NOUN
ajlm-100	75	14	weakness	weakness	NOUN
ajlm-100	75	15	,	,	PUNCT
ajlm-100	75	16	sleepiness	sleepiness	NOUN
ajlm-100	75	17	,	,	PUNCT
ajlm-100	75	18	ataxia	ataxia	NOUN
ajlm-100	75	19	and	and	CCONJ
ajlm-100	75	20	an	an	DET
ajlm-100	75	21	arched	arched	ADJ
ajlm-100	75	22	back	back	ADV
ajlm-100	75	23	when	when	SCONJ
ajlm-100	75	24	sitting	sit	VERB
ajlm-100	75	25	on	on	ADP
ajlm-100	75	26	the	the	DET
ajlm-100	75	27	cage	cage	NOUN
ajlm-100	75	28	floor	floor	NOUN
ajlm-100	75	29	and	and	CCONJ
ajlm-100	75	30	was	be	AUX
ajlm-100	75	31	euthanased	euthanase	VERB
ajlm-100	75	32	for	for	ADP
ajlm-100	75	33	humane	humane	ADJ
ajlm-100	75	34	reasons	reason	NOUN
ajlm-100	75	35	.	.	PUNCT
ajlm-100	76	1	the	the	DET
ajlm-100	76	2	other	other	ADJ
ajlm-100	76	3	two	two	NUM
ajlm-100	76	4	infected	infected	ADJ
ajlm-100	76	5	monkeys	monkey	NOUN
ajlm-100	76	6	had	have	VERB
ajlm-100	76	7	relapses	relapse	NOUN
ajlm-100	76	8	of	of	ADP
ajlm-100	76	9	parasitaemia	parasitaemia	NOUN
ajlm-100	76	10	from	from	ADP
ajlm-100	76	11	114–119	114–119	NUM
ajlm-100	76	12	dpi	dpi	NOUN
ajlm-100	76	13	with	with	ADP
ajlm-100	76	14	clinical	clinical	ADJ
ajlm-100	76	15	signs	sign	NOUN
ajlm-100	76	16	that	that	PRON
ajlm-100	76	17	included	include	VERB
ajlm-100	76	18	stiffness	stiffness	NOUN
ajlm-100	76	19	of	of	ADP
ajlm-100	76	20	joints	joint	NOUN
ajlm-100	76	21	and	and	CCONJ
ajlm-100	76	22	hind	hind	NOUN
ajlm-100	76	23	leg	leg	NOUN
ajlm-100	76	24	paralyses	paralysis	NOUN
ajlm-100	76	25	.	.	PUNCT
ajlm-100	77	1	these	these	DET
ajlm-100	77	2	signs	sign	NOUN
ajlm-100	77	3	disappeared	disappear	VERB
ajlm-100	77	4	within	within	ADP
ajlm-100	77	5	14	14	NUM
ajlm-100	77	6	days	day	NOUN
ajlm-100	77	7	after	after	ADP
ajlm-100	77	8	curative	curative	ADJ
ajlm-100	77	9	treatment	treatment	NOUN
ajlm-100	77	10	with	with	ADP
ajlm-100	77	11	melarsoprol	melarsoprol	NOUN
ajlm-100	77	12	.	.	PUNCT
ajlm-100	78	1	parasitaemia	parasitaemia	NOUN
ajlm-100	78	2	and	and	CCONJ
ajlm-100	78	3	cerebrospinal	cerebrospinal	ADJ
ajlm-100	78	4	fluid	fluid	ADJ
ajlm-100	78	5	parasitosis	parasitosis	NOUN
ajlm-100	78	6	all	all	DET
ajlm-100	78	7	experimentally	experimentally	ADV
ajlm-100	78	8	-	-	PUNCT
ajlm-100	78	9	infected	infect	VERB
ajlm-100	78	10	animals	animal	NOUN
ajlm-100	78	11	had	have	VERB
ajlm-100	78	12	a	a	DET
ajlm-100	78	13	prepatent	prepatent	ADJ
ajlm-100	78	14	period	period	NOUN
ajlm-100	78	15	ranging	range	VERB
ajlm-100	78	16	from	from	ADP
ajlm-100	78	17	two	two	NUM
ajlm-100	78	18	to	to	PART
ajlm-100	78	19	four	four	NUM
ajlm-100	78	20	days	day	NOUN
ajlm-100	78	21	.	.	PUNCT
ajlm-100	79	1	the	the	DET
ajlm-100	79	2	first	first	ADJ
ajlm-100	79	3	parasitaemia	parasitaemia	PROPN
ajlm-100	79	4	peak	peak	NOUN
ajlm-100	79	5	of	of	ADP
ajlm-100	79	6	107	107	NUM
ajlm-100	79	7	trypanosomes	trypanosome	NOUN
ajlm-100	79	8	per	per	ADP
ajlm-100	79	9	ml	ml	NOUN
ajlm-100	79	10	of	of	ADP
ajlm-100	79	11	blood	blood	NOUN
ajlm-100	79	12	occurred	occur	VERB
ajlm-100	79	13	between	between	ADP
ajlm-100	79	14	7–9	7–9	PROPN
ajlm-100	79	15	dpi	dpi	NOUN
ajlm-100	79	16	(	(	PUNCT
ajlm-100	79	17	figure	figure	NOUN
ajlm-100	79	18	1	1	NUM
ajlm-100	79	19	)	)	PUNCT
ajlm-100	79	20	.	.	PUNCT
ajlm-100	80	1	treatment	treatment	NOUN
ajlm-100	80	2	with	with	ADP
ajlm-100	80	3	diminazene	diminazene	NOUN
ajlm-100	80	4	aceturate	aceturate	NOUN
ajlm-100	80	5	resulted	result	VERB
ajlm-100	80	6	in	in	ADP
ajlm-100	80	7	clearance	clearance	NOUN
ajlm-100	80	8	of	of	ADP
ajlm-100	80	9	the	the	DET
ajlm-100	80	10	trypanosomes	trypanosome	NOUN
ajlm-100	80	11	in	in	ADP
ajlm-100	80	12	the	the	DET
ajlm-100	80	13	blood	blood	NOUN
ajlm-100	80	14	.	.	PUNCT
ajlm-100	81	1	in	in	ADP
ajlm-100	81	2	all	all	DET
ajlm-100	81	3	three	three	NUM
ajlm-100	81	4	infected	infected	ADJ
ajlm-100	81	5	monkeys	monkey	NOUN
ajlm-100	81	6	,	,	PUNCT
ajlm-100	81	7	the	the	DET
ajlm-100	81	8	parasites	parasite	NOUN
ajlm-100	81	9	relapsed	relapse	VERB
ajlm-100	81	10	,	,	PUNCT
ajlm-100	81	11	starting	start	VERB
ajlm-100	81	12	at	at	ADP
ajlm-100	81	13	114	114	NUM
ajlm-100	81	14	dpi	dpi	NOUN
ajlm-100	81	15	.	.	PUNCT
ajlm-100	82	1	trypanosomes	trypanosome	NOUN
ajlm-100	82	2	were	be	AUX
ajlm-100	82	3	detected	detect	VERB
ajlm-100	82	4	in	in	ADP
ajlm-100	82	5	the	the	DET
ajlm-100	82	6	csf	csf	NOUN
ajlm-100	82	7	of	of	ADP
ajlm-100	82	8	two	two	NUM
ajlm-100	82	9	monkeys	monkey	NOUN
ajlm-100	82	10	on	on	ADP
ajlm-100	82	11	days	day	NOUN
ajlm-100	82	12	28	28	NUM
ajlm-100	82	13	and	and	CCONJ
ajlm-100	82	14	105	105	NUM
ajlm-100	82	15	post	post	ADJ
ajlm-100	82	16	-	-	NOUN
ajlm-100	82	17	infection	infection	NOUN
ajlm-100	82	18	.	.	PUNCT
ajlm-100	83	1	treatment	treatment	NOUN
ajlm-100	83	2	with	with	ADP
ajlm-100	83	3	melarsoprol	melarsoprol	NOUN
ajlm-100	83	4	at	at	ADP
ajlm-100	83	5	119	119	NUM
ajlm-100	83	6	dpi	dpi	NOUN
ajlm-100	83	7	led	lead	VERB
ajlm-100	83	8	to	to	ADP
ajlm-100	83	9	clearance	clearance	NOUN
ajlm-100	83	10	of	of	ADP
ajlm-100	83	11	both	both	CCONJ
ajlm-100	83	12	the	the	DET
ajlm-100	83	13	parasitaemia	parasitaemia	NOUN
ajlm-100	83	14	and	and	CCONJ
ajlm-100	83	15	csf	csf	ADJ
ajlm-100	83	16	parasitosis	parasitosis	NOUN
ajlm-100	83	17	by	by	ADP
ajlm-100	83	18	123	123	NUM
ajlm-100	83	19	dpi	dpi	NOUN
ajlm-100	83	20	.	.	PUNCT
ajlm-100	84	1	there	there	PRON
ajlm-100	84	2	was	be	VERB
ajlm-100	84	3	an	an	DET
ajlm-100	84	4	increase	increase	NOUN
ajlm-100	84	5	in	in	ADP
ajlm-100	84	6	csf	csf	ADJ
ajlm-100	84	7	wbc	wbc	NOUN
ajlm-100	84	8	counts	count	NOUN
ajlm-100	84	9	during	during	ADP
ajlm-100	84	10	the	the	DET
ajlm-100	84	11	late	late	ADJ
ajlm-100	84	12	stage	stage	NOUN
ajlm-100	84	13	(	(	PUNCT
ajlm-100	84	14	figure	figure	NOUN
ajlm-100	84	15	2	2	NUM
ajlm-100	84	16	)	)	PUNCT
ajlm-100	84	17	.	.	PUNCT
ajlm-100	85	1	figure	figure	VERB
ajlm-100	85	2	1	1	NUM
ajlm-100	85	3	:	:	PUNCT
ajlm-100	85	4	mean	mean	VERB
ajlm-100	85	5	daily	daily	ADJ
ajlm-100	85	6	parasitaemia	parasitaemia	NOUN
ajlm-100	85	7	of	of	ADP
ajlm-100	85	8	vervet	vervet	PROPN
ajlm-100	85	9	monkeys	monkey	NOUN
ajlm-100	85	10	infected	infect	VERB
ajlm-100	85	11	with	with	ADP
ajlm-100	85	12	t.	t.	PROPN
ajlm-100	85	13	b.	b.	PROPN
ajlm-100	85	14	brucei	brucei	PROPN
ajlm-100	85	15	gutat	gutat	PROPN
ajlm-100	85	16	1	1	NUM
ajlm-100	85	17	,	,	PUNCT
ajlm-100	85	18	indicating	indicate	VERB
ajlm-100	85	19	the	the	DET
ajlm-100	85	20	point	point	NOUN
ajlm-100	85	21	of	of	ADP
ajlm-100	85	22	subcurative	subcurative	ADJ
ajlm-100	85	23	treatment	treatment	NOUN
ajlm-100	85	24	with	with	ADP
ajlm-100	85	25	diminazene	diminazene	NOUN
ajlm-100	85	26	aceturate	aceturate	NOUN
ajlm-100	85	27	(	(	PUNCT
ajlm-100	85	28	da	da	NOUN
ajlm-100	85	29	)	)	PUNCT
ajlm-100	85	30	and	and	CCONJ
ajlm-100	85	31	curative	curative	ADJ
ajlm-100	85	32	treatment	treatment	NOUN
ajlm-100	85	33	with	with	ADP
ajlm-100	85	34	melarsoprol	melarsoprol	NOUN
ajlm-100	85	35	(	(	PUNCT
ajlm-100	85	36	mel	mel	PROPN
ajlm-100	85	37	b	b	PROPN
ajlm-100	85	38	)	)	PUNCT
ajlm-100	85	39	.	.	PUNCT
ajlm-100	86	1	figure	figure	NOUN
ajlm-100	86	2	2	2	NUM
ajlm-100	86	3	:	:	PUNCT
ajlm-100	86	4	white	white	ADJ
ajlm-100	86	5	blood	blood	NOUN
ajlm-100	86	6	cell	cell	NOUN
ajlm-100	86	7	(	(	PUNCT
ajlm-100	86	8	wbc	wbc	NOUN
ajlm-100	86	9	)	)	PUNCT
ajlm-100	86	10	count	count	NOUN
ajlm-100	86	11	numbers	number	NOUN
ajlm-100	86	12	in	in	ADP
ajlm-100	86	13	the	the	DET
ajlm-100	86	14	cerebrospinal	cerebrospinal	ADJ
ajlm-100	86	15	fluid	fluid	NOUN
ajlm-100	86	16	of	of	ADP
ajlm-100	86	17	t.	t.	PROPN
ajlm-100	86	18	b.	b.	PROPN
ajlm-100	86	19	brucei	brucei	PROPN
ajlm-100	86	20	-	-	PUNCT
ajlm-100	86	21	infected	infect	VERB
ajlm-100	86	22	vervet	vervet	NOUN
ajlm-100	86	23	monkeys	monkey	NOUN
ajlm-100	86	24	,	,	PUNCT
ajlm-100	86	25	showing	show	VERB
ajlm-100	86	26	the	the	DET
ajlm-100	86	27	point	point	NOUN
ajlm-100	86	28	of	of	ADP
ajlm-100	86	29	subcurative	subcurative	ADJ
ajlm-100	86	30	treatment	treatment	NOUN
ajlm-100	86	31	with	with	ADP
ajlm-100	86	32	diminazene	diminazene	NOUN
ajlm-100	86	33	aceturate	aceturate	NOUN
ajlm-100	86	34	(	(	PUNCT
ajlm-100	86	35	da	da	NOUN
ajlm-100	86	36	)	)	PUNCT
ajlm-100	86	37	(	(	PUNCT
ajlm-100	86	38	28	28	NUM
ajlm-100	86	39	dpi	dpi	NOUN
ajlm-100	86	40	)	)	PUNCT
ajlm-100	86	41	and	and	CCONJ
ajlm-100	86	42	curative	curative	ADJ
ajlm-100	86	43	treatment	treatment	NOUN
ajlm-100	86	44	with	with	ADP
ajlm-100	86	45	melarsoprol	melarsoprol	NOUN
ajlm-100	86	46	(	(	PUNCT
ajlm-100	86	47	mel	mel	PROPN
ajlm-100	86	48	b	b	PROPN
ajlm-100	86	49	)	)	PUNCT
ajlm-100	86	50	(	(	PUNCT
ajlm-100	86	51	119	119	NUM
ajlm-100	86	52	dpi	dpi	NOUN
ajlm-100	86	53	)	)	PUNCT
ajlm-100	86	54	.	.	PUNCT
ajlm-100	87	1	haematology	haematology	NOUN
ajlm-100	87	2	profiles	profile	NOUN
ajlm-100	87	3	erythrocyte	erythrocyte	NOUN
ajlm-100	87	4	changes	change	NOUN
ajlm-100	87	5	in	in	ADP
ajlm-100	87	6	the	the	DET
ajlm-100	87	7	control	control	NOUN
ajlm-100	87	8	animals	animal	NOUN
ajlm-100	87	9	,	,	PUNCT
ajlm-100	87	10	the	the	DET
ajlm-100	87	11	mean	mean	ADJ
ajlm-100	87	12	total	total	ADJ
ajlm-100	87	13	red	red	ADJ
ajlm-100	87	14	blood	blood	NOUN
ajlm-100	87	15	cell	cell	NOUN
ajlm-100	87	16	(	(	PUNCT
ajlm-100	87	17	rbc	rbc	PROPN
ajlm-100	87	18	)	)	PUNCT
ajlm-100	87	19	count	count	NOUN
ajlm-100	87	20	was	be	AUX
ajlm-100	87	21	5.4	5.4	NUM
ajlm-100	87	22	x	x	SYM
ajlm-100	87	23	106	106	NUM
ajlm-100	87	24	cells	cell	NOUN
ajlm-100	87	25	/	/	SYM
ajlm-100	87	26	μl	μl	CCONJ
ajlm-100	87	27	,	,	PUNCT
ajlm-100	87	28	packed	packed	ADJ
ajlm-100	87	29	cell	cell	NOUN
ajlm-100	87	30	volume	volume	NOUN
ajlm-100	87	31	(	(	PUNCT
ajlm-100	87	32	pcv	pcv	NOUN
ajlm-100	87	33	)	)	PUNCT
ajlm-100	87	34	was	be	AUX
ajlm-100	87	35	42	42	NUM
ajlm-100	87	36	%	%	NOUN
ajlm-100	87	37	and	and	CCONJ
ajlm-100	87	38	haemoglobin	haemoglobin	NOUN
ajlm-100	87	39	(	(	PUNCT
ajlm-100	87	40	hb	hb	X
ajlm-100	87	41	)	)	PUNCT
ajlm-100	87	42	was	be	AUX
ajlm-100	87	43	12	12	NUM
ajlm-100	87	44	g	g	PROPN
ajlm-100	87	45	/	/	SYM
ajlm-100	87	46	dl	dl	PROPN
ajlm-100	87	47	.	.	PUNCT
ajlm-100	87	48	blood	blood	NOUN
ajlm-100	87	49	count	count	NOUN
ajlm-100	87	50	parameters	parameter	NOUN
ajlm-100	87	51	did	do	AUX
ajlm-100	87	52	not	not	PART
ajlm-100	87	53	change	change	VERB
ajlm-100	87	54	significantly	significantly	ADV
ajlm-100	87	55	throughout	throughout	ADP
ajlm-100	87	56	the	the	DET
ajlm-100	87	57	experimental	experimental	ADJ
ajlm-100	87	58	period	period	NOUN
ajlm-100	87	59	.	.	PUNCT
ajlm-100	88	1	however	however	ADV
ajlm-100	88	2	,	,	PUNCT
ajlm-100	88	3	by	by	ADP
ajlm-100	88	4	28	28	NUM
ajlm-100	88	5	dpi	dpi	NOUN
ajlm-100	88	6	,	,	PUNCT
ajlm-100	88	7	the	the	DET
ajlm-100	88	8	infected	infected	ADJ
ajlm-100	88	9	vervet	vervet	NOUN
ajlm-100	88	10	monkeys	monkey	NOUN
ajlm-100	88	11	had	have	VERB
ajlm-100	88	12	a	a	DET
ajlm-100	88	13	decrease	decrease	NOUN
ajlm-100	88	14	(	(	PUNCT
ajlm-100	88	15	p	p	X
ajlm-100	88	16	<	<	X
ajlm-100	88	17	0.05	0.05	NUM
ajlm-100	88	18	)	)	PUNCT
ajlm-100	88	19	in	in	ADP
ajlm-100	88	20	the	the	DET
ajlm-100	88	21	mean	mean	ADJ
ajlm-100	88	22	values	value	NOUN
ajlm-100	88	23	for	for	ADP
ajlm-100	88	24	the	the	DET
ajlm-100	88	25	rbc	rbc	PROPN
ajlm-100	88	26	count	count	PROPN
ajlm-100	88	27	,	,	PUNCT
ajlm-100	88	28	pcv	pcv	NOUN
ajlm-100	88	29	and	and	CCONJ
ajlm-100	88	30	hb	hb	PROPN
ajlm-100	88	31	values	value	NOUN
ajlm-100	88	32	to	to	ADP
ajlm-100	88	33	4.7	4.7	NUM
ajlm-100	88	34	x	x	SYM
ajlm-100	88	35	106	106	NUM
ajlm-100	88	36	±	±	NUM
ajlm-100	88	37	0.72	0.72	NUM
ajlm-100	88	38	cells	cell	NOUN
ajlm-100	88	39	/	/	SYM
ajlm-100	88	40	μl	μl	CCONJ
ajlm-100	88	41	,	,	PUNCT
ajlm-100	88	42	27	27	NUM
ajlm-100	88	43	±	±	NUM
ajlm-100	88	44	2.05	2.05	NUM
ajlm-100	88	45	%	%	NOUN
ajlm-100	88	46	and	and	CCONJ
ajlm-100	88	47	8.2	8.2	NUM
ajlm-100	88	48	±	±	NUM
ajlm-100	88	49	0.8	0.8	NUM
ajlm-100	88	50	g	g	PROPN
ajlm-100	88	51	/	/	SYM
ajlm-100	88	52	dl	dl	PROPN
ajlm-100	88	53	,	,	PUNCT
ajlm-100	88	54	respectively	respectively	ADV
ajlm-100	88	55	(	(	PUNCT
ajlm-100	88	56	figure	figure	NOUN
ajlm-100	88	57	3	3	NUM
ajlm-100	88	58	)	)	PUNCT
ajlm-100	88	59	.	.	PUNCT
ajlm-100	89	1	after	after	ADP
ajlm-100	89	2	subcurative	subcurative	ADJ
ajlm-100	89	3	treatment	treatment	NOUN
ajlm-100	89	4	,	,	PUNCT
ajlm-100	89	5	the	the	DET
ajlm-100	89	6	levels	level	NOUN
ajlm-100	89	7	increased	increase	VERB
ajlm-100	89	8	gradually	gradually	ADV
ajlm-100	89	9	to	to	ADP
ajlm-100	89	10	those	those	PRON
ajlm-100	89	11	of	of	ADP
ajlm-100	89	12	pre	pre	NOUN
ajlm-100	89	13	-	-	NOUN
ajlm-100	89	14	infection	infection	NOUN
ajlm-100	89	15	within	within	ADP
ajlm-100	89	16	14	14	NUM
ajlm-100	89	17	days	day	NOUN
ajlm-100	89	18	post	post	ADJ
ajlm-100	89	19	-	-	ADJ
ajlm-100	89	20	diminazene	diminazene	ADJ
ajlm-100	89	21	aceturate	aceturate	NOUN
ajlm-100	89	22	treatment	treatment	NOUN
ajlm-100	89	23	.	.	PUNCT
ajlm-100	90	1	blood	blood	NOUN
ajlm-100	90	2	count	count	NOUN
ajlm-100	90	3	parameters	parameter	NOUN
ajlm-100	90	4	decreased	decrease	VERB
ajlm-100	90	5	again	again	ADV
ajlm-100	90	6	at	at	ADP
ajlm-100	90	7	98	98	NUM
ajlm-100	90	8	dpi	dpi	NOUN
ajlm-100	90	9	but	but	CCONJ
ajlm-100	90	10	recovered	recover	VERB
ajlm-100	90	11	and	and	CCONJ
ajlm-100	90	12	attained	attain	VERB
ajlm-100	90	13	the	the	DET
ajlm-100	90	14	pre	pre	ADJ
ajlm-100	90	15	-	-	ADJ
ajlm-100	90	16	infection	infection	ADJ
ajlm-100	90	17	levels	level	NOUN
ajlm-100	90	18	within	within	ADP
ajlm-100	90	19	seven	seven	NUM
ajlm-100	90	20	days	day	NOUN
ajlm-100	90	21	of	of	ADP
ajlm-100	90	22	curative	curative	ADJ
ajlm-100	90	23	treatment	treatment	NOUN
ajlm-100	90	24	with	with	ADP
ajlm-100	90	25	melarsoprol	melarsoprol	PROPN
ajlm-100	90	26	.	.	PUNCT
ajlm-100	91	1	figure	figure	VERB
ajlm-100	91	2	3	3	NUM
ajlm-100	91	3	:	:	PUNCT
ajlm-100	91	4	mean	mean	ADJ
ajlm-100	91	5	changes	change	NOUN
ajlm-100	91	6	in	in	ADP
ajlm-100	91	7	red	red	ADJ
ajlm-100	91	8	blood	blood	NOUN
ajlm-100	91	9	cell	cell	NOUN
ajlm-100	91	10	(	(	PUNCT
ajlm-100	91	11	rbc	rbc	PROPN
ajlm-100	91	12	)	)	PUNCT
ajlm-100	91	13	counts	count	NOUN
ajlm-100	91	14	,	,	PUNCT
ajlm-100	91	15	packed	packed	ADJ
ajlm-100	91	16	cell	cell	NOUN
ajlm-100	91	17	volume	volume	NOUN
ajlm-100	91	18	(	(	PUNCT
ajlm-100	91	19	pcv	pcv	NOUN
ajlm-100	91	20	)	)	PUNCT
ajlm-100	91	21	and	and	CCONJ
ajlm-100	91	22	haemoglobin	haemoglobin	PROPN
ajlm-100	91	23	(	(	PUNCT
ajlm-100	91	24	hb	hb	X
ajlm-100	91	25	)	)	PUNCT
ajlm-100	91	26	of	of	ADP
ajlm-100	91	27	vervet	vervet	NOUN
ajlm-100	91	28	monkeys	monkey	NOUN
ajlm-100	91	29	infected	infect	VERB
ajlm-100	91	30	with	with	ADP
ajlm-100	91	31	t.	t.	PROPN
ajlm-100	91	32	b.	b.	PROPN
ajlm-100	91	33	brucei	brucei	PROPN
ajlm-100	91	34	gutat	gutat	PROPN
ajlm-100	91	35	1	1	NUM
ajlm-100	91	36	,	,	PUNCT
ajlm-100	91	37	showing	show	VERB
ajlm-100	91	38	the	the	DET
ajlm-100	91	39	point	point	NOUN
ajlm-100	91	40	of	of	ADP
ajlm-100	91	41	subcurative	subcurative	ADJ
ajlm-100	91	42	treatment	treatment	NOUN
ajlm-100	91	43	with	with	ADP
ajlm-100	91	44	diminazene	diminazene	NOUN
ajlm-100	91	45	aceturate	aceturate	NOUN
ajlm-100	91	46	(	(	PUNCT
ajlm-100	91	47	da	da	NOUN
ajlm-100	91	48	)	)	PUNCT
ajlm-100	91	49	(	(	PUNCT
ajlm-100	91	50	28	28	NUM
ajlm-100	91	51	dpi	dpi	NOUN
ajlm-100	91	52	)	)	PUNCT
ajlm-100	91	53	and	and	CCONJ
ajlm-100	91	54	curative	curative	ADJ
ajlm-100	91	55	treatment	treatment	NOUN
ajlm-100	91	56	with	with	ADP
ajlm-100	91	57	melarsoprol	melarsoprol	NOUN
ajlm-100	91	58	(	(	PUNCT
ajlm-100	91	59	mel	mel	PROPN
ajlm-100	91	60	b	b	PROPN
ajlm-100	91	61	)	)	PUNCT
ajlm-100	91	62	(	(	PUNCT
ajlm-100	91	63	119	119	NUM
ajlm-100	91	64	dpi	dpi	NOUN
ajlm-100	91	65	)	)	PUNCT
ajlm-100	91	66	.	.	PUNCT
ajlm-100	92	1	red	red	ADJ
ajlm-100	92	2	cell	cell	NOUN
ajlm-100	92	3	distribution	distribution	NOUN
ajlm-100	92	4	width	width	NOUN
ajlm-100	92	5	(	(	PUNCT
ajlm-100	92	6	rdw	rdw	X
ajlm-100	92	7	)	)	PUNCT
ajlm-100	92	8	increased	increase	VERB
ajlm-100	92	9	during	during	ADP
ajlm-100	92	10	early	early	ADJ
ajlm-100	92	11	-	-	PUNCT
ajlm-100	92	12	stage	stage	NOUN
ajlm-100	92	13	infection	infection	NOUN
ajlm-100	92	14	and	and	CCONJ
ajlm-100	92	15	peaked	peak	VERB
ajlm-100	92	16	(	(	PUNCT
ajlm-100	92	17	14.2	14.2	NUM
ajlm-100	92	18	±	±	NUM
ajlm-100	92	19	1.5	1.5	NUM
ajlm-100	92	20	%	%	NOUN
ajlm-100	92	21	)	)	PUNCT
ajlm-100	92	22	at	at	ADP
ajlm-100	92	23	42	42	NUM
ajlm-100	92	24	dpi	dpi	NOUN
ajlm-100	92	25	.	.	PUNCT
ajlm-100	93	1	thereafter	thereafter	ADV
ajlm-100	93	2	,	,	PUNCT
ajlm-100	93	3	rdw	rdw	PROPN
ajlm-100	93	4	decreased	decrease	VERB
ajlm-100	93	5	during	during	ADP
ajlm-100	93	6	late	late	ADJ
ajlm-100	93	7	-	-	PUNCT
ajlm-100	93	8	stage	stage	NOUN
ajlm-100	93	9	disease	disease	NOUN
ajlm-100	93	10	to	to	ADP
ajlm-100	93	11	normal	normal	ADJ
ajlm-100	93	12	levels	level	NOUN
ajlm-100	93	13	(	(	PUNCT
ajlm-100	93	14	10.5	10.5	NUM
ajlm-100	93	15	±	±	NUM
ajlm-100	93	16	0.6	0.6	NUM
ajlm-100	93	17	%	%	NOUN
ajlm-100	93	18	)	)	PUNCT
ajlm-100	93	19	at	at	ADP
ajlm-100	93	20	140	140	NUM
ajlm-100	93	21	dpi	dpi	NOUN
ajlm-100	93	22	.	.	PUNCT
ajlm-100	94	1	a	a	DET
ajlm-100	94	2	decrease	decrease	NOUN
ajlm-100	94	3	in	in	ADP
ajlm-100	94	4	mean	mean	ADJ
ajlm-100	94	5	corpuscular	corpuscular	NOUN
ajlm-100	94	6	volume	volume	NOUN
ajlm-100	94	7	(	(	PUNCT
ajlm-100	94	8	mcv	mcv	PROPN
ajlm-100	94	9	)	)	PUNCT
ajlm-100	94	10	was	be	AUX
ajlm-100	94	11	observed	observe	VERB
ajlm-100	94	12	from	from	ADP
ajlm-100	94	13	the	the	DET
ajlm-100	94	14	onset	onset	NOUN
ajlm-100	94	15	of	of	ADP
ajlm-100	94	16	infection	infection	NOUN
ajlm-100	94	17	until	until	SCONJ
ajlm-100	94	18	7	7	NUM
ajlm-100	94	19	dpi	dpi	NOUN
ajlm-100	94	20	,	,	PUNCT
ajlm-100	94	21	after	after	SCONJ
ajlm-100	94	22	subcurative	subcurative	ADJ
ajlm-100	94	23	treatment	treatment	NOUN
ajlm-100	94	24	with	with	ADP
ajlm-100	94	25	diminazene	diminazene	NOUN
ajlm-100	94	26	aceturate	aceturate	VERB
ajlm-100	94	27	,	,	PUNCT
ajlm-100	94	28	thereafter	thereafter	ADV
ajlm-100	94	29	returning	return	VERB
ajlm-100	94	30	to	to	ADP
ajlm-100	94	31	pre	pre	ADJ
ajlm-100	94	32	-	-	ADJ
ajlm-100	94	33	infection	infection	ADJ
ajlm-100	94	34	levels	level	NOUN
ajlm-100	94	35	(	(	PUNCT
ajlm-100	94	36	figure	figure	NOUN
ajlm-100	94	37	4	4	NUM
ajlm-100	94	38	)	)	PUNCT
ajlm-100	94	39	.	.	PUNCT
ajlm-100	95	1	mean	mean	VERB
ajlm-100	95	2	corpuscular	corpuscular	PROPN
ajlm-100	95	3	haemoglobin	haemoglobin	NOUN
ajlm-100	95	4	(	(	PUNCT
ajlm-100	95	5	mch	mch	PROPN
ajlm-100	95	6	)	)	PUNCT
ajlm-100	95	7	decreased	decrease	VERB
ajlm-100	95	8	14	14	NUM
ajlm-100	95	9	dpi	dpi	NOUN
ajlm-100	95	10	from	from	ADP
ajlm-100	95	11	23.5	23.5	NUM
ajlm-100	95	12	to	to	PART
ajlm-100	95	13	22.5	22.5	NUM
ajlm-100	95	14	pg	pg	NOUN
ajlm-100	95	15	,	,	PUNCT
ajlm-100	95	16	levelling	level	VERB
ajlm-100	95	17	off	off	ADP
ajlm-100	95	18	by	by	ADP
ajlm-100	95	19	28	28	NUM
ajlm-100	95	20	dpi	dpi	NOUN
ajlm-100	95	21	.	.	PUNCT
ajlm-100	96	1	levels	level	NOUN
ajlm-100	96	2	appeared	appear	VERB
ajlm-100	96	3	stable	stable	ADJ
ajlm-100	96	4	after	after	ADP
ajlm-100	96	5	melarsoprol	melarsoprol	NOUN
ajlm-100	96	6	treatment	treatment	NOUN
ajlm-100	96	7	(	(	PUNCT
ajlm-100	96	8	119	119	NUM
ajlm-100	96	9	dpi	dpi	NOUN
ajlm-100	96	10	)	)	PUNCT
ajlm-100	96	11	,	,	PUNCT
ajlm-100	96	12	returning	return	VERB
ajlm-100	96	13	to	to	ADP
ajlm-100	96	14	pre	pre	ADJ
ajlm-100	96	15	-	-	ADJ
ajlm-100	96	16	infection	infection	ADJ
ajlm-100	96	17	levels	level	NOUN
ajlm-100	96	18	by	by	ADP
ajlm-100	96	19	140	140	NUM
ajlm-100	96	20	dpi	dpi	NOUN
ajlm-100	96	21	(	(	PUNCT
ajlm-100	96	22	figure	figure	NOUN
ajlm-100	96	23	5	5	NUM
ajlm-100	96	24	)	)	PUNCT
ajlm-100	96	25	.	.	PUNCT
ajlm-100	97	1	figure	figure	VERB
ajlm-100	97	2	4	4	NUM
ajlm-100	97	3	:	:	PUNCT
ajlm-100	97	4	mean	mean	ADJ
ajlm-100	97	5	changes	change	NOUN
ajlm-100	97	6	in	in	ADP
ajlm-100	97	7	red	red	ADJ
ajlm-100	97	8	cell	cell	NOUN
ajlm-100	97	9	distribution	distribution	NOUN
ajlm-100	97	10	width	width	NOUN
ajlm-100	97	11	(	(	PUNCT
ajlm-100	97	12	rdw	rdw	NOUN
ajlm-100	97	13	)	)	PUNCT
ajlm-100	97	14	and	and	CCONJ
ajlm-100	97	15	mean	mean	VERB
ajlm-100	97	16	cell	cell	NOUN
ajlm-100	97	17	volume	volume	NOUN
ajlm-100	97	18	(	(	PUNCT
ajlm-100	97	19	mcv	mcv	PROPN
ajlm-100	97	20	)	)	PUNCT
ajlm-100	97	21	of	of	ADP
ajlm-100	97	22	vervet	vervet	NOUN
ajlm-100	97	23	monkeys	monkey	NOUN
ajlm-100	97	24	infected	infect	VERB
ajlm-100	97	25	with	with	ADP
ajlm-100	97	26	t.	t.	PROPN
ajlm-100	97	27	b.	b.	PROPN
ajlm-100	97	28	brucei	brucei	PROPN
ajlm-100	97	29	gutat	gutat	PROPN
ajlm-100	97	30	1	1	NUM
ajlm-100	97	31	,	,	PUNCT
ajlm-100	97	32	showing	show	VERB
ajlm-100	97	33	the	the	DET
ajlm-100	97	34	point	point	NOUN
ajlm-100	97	35	of	of	ADP
ajlm-100	97	36	subcurative	subcurative	ADJ
ajlm-100	97	37	treatment	treatment	NOUN
ajlm-100	97	38	with	with	ADP
ajlm-100	97	39	diminazene	diminazene	NOUN
ajlm-100	97	40	aceturate	aceturate	NOUN
ajlm-100	97	41	(	(	PUNCT
ajlm-100	97	42	da	da	NOUN
ajlm-100	97	43	)	)	PUNCT
ajlm-100	97	44	(	(	PUNCT
ajlm-100	97	45	28	28	NUM
ajlm-100	97	46	dpi	dpi	NOUN
ajlm-100	97	47	)	)	PUNCT
ajlm-100	97	48	and	and	CCONJ
ajlm-100	97	49	curative	curative	ADJ
ajlm-100	97	50	treatment	treatment	NOUN
ajlm-100	97	51	with	with	ADP
ajlm-100	97	52	melarsoprol	melarsoprol	NOUN
ajlm-100	97	53	(	(	PUNCT
ajlm-100	97	54	mel	mel	PROPN
ajlm-100	97	55	b	b	PROPN
ajlm-100	97	56	)	)	PUNCT
ajlm-100	97	57	(	(	PUNCT
ajlm-100	97	58	119	119	NUM
ajlm-100	97	59	dpi	dpi	NOUN
ajlm-100	97	60	)	)	PUNCT
ajlm-100	97	61	.	.	PUNCT
ajlm-100	98	1	figure	figure	VERB
ajlm-100	98	2	5	5	NUM
ajlm-100	98	3	:	:	PUNCT
ajlm-100	98	4	mean	mean	ADJ
ajlm-100	98	5	changes	change	NOUN
ajlm-100	98	6	in	in	ADP
ajlm-100	98	7	mean	mean	ADJ
ajlm-100	98	8	corpuscular	corpuscular	ADJ
ajlm-100	98	9	haemoglobin	haemoglobin	NOUN
ajlm-100	98	10	(	(	PUNCT
ajlm-100	98	11	mch	mch	PROPN
ajlm-100	98	12	)	)	PUNCT
ajlm-100	98	13	and	and	CCONJ
ajlm-100	98	14	mean	mean	VERB
ajlm-100	98	15	corpuscular	corpuscular	ADJ
ajlm-100	98	16	haemoglobin	haemoglobin	NOUN
ajlm-100	98	17	concentration	concentration	NOUN
ajlm-100	98	18	(	(	PUNCT
ajlm-100	98	19	mchc	mchc	NOUN
ajlm-100	98	20	)	)	PUNCT
ajlm-100	98	21	in	in	ADP
ajlm-100	98	22	vervet	vervet	NOUN
ajlm-100	98	23	monkeys	monkey	NOUN
ajlm-100	98	24	infected	infect	VERB
ajlm-100	98	25	with	with	ADP
ajlm-100	98	26	t.	t.	PROPN
ajlm-100	98	27	b.	b.	PROPN
ajlm-100	98	28	brucei	brucei	PROPN
ajlm-100	98	29	gutat	gutat	PROPN
ajlm-100	98	30	1	1	NUM
ajlm-100	98	31	,	,	PUNCT
ajlm-100	98	32	showing	show	VERB
ajlm-100	98	33	the	the	DET
ajlm-100	98	34	point	point	NOUN
ajlm-100	98	35	of	of	ADP
ajlm-100	98	36	subcurative	subcurative	ADJ
ajlm-100	98	37	treatment	treatment	NOUN
ajlm-100	98	38	with	with	ADP
ajlm-100	98	39	diminazene	diminazene	NOUN
ajlm-100	98	40	aceturate	aceturate	NOUN
ajlm-100	98	41	(	(	PUNCT
ajlm-100	98	42	da	da	NOUN
ajlm-100	98	43	)	)	PUNCT
ajlm-100	98	44	(	(	PUNCT
ajlm-100	98	45	28	28	NUM
ajlm-100	98	46	dpi	dpi	NOUN
ajlm-100	98	47	)	)	PUNCT
ajlm-100	98	48	and	and	CCONJ
ajlm-100	98	49	curative	curative	ADJ
ajlm-100	98	50	treatment	treatment	NOUN
ajlm-100	98	51	with	with	ADP
ajlm-100	98	52	melarsoprol	melarsoprol	NOUN
ajlm-100	98	53	(	(	PUNCT
ajlm-100	98	54	mel	mel	PROPN
ajlm-100	98	55	b	b	PROPN
ajlm-100	98	56	)	)	PUNCT
ajlm-100	98	57	(	(	PUNCT
ajlm-100	98	58	119	119	NUM
ajlm-100	98	59	dpi	dpi	NOUN
ajlm-100	98	60	)	)	PUNCT
ajlm-100	98	61	.	.	PUNCT
ajlm-100	99	1	platelets	platelet	VERB
ajlm-100	99	2	platelet	platelet	NOUN
ajlm-100	99	3	numbers	number	NOUN
ajlm-100	99	4	declined	decline	VERB
ajlm-100	99	5	after	after	ADP
ajlm-100	99	6	infection	infection	NOUN
ajlm-100	99	7	,	,	PUNCT
ajlm-100	99	8	reaching	reach	VERB
ajlm-100	99	9	their	their	PRON
ajlm-100	99	10	lowest	low	ADJ
ajlm-100	99	11	levels	level	NOUN
ajlm-100	99	12	(	(	PUNCT
ajlm-100	99	13	58.5	58.5	NUM
ajlm-100	99	14	×	×	NOUN
ajlm-100	99	15	10³	10³	NUM
ajlm-100	99	16	±	±	NUM
ajlm-100	99	17	0.15	0.15	NUM
ajlm-100	99	18	cells/µl	cells/µl	NOUN
ajlm-100	99	19	)	)	PUNCT
ajlm-100	99	20	at	at	ADP
ajlm-100	99	21	21	21	NUM
ajlm-100	99	22	dpi	dpi	NOUN
ajlm-100	99	23	.	.	PUNCT
ajlm-100	100	1	levels	level	NOUN
ajlm-100	100	2	increased	increase	VERB
ajlm-100	100	3	after	after	SCONJ
ajlm-100	100	4	subcurative	subcurative	ADJ
ajlm-100	100	5	treatment	treatment	NOUN
ajlm-100	100	6	with	with	ADP
ajlm-100	100	7	diminazene	diminazene	NOUN
ajlm-100	100	8	aceturate	aceturate	VERB
ajlm-100	100	9	,	,	PUNCT
ajlm-100	100	10	returning	return	VERB
ajlm-100	100	11	to	to	ADP
ajlm-100	100	12	those	those	PRON
ajlm-100	100	13	of	of	ADP
ajlm-100	100	14	pre	pre	NOUN
ajlm-100	100	15	-	-	NOUN
ajlm-100	100	16	infection	infection	NOUN
ajlm-100	100	17	by	by	ADP
ajlm-100	100	18	56	56	NUM
ajlm-100	100	19	dpi	dpi	NOUN
ajlm-100	100	20	(	(	PUNCT
ajlm-100	100	21	figure	figure	NOUN
ajlm-100	100	22	6	6	NUM
ajlm-100	100	23	)	)	PUNCT
ajlm-100	100	24	.	.	PUNCT
ajlm-100	101	1	platelet	platelet	NOUN
ajlm-100	101	2	counts	count	NOUN
ajlm-100	101	3	decreased	decrease	VERB
ajlm-100	101	4	steadily	steadily	ADV
ajlm-100	101	5	for	for	ADP
ajlm-100	101	6	three	three	NUM
ajlm-100	101	7	weeks	week	NOUN
ajlm-100	101	8	before	before	ADP
ajlm-100	101	9	trypanosome	trypanosome	NOUN
ajlm-100	101	10	relapse	relapse	NOUN
ajlm-100	101	11	in	in	ADP
ajlm-100	101	12	the	the	DET
ajlm-100	101	13	blood	blood	NOUN
ajlm-100	101	14	(	(	PUNCT
ajlm-100	101	15	84	84	NUM
ajlm-100	101	16	dpi	dpi	NOUN
ajlm-100	101	17	)	)	PUNCT
ajlm-100	101	18	,	,	PUNCT
ajlm-100	101	19	but	but	CCONJ
ajlm-100	101	20	stabilised	stabilise	VERB
ajlm-100	101	21	to	to	ADP
ajlm-100	101	22	pre	pre	ADJ
ajlm-100	101	23	-	-	ADJ
ajlm-100	101	24	infection	infection	ADJ
ajlm-100	101	25	levels	level	NOUN
ajlm-100	101	26	(	(	PUNCT
ajlm-100	101	27	550	550	NUM
ajlm-100	101	28	×	×	NOUN
ajlm-100	101	29	10³	10³	NUM
ajlm-100	101	30	cells/µl	cells/µl	NOUN
ajlm-100	101	31	)	)	PUNCT
ajlm-100	101	32	after	after	ADP
ajlm-100	101	33	melarsoprol	melarsoprol	NOUN
ajlm-100	101	34	treatment	treatment	NOUN
ajlm-100	101	35	(	(	PUNCT
ajlm-100	101	36	119	119	NUM
ajlm-100	101	37	dpi	dpi	NOUN
ajlm-100	101	38	)	)	PUNCT
ajlm-100	101	39	.	.	PUNCT
ajlm-100	102	1	figure	figure	VERB
ajlm-100	102	2	6	6	NUM
ajlm-100	102	3	:	:	PUNCT
ajlm-100	102	4	changes	change	NOUN
ajlm-100	102	5	in	in	ADP
ajlm-100	102	6	mean	mean	ADJ
ajlm-100	102	7	platelet	platelet	NOUN
ajlm-100	102	8	numbers	number	NOUN
ajlm-100	102	9	in	in	ADP
ajlm-100	102	10	vervet	vervet	NOUN
ajlm-100	102	11	monkeys	monkey	NOUN
ajlm-100	102	12	infected	infect	VERB
ajlm-100	102	13	with	with	ADP
ajlm-100	102	14	t.	t.	PROPN
ajlm-100	102	15	b.	b.	PROPN
ajlm-100	102	16	brucei	brucei	PROPN
ajlm-100	102	17	gutat	gutat	PROPN
ajlm-100	102	18	1	1	NUM
ajlm-100	102	19	,	,	PUNCT
ajlm-100	102	20	showing	show	VERB
ajlm-100	102	21	the	the	DET
ajlm-100	102	22	point	point	NOUN
ajlm-100	102	23	of	of	ADP
ajlm-100	102	24	subcurative	subcurative	ADJ
ajlm-100	102	25	treatment	treatment	NOUN
ajlm-100	102	26	with	with	ADP
ajlm-100	102	27	diminazene	diminazene	NOUN
ajlm-100	102	28	aceturate	aceturate	NOUN
ajlm-100	102	29	(	(	PUNCT
ajlm-100	102	30	da	da	NOUN
ajlm-100	102	31	)	)	PUNCT
ajlm-100	102	32	(	(	PUNCT
ajlm-100	102	33	28	28	NUM
ajlm-100	102	34	dpi	dpi	NOUN
ajlm-100	102	35	)	)	PUNCT
ajlm-100	102	36	and	and	CCONJ
ajlm-100	102	37	curative	curative	ADJ
ajlm-100	102	38	treatment	treatment	NOUN
ajlm-100	102	39	with	with	ADP
ajlm-100	102	40	melarsoprol	melarsoprol	NOUN
ajlm-100	102	41	(	(	PUNCT
ajlm-100	102	42	mel	mel	PROPN
ajlm-100	102	43	b	b	PROPN
ajlm-100	102	44	)	)	PUNCT
ajlm-100	102	45	(	(	PUNCT
ajlm-100	102	46	119	119	NUM
ajlm-100	102	47	dpi	dpi	NOUN
ajlm-100	102	48	)	)	PUNCT
ajlm-100	102	49	.	.	PUNCT
ajlm-100	103	1	leucocytes	leucocyte	NOUN
ajlm-100	103	2	in	in	ADP
ajlm-100	103	3	uninfected	uninfected	ADJ
ajlm-100	103	4	animals	animal	NOUN
ajlm-100	103	5	,	,	PUNCT
ajlm-100	103	6	the	the	DET
ajlm-100	103	7	mean	mean	ADJ
ajlm-100	103	8	total	total	ADJ
ajlm-100	103	9	wbc	wbc	PROPN
ajlm-100	103	10	count	count	NOUN
ajlm-100	103	11	ranged	range	VERB
ajlm-100	103	12	from	from	ADP
ajlm-100	103	13	4.3	4.3	NUM
ajlm-100	103	14	x	x	SYM
ajlm-100	103	15	103	103	NUM
ajlm-100	103	16	cells	cell	NOUN
ajlm-100	103	17	/	/	SYM
ajlm-100	103	18	μl	μl	ADV
ajlm-100	103	19	to	to	ADP
ajlm-100	103	20	5.7	5.7	NUM
ajlm-100	103	21	x	x	SYM
ajlm-100	103	22	103	103	NUM
ajlm-100	103	23	cells	cell	NOUN
ajlm-100	103	24	/	/	SYM
ajlm-100	103	25	μl	μl	ADV
ajlm-100	103	26	and	and	CCONJ
ajlm-100	103	27	did	do	AUX
ajlm-100	103	28	not	not	PART
ajlm-100	103	29	change	change	VERB
ajlm-100	103	30	significantly	significantly	ADV
ajlm-100	103	31	throughout	throughout	ADP
ajlm-100	103	32	the	the	DET
ajlm-100	103	33	experimental	experimental	ADJ
ajlm-100	103	34	period	period	NOUN
ajlm-100	103	35	(	(	PUNCT
ajlm-100	103	36	p	p	X
ajlm-100	103	37	<	<	X
ajlm-100	103	38	0.05	0.05	NUM
ajlm-100	103	39	)	)	PUNCT
ajlm-100	103	40	.	.	PUNCT
ajlm-100	103	41	.	.	PUNCT
ajlm-100	104	1	mean	mean	VERB
ajlm-100	104	2	neutrophil	neutrophil	ADJ
ajlm-100	104	3	counts	count	NOUN
ajlm-100	104	4	ranged	range	VERB
ajlm-100	104	5	from	from	ADP
ajlm-100	104	6	1.72	1.72	NUM
ajlm-100	104	7	x	x	SYM
ajlm-100	104	8	103	103	NUM
ajlm-100	104	9	cells/µl	cells/µl	NOUN
ajlm-100	104	10	to	to	ADP
ajlm-100	104	11	2.12	2.12	NUM
ajlm-100	104	12	x103	x103	NUM
ajlm-100	104	13	cells/µl	cells/µl	NOUN
ajlm-100	104	14	,	,	PUNCT
ajlm-100	104	15	lymphocyte	lymphocyte	ADJ
ajlm-100	104	16	counts	count	NOUN
ajlm-100	104	17	from	from	ADP
ajlm-100	104	18	3.6	3.6	NUM
ajlm-100	104	19	x103	x103	NUM
ajlm-100	104	20	cells/µl	cells/µl	NOUN
ajlm-100	104	21	to	to	ADP
ajlm-100	104	22	4.48	4.48	NUM
ajlm-100	104	23	x	x	SYM
ajlm-100	104	24	103	103	NUM
ajlm-100	104	25	cells	cell	NOUN
ajlm-100	104	26	/	/	SYM
ajlm-100	104	27	ul	ul	NOUN
ajlm-100	104	28	and	and	CCONJ
ajlm-100	104	29	monocyte	monocyte	NOUN
ajlm-100	104	30	counts	count	VERB
ajlm-100	104	31	from	from	ADP
ajlm-100	104	32	0.3	0.3	NUM
ajlm-100	104	33	x	x	SYM
ajlm-100	104	34	103	103	NUM
ajlm-100	104	35	cells/µl	cells/µl	NOUN
ajlm-100	104	36	to	to	ADP
ajlm-100	104	37	0.26	0.26	NUM
ajlm-100	104	38	x	x	SYM
ajlm-100	104	39	103	103	NUM
ajlm-100	104	40	cells/µl	cells/µl	NOUN
ajlm-100	104	41	.	.	PUNCT
ajlm-100	105	1	none	none	NOUN
ajlm-100	105	2	of	of	ADP
ajlm-100	105	3	these	these	DET
ajlm-100	105	4	counts	count	NOUN
ajlm-100	105	5	changed	change	VERB
ajlm-100	105	6	significantly	significantly	ADV
ajlm-100	105	7	throughout	throughout	ADP
ajlm-100	105	8	the	the	DET
ajlm-100	105	9	experimental	experimental	ADJ
ajlm-100	105	10	period	period	NOUN
ajlm-100	105	11	(	(	PUNCT
ajlm-100	105	12	p	p	X
ajlm-100	105	13	<	<	X
ajlm-100	105	14	0.05	0.05	NUM
ajlm-100	105	15	)	)	PUNCT
ajlm-100	105	16	.	.	PUNCT
ajlm-100	106	1	in	in	ADP
ajlm-100	106	2	infected	infected	ADJ
ajlm-100	106	3	animals	animal	NOUN
ajlm-100	106	4	,	,	PUNCT
ajlm-100	106	5	total	total	ADJ
ajlm-100	106	6	wbc	wbc	PROPN
ajlm-100	106	7	counts	count	NOUN
ajlm-100	106	8	declined	decline	VERB
ajlm-100	106	9	during	during	ADP
ajlm-100	106	10	early	early	ADJ
ajlm-100	106	11	stage	stage	NOUN
ajlm-100	106	12	infection	infection	NOUN
ajlm-100	106	13	(	(	PUNCT
ajlm-100	106	14	4.7	4.7	NUM
ajlm-100	106	15	x	x	SYM
ajlm-100	106	16	103	103	NUM
ajlm-100	106	17	cells/µl	cells/µl	NOUN
ajlm-100	106	18	to	to	ADP
ajlm-100	106	19	2.5	2.5	NUM
ajlm-100	106	20	x	x	SYM
ajlm-100	106	21	103	103	NUM
ajlm-100	106	22	cells/µl	cells/µl	NOUN
ajlm-100	106	23	)	)	PUNCT
ajlm-100	106	24	.	.	PUNCT
ajlm-100	107	1	after	after	SCONJ
ajlm-100	107	2	subcurative	subcurative	ADJ
ajlm-100	107	3	treatment	treatment	NOUN
ajlm-100	107	4	with	with	ADP
ajlm-100	107	5	diminazene	diminazene	NOUN
ajlm-100	107	6	aceturate	aceturate	VERB
ajlm-100	107	7	,	,	PUNCT
ajlm-100	107	8	wbc	wbc	PROPN
ajlm-100	107	9	counts	count	NOUN
ajlm-100	107	10	increased	increase	VERB
ajlm-100	107	11	and	and	CCONJ
ajlm-100	107	12	were	be	AUX
ajlm-100	107	13	significantly	significantly	ADV
ajlm-100	107	14	higher	high	ADJ
ajlm-100	107	15	at	at	ADP
ajlm-100	107	16	84	84	NUM
ajlm-100	107	17	dpi	dpi	NOUN
ajlm-100	107	18	(	(	PUNCT
ajlm-100	107	19	7.7	7.7	NUM
ajlm-100	107	20	x	x	SYM
ajlm-100	107	21	103	103	NUM
ajlm-100	107	22	±	±	NUM
ajlm-100	107	23	1.75	1.75	NUM
ajlm-100	107	24	cell/µl	cell/µl	PROPN
ajlm-100	107	25	,	,	PUNCT
ajlm-100	107	26	p	p	X
ajlm-100	107	27	<	<	X
ajlm-100	107	28	0.05	0.05	NUM
ajlm-100	107	29	)	)	PUNCT
ajlm-100	107	30	than	than	ADP
ajlm-100	107	31	pre	pre	ADJ
ajlm-100	107	32	-	-	ADJ
ajlm-100	107	33	infection	infection	ADJ
ajlm-100	107	34	levels	level	NOUN
ajlm-100	107	35	(	(	PUNCT
ajlm-100	107	36	4.3	4.3	NUM
ajlm-100	107	37	x	x	SYM
ajlm-100	107	38	103	103	NUM
ajlm-100	107	39	±	±	NUM
ajlm-100	107	40	1.18	1.18	NUM
ajlm-100	107	41	cells/µl	cells/µl	NOUN
ajlm-100	107	42	)	)	PUNCT
ajlm-100	107	43	.	.	PUNCT
ajlm-100	108	1	thereafter	thereafter	ADV
ajlm-100	108	2	,	,	PUNCT
ajlm-100	108	3	wbc	wbc	PROPN
ajlm-100	108	4	counts	count	NOUN
ajlm-100	108	5	declined	decline	VERB
ajlm-100	108	6	to	to	ADP
ajlm-100	108	7	3	3	NUM
ajlm-100	108	8	x	x	SYM
ajlm-100	108	9	103	103	NUM
ajlm-100	108	10	cells/µl	cells/µl	NOUN
ajlm-100	108	11	by	by	ADP
ajlm-100	108	12	154	154	NUM
ajlm-100	108	13	dpi	dpi	NOUN
ajlm-100	108	14	.	.	PUNCT
ajlm-100	109	1	both	both	CCONJ
ajlm-100	109	2	lymphocyte	lymphocyte	ADJ
ajlm-100	109	3	and	and	CCONJ
ajlm-100	109	4	neutrophil	neutrophil	ADJ
ajlm-100	109	5	counts	count	NOUN
ajlm-100	109	6	followed	follow	VERB
ajlm-100	109	7	a	a	DET
ajlm-100	109	8	similar	similar	ADJ
ajlm-100	109	9	pattern	pattern	NOUN
ajlm-100	109	10	(	(	PUNCT
ajlm-100	109	11	figure	figure	NOUN
ajlm-100	109	12	7	7	NUM
ajlm-100	109	13	)	)	PUNCT
ajlm-100	109	14	.	.	PUNCT
ajlm-100	110	1	changes	change	NOUN
ajlm-100	110	2	in	in	ADP
ajlm-100	110	3	eosinophil	eosinophil	ADJ
ajlm-100	110	4	and	and	CCONJ
ajlm-100	110	5	basophil	basophil	NOUN
ajlm-100	110	6	counts	count	NOUN
ajlm-100	110	7	were	be	AUX
ajlm-100	110	8	not	not	PART
ajlm-100	110	9	significant	significant	ADJ
ajlm-100	110	10	during	during	ADP
ajlm-100	110	11	the	the	DET
ajlm-100	110	12	course	course	NOUN
ajlm-100	110	13	of	of	ADP
ajlm-100	110	14	the	the	DET
ajlm-100	110	15	disease	disease	NOUN
ajlm-100	110	16	.	.	PUNCT
ajlm-100	111	1	monocyte	monocyte	PROPN
ajlm-100	111	2	counts	count	NOUN
ajlm-100	111	3	dropped	drop	VERB
ajlm-100	111	4	significantly	significantly	ADV
ajlm-100	111	5	from	from	ADP
ajlm-100	111	6	0.2	0.2	NUM
ajlm-100	111	7	x	x	SYM
ajlm-100	111	8	103	103	NUM
ajlm-100	111	9	cells/µl	cells/µl	NOUN
ajlm-100	111	10	to	to	ADP
ajlm-100	111	11	0.07	0.07	NUM
ajlm-100	111	12	x	x	SYM
ajlm-100	111	13	103	103	NUM
ajlm-100	111	14	cells/µl	cells/µl	NOUN
ajlm-100	111	15	between	between	ADP
ajlm-100	111	16	0	0	NUM
ajlm-100	111	17	and	and	CCONJ
ajlm-100	111	18	14	14	NUM
ajlm-100	111	19	dpi	dpi	NOUN
ajlm-100	111	20	.	.	PUNCT
ajlm-100	112	1	they	they	PRON
ajlm-100	112	2	then	then	ADV
ajlm-100	112	3	peaked	peak	VERB
ajlm-100	112	4	at	at	ADP
ajlm-100	112	5	42	42	NUM
ajlm-100	112	6	dpi	dpi	NOUN
ajlm-100	112	7	(	(	PUNCT
ajlm-100	112	8	0.38	0.38	NUM
ajlm-100	112	9	x	x	SYM
ajlm-100	112	10	103	103	NUM
ajlm-100	112	11	±	±	NUM
ajlm-100	112	12	0.04	0.04	NUM
ajlm-100	112	13	cells/µl	cells/µl	NOUN
ajlm-100	112	14	)	)	PUNCT
ajlm-100	112	15	,	,	PUNCT
ajlm-100	112	16	after	after	ADP
ajlm-100	112	17	which	which	PRON
ajlm-100	112	18	there	there	PRON
ajlm-100	112	19	was	be	VERB
ajlm-100	112	20	a	a	DET
ajlm-100	112	21	decline	decline	NOUN
ajlm-100	112	22	.	.	PUNCT
ajlm-100	113	1	a	a	DET
ajlm-100	113	2	further	further	ADJ
ajlm-100	113	3	increase	increase	NOUN
ajlm-100	113	4	in	in	ADP
ajlm-100	113	5	monocyte	monocyte	NOUN
ajlm-100	113	6	counts	count	NOUN
ajlm-100	113	7	was	be	AUX
ajlm-100	113	8	noted	note	VERB
ajlm-100	113	9	,	,	PUNCT
ajlm-100	113	10	starting	start	VERB
ajlm-100	113	11	at	at	ADP
ajlm-100	113	12	112	112	NUM
ajlm-100	113	13	dpi	dpi	NOUN
ajlm-100	113	14	with	with	ADP
ajlm-100	113	15	a	a	DET
ajlm-100	113	16	peak	peak	NOUN
ajlm-100	113	17	at	at	ADP
ajlm-100	113	18	126	126	NUM
ajlm-100	113	19	dpi	dpi	NOUN
ajlm-100	113	20	(	(	PUNCT
ajlm-100	113	21	0.3	0.3	NUM
ajlm-100	113	22	x	x	SYM
ajlm-100	113	23	103	103	NUM
ajlm-100	113	24	±	±	NUM
ajlm-100	113	25	0.05	0.05	NUM
ajlm-100	113	26	cells/µl	cells/µl	NOUN
ajlm-100	113	27	)	)	PUNCT
ajlm-100	113	28	(	(	PUNCT
ajlm-100	113	29	figure	figure	NOUN
ajlm-100	113	30	8)	8)	NUM
ajlm-100	113	31	.	.	PUNCT
ajlm-100	114	1	figure	figure	NOUN
ajlm-100	114	2	7	7	NUM
ajlm-100	114	3	:	:	PUNCT
ajlm-100	114	4	mean	mean	ADJ
ajlm-100	114	5	changes	change	NOUN
ajlm-100	114	6	in	in	ADP
ajlm-100	114	7	total	total	ADJ
ajlm-100	114	8	white	white	ADJ
ajlm-100	114	9	blood	blood	NOUN
ajlm-100	114	10	cells	cell	NOUN
ajlm-100	114	11	(	(	PUNCT
ajlm-100	114	12	wbc	wbc	PROPN
ajlm-100	114	13	)	)	PUNCT
ajlm-100	114	14	,	,	PUNCT
ajlm-100	114	15	lymphocyte	lymphocyte	ADJ
ajlm-100	114	16	and	and	CCONJ
ajlm-100	114	17	neutrophil	neutrophil	ADJ
ajlm-100	114	18	counts	count	NOUN
ajlm-100	114	19	of	of	ADP
ajlm-100	114	20	t.	t.	PROPN
ajlm-100	114	21	b.	b.	PROPN
ajlm-100	114	22	brucei	brucei	PROPN
ajlm-100	114	23	gutat	gutat	PROPN
ajlm-100	114	24	1	1	NUM
ajlm-100	114	25	-	-	PUNCT
ajlm-100	114	26	infected	infect	VERB
ajlm-100	114	27	vervet	vervet	NOUN
ajlm-100	114	28	monkeys	monkey	NOUN
ajlm-100	114	29	showing	show	VERB
ajlm-100	114	30	the	the	DET
ajlm-100	114	31	point	point	NOUN
ajlm-100	114	32	of	of	ADP
ajlm-100	114	33	subcurative	subcurative	ADJ
ajlm-100	114	34	treatment	treatment	NOUN
ajlm-100	114	35	with	with	ADP
ajlm-100	114	36	diminazene	diminazene	NOUN
ajlm-100	114	37	aceturate	aceturate	NOUN
ajlm-100	114	38	(	(	PUNCT
ajlm-100	114	39	da	da	NOUN
ajlm-100	114	40	)	)	PUNCT
ajlm-100	114	41	(	(	PUNCT
ajlm-100	114	42	28	28	NUM
ajlm-100	114	43	dpi	dpi	NOUN
ajlm-100	114	44	)	)	PUNCT
ajlm-100	114	45	and	and	CCONJ
ajlm-100	114	46	curative	curative	ADJ
ajlm-100	114	47	treatment	treatment	NOUN
ajlm-100	114	48	with	with	ADP
ajlm-100	114	49	melarsoprol	melarsoprol	NOUN
ajlm-100	114	50	(	(	PUNCT
ajlm-100	114	51	mel	mel	PROPN
ajlm-100	114	52	b	b	PROPN
ajlm-100	114	53	)	)	PUNCT
ajlm-100	114	54	(	(	PUNCT
ajlm-100	114	55	119	119	NUM
ajlm-100	114	56	dpi	dpi	NOUN
ajlm-100	114	57	)	)	PUNCT
ajlm-100	114	58	.	.	PUNCT
ajlm-100	115	1	figure	figure	VERB
ajlm-100	115	2	8	8	NUM
ajlm-100	115	3	:	:	PUNCT
ajlm-100	116	1	mean	mean	VERB
ajlm-100	116	2	changes	change	NOUN
ajlm-100	116	3	in	in	ADP
ajlm-100	116	4	monocyte	monocyte	NOUN
ajlm-100	116	5	counts	count	NOUN
ajlm-100	116	6	of	of	ADP
ajlm-100	116	7	t.	t.	PROPN
ajlm-100	116	8	b.	b.	PROPN
ajlm-100	116	9	brucei	brucei	PROPN
ajlm-100	116	10	gutat	gutat	PROPN
ajlm-100	116	11	1	1	NUM
ajlm-100	116	12	-	-	PUNCT
ajlm-100	116	13	infected	infect	VERB
ajlm-100	116	14	vervet	vervet	NOUN
ajlm-100	116	15	monkeys	monkey	NOUN
ajlm-100	116	16	,	,	PUNCT
ajlm-100	116	17	showing	show	VERB
ajlm-100	116	18	the	the	DET
ajlm-100	116	19	point	point	NOUN
ajlm-100	116	20	of	of	ADP
ajlm-100	116	21	subcurative	subcurative	ADJ
ajlm-100	116	22	treatment	treatment	NOUN
ajlm-100	116	23	with	with	ADP
ajlm-100	116	24	diminazene	diminazene	NOUN
ajlm-100	116	25	aceturate	aceturate	NOUN
ajlm-100	116	26	(	(	PUNCT
ajlm-100	116	27	da	da	NOUN
ajlm-100	116	28	)	)	PUNCT
ajlm-100	116	29	(	(	PUNCT
ajlm-100	116	30	28	28	NUM
ajlm-100	116	31	dpi	dpi	NOUN
ajlm-100	116	32	)	)	PUNCT
ajlm-100	116	33	and	and	CCONJ
ajlm-100	116	34	curative	curative	ADJ
ajlm-100	116	35	treatment	treatment	NOUN
ajlm-100	116	36	with	with	ADP
ajlm-100	116	37	melarsoprol	melarsoprol	NOUN
ajlm-100	116	38	(	(	PUNCT
ajlm-100	116	39	mel	mel	PROPN
ajlm-100	116	40	b	b	PROPN
ajlm-100	116	41	)	)	PUNCT
ajlm-100	116	42	(	(	PUNCT
ajlm-100	116	43	119	119	NUM
ajlm-100	116	44	dpi	dpi	NOUN
ajlm-100	116	45	)	)	PUNCT
ajlm-100	116	46	.	.	PUNCT
ajlm-100	117	1	trustworthiness	trustworthiness	PROPN
ajlm-100	117	2	top	top	PROPN
ajlm-100	117	3	↑	↑	PROPN
ajlm-100	117	4	to	to	PART
ajlm-100	117	5	judge	judge	VERB
ajlm-100	117	6	from	from	ADP
ajlm-100	117	7	the	the	DET
ajlm-100	117	8	outcome	outcome	NOUN
ajlm-100	117	9	of	of	ADP
ajlm-100	117	10	t.	t.	PROPN
ajlm-100	117	11	b.	b.	PROPN
ajlm-100	117	12	brucei	brucei	PROPN
ajlm-100	117	13	infection	infection	NOUN
ajlm-100	117	14	in	in	ADP
ajlm-100	117	15	vervet	vervet	PROPN
ajlm-100	117	16	monkeys	monkey	NOUN
ajlm-100	117	17	,	,	PUNCT
ajlm-100	117	18	the	the	DET
ajlm-100	117	19	observations	observation	NOUN
ajlm-100	117	20	obtained	obtain	VERB
ajlm-100	117	21	here	here	ADV
ajlm-100	117	22	appeared	appear	VERB
ajlm-100	117	23	to	to	PART
ajlm-100	117	24	compare	compare	VERB
ajlm-100	117	25	well	well	ADV
ajlm-100	117	26	with	with	ADP
ajlm-100	117	27	those	those	PRON
ajlm-100	117	28	arising	arise	VERB
ajlm-100	117	29	from	from	ADP
ajlm-100	117	30	t.	t.	PROPN
ajlm-100	117	31	b.	b.	PROPN
ajlm-100	117	32	rhodesiense	rhodesiense	PROPN
ajlm-100	117	33	and	and	CCONJ
ajlm-100	117	34	other	other	ADJ
ajlm-100	117	35	related	related	ADJ
ajlm-100	117	36	studies	study	NOUN
ajlm-100	117	37	.	.	PUNCT
ajlm-100	118	1	reliability	reliability	NOUN
ajlm-100	118	2	and	and	CCONJ
ajlm-100	118	3	validity	validity	NOUN
ajlm-100	118	4	of	of	ADP
ajlm-100	118	5	the	the	DET
ajlm-100	118	6	research	research	NOUN
ajlm-100	118	7	the	the	DET
ajlm-100	118	8	experimental	experimental	ADJ
ajlm-100	118	9	design	design	NOUN
ajlm-100	118	10	of	of	ADP
ajlm-100	118	11	this	this	DET
ajlm-100	118	12	study	study	NOUN
ajlm-100	118	13	is	be	AUX
ajlm-100	118	14	reliable	reliable	ADJ
ajlm-100	118	15	and	and	CCONJ
ajlm-100	118	16	valid	valid	ADJ
ajlm-100	118	17	.	.	PUNCT
ajlm-100	119	1	the	the	DET
ajlm-100	119	2	procedures	procedure	NOUN
ajlm-100	119	3	used	use	VERB
ajlm-100	119	4	in	in	ADP
ajlm-100	119	5	this	this	DET
ajlm-100	119	6	research	research	NOUN
ajlm-100	119	7	have	have	AUX
ajlm-100	119	8	been	be	AUX
ajlm-100	119	9	tested	test	VERB
ajlm-100	119	10	in	in	ADP
ajlm-100	119	11	other	other	ADJ
ajlm-100	119	12	studies	study	NOUN
ajlm-100	119	13	as	as	SCONJ
ajlm-100	119	14	cited	cite	VERB
ajlm-100	119	15	in	in	ADP
ajlm-100	119	16	this	this	DET
ajlm-100	119	17	article	article	NOUN
ajlm-100	119	18	.	.	PUNCT
ajlm-100	120	1	discussion	discussion	NOUN
ajlm-100	120	2	top	top	PROPN
ajlm-100	120	3	↑	↑	PROPN
ajlm-100	120	4	this	this	PRON
ajlm-100	120	5	is	be	AUX
ajlm-100	120	6	the	the	DET
ajlm-100	120	7	first	first	ADJ
ajlm-100	120	8	study	study	NOUN
ajlm-100	120	9	reporting	report	VERB
ajlm-100	120	10	the	the	DET
ajlm-100	120	11	infection	infection	NOUN
ajlm-100	120	12	of	of	ADP
ajlm-100	120	13	vervet	vervet	NOUN
ajlm-100	120	14	monkeys	monkey	NOUN
ajlm-100	120	15	with	with	ADP
ajlm-100	120	16	t.	t.	PROPN
ajlm-100	120	17	b.	b.	PROPN
ajlm-100	120	18	brucei	brucei	PROPN
ajlm-100	120	19	.	.	PUNCT
ajlm-100	121	1	human	human	ADJ
ajlm-100	121	2	beings	being	NOUN
ajlm-100	121	3	and	and	CCONJ
ajlm-100	121	4	some	some	DET
ajlm-100	121	5	non	non	ADJ
ajlm-100	121	6	-	-	ADJ
ajlm-100	121	7	human	human	ADJ
ajlm-100	121	8	primates	primate	NOUN
ajlm-100	121	9	have	have	VERB
ajlm-100	121	10	a	a	DET
ajlm-100	121	11	trypanolytic	trypanolytic	ADJ
ajlm-100	121	12	factor	factor	NOUN
ajlm-100	121	13	,	,	PUNCT
ajlm-100	121	14	which	which	PRON
ajlm-100	121	15	prevents	prevent	VERB
ajlm-100	121	16	them	they	PRON
ajlm-100	121	17	from	from	ADP
ajlm-100	121	18	being	be	AUX
ajlm-100	121	19	infected	infect	VERB
ajlm-100	121	20	with	with	ADP
ajlm-100	121	21	t.	t.	PROPN
ajlm-100	121	22	b.	b.	PROPN
ajlm-100	121	23	brucei	brucei	PROPN
ajlm-100	121	24	and	and	CCONJ
ajlm-100	121	25	other	other	ADJ
ajlm-100	121	26	livestock	livestock	NOUN
ajlm-100	121	27	trypanosomes.13,14	trypanosomes.13,14	ADV
ajlm-100	121	28	results	result	VERB
ajlm-100	121	29	from	from	ADP
ajlm-100	121	30	this	this	DET
ajlm-100	121	31	study	study	NOUN
ajlm-100	121	32	suggest	suggest	VERB
ajlm-100	121	33	that	that	SCONJ
ajlm-100	121	34	vervet	vervet	NOUN
ajlm-100	121	35	monkeys	monkey	NOUN
ajlm-100	121	36	may	may	AUX
ajlm-100	121	37	lack	lack	VERB
ajlm-100	121	38	trypanolytic	trypanolytic	ADJ
ajlm-100	121	39	factors	factor	NOUN
ajlm-100	121	40	,	,	PUNCT
ajlm-100	121	41	which	which	PRON
ajlm-100	121	42	have	have	AUX
ajlm-100	121	43	been	be	AUX
ajlm-100	121	44	reported	report	VERB
ajlm-100	121	45	to	to	PART
ajlm-100	121	46	be	be	AUX
ajlm-100	121	47	present	present	ADJ
ajlm-100	121	48	in	in	ADP
ajlm-100	121	49	other	other	ADJ
ajlm-100	121	50	non	non	ADJ
ajlm-100	121	51	-	-	ADJ
ajlm-100	121	52	human	human	ADJ
ajlm-100	121	53	primates	primate	NOUN
ajlm-100	121	54	,	,	PUNCT
ajlm-100	121	55	such	such	ADJ
ajlm-100	121	56	as	as	ADP
ajlm-100	121	57	baboons	baboon	NOUN
ajlm-100	121	58	and	and	CCONJ
ajlm-100	121	59	gorillas	gorilla	NOUN
ajlm-100	121	60	.	.	PUNCT
ajlm-100	122	1	the	the	DET
ajlm-100	122	2	haptoglobin	haptoglobin	NOUN
ajlm-100	122	3	-	-	PUNCT
ajlm-100	122	4	related	relate	VERB
ajlm-100	122	5	protein	protein	NOUN
ajlm-100	122	6	which	which	PRON
ajlm-100	122	7	has	have	AUX
ajlm-100	122	8	been	be	AUX
ajlm-100	122	9	demonstrated	demonstrate	VERB
ajlm-100	122	10	to	to	PART
ajlm-100	122	11	have	have	VERB
ajlm-100	122	12	trypanolytic	trypanolytic	ADJ
ajlm-100	122	13	activity	activity	NOUN
ajlm-100	122	14	might	might	AUX
ajlm-100	122	15	be	be	AUX
ajlm-100	122	16	absent	absent	ADJ
ajlm-100	122	17	in	in	ADP
ajlm-100	122	18	the	the	DET
ajlm-100	122	19	sera	sera	NOUN
ajlm-100	122	20	of	of	ADP
ajlm-100	122	21	vervet	vervet	NOUN
ajlm-100	122	22	monkeys	monkey	NOUN
ajlm-100	122	23	.	.	PUNCT
ajlm-100	123	1	in	in	ADP
ajlm-100	123	2	spite	spite	NOUN
ajlm-100	123	3	of	of	ADP
ajlm-100	123	4	the	the	DET
ajlm-100	123	5	lack	lack	NOUN
ajlm-100	123	6	of	of	ADP
ajlm-100	123	7	human	human	ADJ
ajlm-100	123	8	infection	infection	NOUN
ajlm-100	123	9	,	,	PUNCT
ajlm-100	123	10	t.	t.	PROPN
ajlm-100	123	11	b.	b.	PROPN
ajlm-100	123	12	brucei	brucei	PROPN
ajlm-100	123	13	infections	infection	NOUN
ajlm-100	123	14	in	in	ADP
ajlm-100	123	15	rodents	rodent	NOUN
ajlm-100	123	16	follow	follow	VERB
ajlm-100	123	17	a	a	DET
ajlm-100	123	18	similar	similar	ADJ
ajlm-100	123	19	pathogenesis	pathogenesis	NOUN
ajlm-100	123	20	to	to	ADP
ajlm-100	123	21	that	that	PRON
ajlm-100	123	22	of	of	ADP
ajlm-100	123	23	t.	t.	PROPN
ajlm-100	123	24	b.	b.	PROPN
ajlm-100	123	25	rhodesiense	rhodesiense	PROPN
ajlm-100	123	26	,	,	PUNCT
ajlm-100	123	27	thus	thus	ADV
ajlm-100	123	28	rodents	rodent	NOUN
ajlm-100	123	29	have	have	AUX
ajlm-100	123	30	been	be	AUX
ajlm-100	123	31	used	use	VERB
ajlm-100	123	32	as	as	ADP
ajlm-100	123	33	models	model	NOUN
ajlm-100	123	34	for	for	ADP
ajlm-100	123	35	hat.8	hat.8	PROPN
ajlm-100	123	36	some	some	PRON
ajlm-100	123	37	of	of	ADP
ajlm-100	123	38	the	the	DET
ajlm-100	123	39	disadvantages	disadvantage	NOUN
ajlm-100	123	40	of	of	ADP
ajlm-100	123	41	rodent	rodent	ADJ
ajlm-100	123	42	hat	hat	NOUN
ajlm-100	123	43	models	model	NOUN
ajlm-100	123	44	include	include	VERB
ajlm-100	123	45	phylogenetic	phylogenetic	ADJ
ajlm-100	123	46	distance	distance	NOUN
ajlm-100	123	47	and	and	CCONJ
ajlm-100	123	48	an	an	DET
ajlm-100	123	49	inability	inability	NOUN
ajlm-100	123	50	to	to	PART
ajlm-100	123	51	perform	perform	VERB
ajlm-100	123	52	sequential	sequential	ADJ
ajlm-100	123	53	monitoring	monitoring	NOUN
ajlm-100	123	54	of	of	ADP
ajlm-100	123	55	csf	csf	ADJ
ajlm-100	123	56	changes	change	NOUN
ajlm-100	123	57	.	.	PUNCT
ajlm-100	124	1	these	these	DET
ajlm-100	124	2	limitations	limitation	NOUN
ajlm-100	124	3	can	can	AUX
ajlm-100	124	4	be	be	AUX
ajlm-100	124	5	addressed	address	VERB
ajlm-100	124	6	by	by	ADP
ajlm-100	124	7	using	use	VERB
ajlm-100	124	8	monkey	monkey	NOUN
ajlm-100	124	9	models.in	models.in	NOUN
ajlm-100	124	10	the	the	DET
ajlm-100	124	11	current	current	ADJ
ajlm-100	124	12	study	study	NOUN
ajlm-100	124	13	,	,	PUNCT
ajlm-100	124	14	infected	infect	VERB
ajlm-100	124	15	vervet	vervet	NOUN
ajlm-100	124	16	monkeys	monkey	NOUN
ajlm-100	124	17	displayed	display	VERB
ajlm-100	124	18	classical	classical	ADJ
ajlm-100	124	19	clinical	clinical	ADJ
ajlm-100	124	20	symptoms	symptom	NOUN
ajlm-100	124	21	,	,	PUNCT
ajlm-100	124	22	parasitological	parasitological	ADJ
ajlm-100	124	23	and	and	CCONJ
ajlm-100	124	24	haematological	haematological	ADJ
ajlm-100	124	25	trends	trend	NOUN
ajlm-100	124	26	that	that	PRON
ajlm-100	124	27	were	be	AUX
ajlm-100	124	28	similar	similar	ADJ
ajlm-100	124	29	to	to	ADP
ajlm-100	124	30	monkeys	monkey	NOUN
ajlm-100	124	31	infected	infect	VERB
ajlm-100	124	32	with	with	ADP
ajlm-100	124	33	t.	t.	PROPN
ajlm-100	124	34	b.	b.	PROPN
ajlm-100	124	35	rhodesiense.15	rhodesiense.15	PROPN
ajlm-100	124	36	in	in	ADP
ajlm-100	124	37	addition	addition	NOUN
ajlm-100	124	38	,	,	PUNCT
ajlm-100	124	39	upon	upon	SCONJ
ajlm-100	124	40	subcurative	subcurative	ADJ
ajlm-100	124	41	treatment	treatment	NOUN
ajlm-100	124	42	with	with	ADP
ajlm-100	124	43	diminazene	diminazene	NOUN
ajlm-100	124	44	aceturate	aceturate	VERB
ajlm-100	124	45	,	,	PUNCT
ajlm-100	124	46	disease	disease	NOUN
ajlm-100	124	47	relapse	relapse	NOUN
ajlm-100	124	48	and	and	CCONJ
ajlm-100	124	49	re	re	NOUN
ajlm-100	124	50	-	-	NOUN
ajlm-100	124	51	emergence	emergence	NOUN
ajlm-100	124	52	of	of	ADP
ajlm-100	124	53	blood	blood	NOUN
ajlm-100	124	54	parasitaemia	parasitaemia	NOUN
ajlm-100	124	55	took	take	VERB
ajlm-100	124	56	85	85	NUM
ajlm-100	124	57	days	day	NOUN
ajlm-100	124	58	,	,	PUNCT
ajlm-100	124	59	which	which	PRON
ajlm-100	124	60	is	be	AUX
ajlm-100	124	61	similar	similar	ADJ
ajlm-100	124	62	to	to	ADP
ajlm-100	124	63	t.	t.	PROPN
ajlm-100	124	64	b.	b.	PROPN
ajlm-100	124	65	rhodesiense	rhodesiense	PROPN
ajlm-100	124	66	ketri	ketri	PROPN
ajlm-100	125	1	2537	2537	NUM
ajlm-100	125	2	infection.16	infection.16	NOUN
ajlm-100	125	3	however	however	ADV
ajlm-100	125	4	,	,	PUNCT
ajlm-100	125	5	the	the	DET
ajlm-100	125	6	duration	duration	NOUN
ajlm-100	125	7	was	be	AUX
ajlm-100	125	8	longer	long	ADJ
ajlm-100	125	9	than	than	SCONJ
ajlm-100	125	10	that	that	PRON
ajlm-100	125	11	reported	report	VERB
ajlm-100	125	12	for	for	ADP
ajlm-100	125	13	t.	t.	PROPN
ajlm-100	125	14	b.	b.	PROPN
ajlm-100	125	15	rhodesiense	rhodesiense	PROPN
ajlm-100	125	16	ipr	ipr	PROPN
ajlm-100	125	17	001	001	NUM
ajlm-100	125	18	infections.15	infections.15	NOUN
ajlm-100	125	19	the	the	DET
ajlm-100	125	20	differences	difference	NOUN
ajlm-100	125	21	noted	note	VERB
ajlm-100	125	22	may	may	AUX
ajlm-100	125	23	be	be	AUX
ajlm-100	125	24	due	due	ADJ
ajlm-100	125	25	to	to	ADP
ajlm-100	125	26	variation	variation	NOUN
ajlm-100	125	27	in	in	ADP
ajlm-100	125	28	parasite	parasite	ADJ
ajlm-100	125	29	virulence	virulence	NOUN
ajlm-100	125	30	.	.	PUNCT
ajlm-100	126	1	anaemia	anaemia	NOUN
ajlm-100	126	2	gives	give	VERB
ajlm-100	126	3	a	a	DET
ajlm-100	126	4	reliable	reliable	ADJ
ajlm-100	126	5	indication	indication	NOUN
ajlm-100	126	6	of	of	ADP
ajlm-100	126	7	the	the	DET
ajlm-100	126	8	disease	disease	NOUN
ajlm-100	126	9	status	status	NOUN
ajlm-100	126	10	and	and	CCONJ
ajlm-100	126	11	productive	productive	ADJ
ajlm-100	126	12	performance	performance	NOUN
ajlm-100	126	13	of	of	ADP
ajlm-100	126	14	trypanosome	trypanosome	ADV
ajlm-100	126	15	-	-	PUNCT
ajlm-100	126	16	infected	infect	VERB
ajlm-100	126	17	animals.17	animals.17	NOUN
ajlm-100	126	18	disease	disease	NOUN
ajlm-100	126	19	in	in	ADP
ajlm-100	126	20	vervet	vervet	NOUN
ajlm-100	126	21	monkeys	monkey	NOUN
ajlm-100	126	22	tended	tend	VERB
ajlm-100	126	23	to	to	PART
ajlm-100	126	24	manifest	manifest	VERB
ajlm-100	126	25	with	with	ADP
ajlm-100	126	26	microcytic	microcytic	ADJ
ajlm-100	126	27	hypochromic	hypochromic	ADJ
ajlm-100	126	28	anaemia	anaemia	NOUN
ajlm-100	126	29	during	during	ADP
ajlm-100	126	30	the	the	DET
ajlm-100	126	31	early	early	ADJ
ajlm-100	126	32	stages	stage	NOUN
ajlm-100	126	33	.	.	PUNCT
ajlm-100	127	1	this	this	DET
ajlm-100	127	2	type	type	NOUN
ajlm-100	127	3	of	of	ADP
ajlm-100	127	4	anaemia	anaemia	NOUN
ajlm-100	127	5	has	have	AUX
ajlm-100	127	6	been	be	AUX
ajlm-100	127	7	associated	associate	VERB
ajlm-100	127	8	with	with	ADP
ajlm-100	127	9	iron	iron	NOUN
ajlm-100	127	10	deficiency	deficiency	NOUN
ajlm-100	127	11	that	that	PRON
ajlm-100	127	12	,	,	PUNCT
ajlm-100	127	13	in	in	ADP
ajlm-100	127	14	hat	hat	NOUN
ajlm-100	127	15	,	,	PUNCT
ajlm-100	127	16	might	might	AUX
ajlm-100	127	17	arise	arise	VERB
ajlm-100	127	18	from	from	ADP
ajlm-100	127	19	lack	lack	NOUN
ajlm-100	127	20	of	of	ADP
ajlm-100	127	21	incorporation	incorporation	NOUN
ajlm-100	127	22	into	into	ADP
ajlm-100	127	23	red	red	ADJ
ajlm-100	127	24	cell	cell	NOUN
ajlm-100	127	25	precursors	precursor	NOUN
ajlm-100	127	26	–	–	PUNCT
ajlm-100	127	27	despite	despite	SCONJ
ajlm-100	127	28	the	the	DET
ajlm-100	127	29	presence	presence	NOUN
ajlm-100	127	30	of	of	ADP
ajlm-100	127	31	adequate	adequate	ADJ
ajlm-100	127	32	iron	iron	NOUN
ajlm-100	127	33	storage	storage	NOUN
ajlm-100	127	34	–	–	PUNCT
ajlm-100	127	35	and	and	CCONJ
ajlm-100	127	36	inefficient	inefficient	ADJ
ajlm-100	127	37	recovery	recovery	NOUN
ajlm-100	127	38	of	of	ADP
ajlm-100	127	39	iron	iron	NOUN
ajlm-100	127	40	from	from	ADP
ajlm-100	127	41	the	the	DET
ajlm-100	127	42	phagocytosed	phagocytose	VERB
ajlm-100	127	43	erythrocytes.18,19	erythrocytes.18,19	NOUN
ajlm-100	127	44	microcytic	microcytic	ADJ
ajlm-100	127	45	hypochromic	hypochromic	ADJ
ajlm-100	127	46	anaemia	anaemia	NOUN
ajlm-100	127	47	has	have	AUX
ajlm-100	127	48	been	be	AUX
ajlm-100	127	49	described	describe	VERB
ajlm-100	127	50	in	in	ADP
ajlm-100	127	51	vervet	vervet	PROPN
ajlm-100	127	52	monkeys	monkey	NOUN
ajlm-100	127	53	infected	infect	VERB
ajlm-100	127	54	with	with	ADP
ajlm-100	127	55	t.	t.	PROPN
ajlm-100	127	56	b.	b.	PROPN
ajlm-100	127	57	rhodesiense.20	rhodesiense.20	PROPN
ajlm-100	127	58	in	in	ADP
ajlm-100	127	59	this	this	DET
ajlm-100	127	60	study	study	NOUN
ajlm-100	127	61	,	,	PUNCT
ajlm-100	127	62	the	the	DET
ajlm-100	127	63	severity	severity	NOUN
ajlm-100	127	64	of	of	ADP
ajlm-100	127	65	anaemia	anaemia	NOUN
ajlm-100	127	66	was	be	AUX
ajlm-100	127	67	greater	great	ADJ
ajlm-100	127	68	in	in	ADP
ajlm-100	127	69	the	the	DET
ajlm-100	127	70	acute	acute	ADJ
ajlm-100	127	71	stage	stage	NOUN
ajlm-100	127	72	of	of	ADP
ajlm-100	127	73	the	the	DET
ajlm-100	127	74	disease	disease	NOUN
ajlm-100	127	75	(	(	PUNCT
ajlm-100	127	76	day	day	NOUN
ajlm-100	127	77	4	4	NUM
ajlm-100	127	78	to	to	PART
ajlm-100	127	79	28	28	NUM
ajlm-100	127	80	pi	pi	NOUN
ajlm-100	127	81	)	)	PUNCT
ajlm-100	127	82	than	than	ADP
ajlm-100	127	83	during	during	ADP
ajlm-100	127	84	the	the	DET
ajlm-100	127	85	late	late	ADJ
ajlm-100	127	86	stage	stage	NOUN
ajlm-100	127	87	(	(	PUNCT
ajlm-100	127	88	day	day	NOUN
ajlm-100	127	89	28	28	NUM
ajlm-100	127	90	to	to	PART
ajlm-100	127	91	119	119	NUM
ajlm-100	127	92	pi	pi	NOUN
ajlm-100	127	93	)	)	PUNCT
ajlm-100	127	94	and	and	CCONJ
ajlm-100	127	95	appeared	appear	VERB
ajlm-100	127	96	to	to	PART
ajlm-100	127	97	be	be	AUX
ajlm-100	127	98	associated	associate	VERB
ajlm-100	127	99	with	with	ADP
ajlm-100	127	100	the	the	DET
ajlm-100	127	101	level	level	NOUN
ajlm-100	127	102	of	of	ADP
ajlm-100	127	103	parasitaemia	parasitaemia	NOUN
ajlm-100	127	104	.	.	PUNCT
ajlm-100	128	1	after	after	ADP
ajlm-100	128	2	curative	curative	ADJ
ajlm-100	128	3	treatment	treatment	NOUN
ajlm-100	128	4	(	(	PUNCT
ajlm-100	128	5	119	119	NUM
ajlm-100	128	6	dpi	dpi	NOUN
ajlm-100	128	7	)	)	PUNCT
ajlm-100	128	8	,	,	PUNCT
ajlm-100	128	9	all	all	PRON
ajlm-100	128	10	of	of	ADP
ajlm-100	128	11	the	the	DET
ajlm-100	128	12	erythrocyte	erythrocyte	NOUN
ajlm-100	128	13	values	value	NOUN
ajlm-100	128	14	recovered	recover	VERB
ajlm-100	128	15	by	by	ADP
ajlm-100	128	16	140	140	NUM
ajlm-100	128	17	dpi	dpi	NOUN
ajlm-100	128	18	because	because	SCONJ
ajlm-100	128	19	melarsoprol	melarsoprol	NOUN
ajlm-100	128	20	can	can	AUX
ajlm-100	128	21	clear	clear	VERB
ajlm-100	128	22	parasites	parasite	NOUN
ajlm-100	128	23	in	in	ADP
ajlm-100	128	24	all	all	DET
ajlm-100	128	25	bodily	bodily	ADV
ajlm-100	128	26	compartments.21	compartments.21	NOUN
ajlm-100	128	27	there	there	PRON
ajlm-100	128	28	was	be	VERB
ajlm-100	128	29	a	a	DET
ajlm-100	128	30	rapid	rapid	ADJ
ajlm-100	128	31	decline	decline	NOUN
ajlm-100	128	32	in	in	ADP
ajlm-100	128	33	platelet	platelet	NOUN
ajlm-100	128	34	counts	count	NOUN
ajlm-100	128	35	in	in	ADP
ajlm-100	128	36	early	early	ADJ
ajlm-100	128	37	-	-	PUNCT
ajlm-100	128	38	stage	stage	NOUN
ajlm-100	128	39	disease	disease	NOUN
ajlm-100	128	40	.	.	PUNCT
ajlm-100	129	1	low	low	ADJ
ajlm-100	129	2	platelet	platelet	NOUN
ajlm-100	129	3	counts	count	NOUN
ajlm-100	129	4	could	could	AUX
ajlm-100	129	5	be	be	AUX
ajlm-100	129	6	indicative	indicative	ADJ
ajlm-100	129	7	of	of	ADP
ajlm-100	129	8	toxic	toxic	ADJ
ajlm-100	129	9	products	product	NOUN
ajlm-100	129	10	,	,	PUNCT
ajlm-100	129	11	originating	originate	VERB
ajlm-100	129	12	from	from	ADP
ajlm-100	129	13	the	the	DET
ajlm-100	129	14	trypanosomes	trypanosome	NOUN
ajlm-100	129	15	,	,	PUNCT
ajlm-100	129	16	which	which	PRON
ajlm-100	129	17	cause	cause	VERB
ajlm-100	129	18	platelet	platelet	NOUN
ajlm-100	129	19	destruction.18	destruction.18	ADJ
ajlm-100	129	20	splenic	splenic	ADJ
ajlm-100	129	21	pooling	pooling	NOUN
ajlm-100	129	22	of	of	ADP
ajlm-100	129	23	platelets	platelet	NOUN
ajlm-100	129	24	and	and	CCONJ
ajlm-100	129	25	phagocytic	phagocytic	ADJ
ajlm-100	129	26	removal	removal	NOUN
ajlm-100	129	27	of	of	ADP
ajlm-100	129	28	platelets	platelet	NOUN
ajlm-100	129	29	by	by	ADP
ajlm-100	129	30	mononuclear	mononuclear	ADJ
ajlm-100	129	31	cells	cell	NOUN
ajlm-100	129	32	has	have	AUX
ajlm-100	129	33	also	also	ADV
ajlm-100	129	34	been	be	AUX
ajlm-100	129	35	associated	associate	VERB
ajlm-100	129	36	with	with	ADP
ajlm-100	129	37	thrombocytopaenia.19	thrombocytopaenia.19	PRON
ajlm-100	129	38	severe	severe	ADJ
ajlm-100	129	39	progressive	progressive	ADJ
ajlm-100	129	40	thrombocytopaenia	thrombocytopaenia	NOUN
ajlm-100	129	41	has	have	AUX
ajlm-100	129	42	been	be	AUX
ajlm-100	129	43	reported	report	VERB
ajlm-100	129	44	in	in	ADP
ajlm-100	129	45	t.	t.	PROPN
ajlm-100	129	46	b.	b.	PROPN
ajlm-100	129	47	rhodesiense	rhodesiense	PROPN
ajlm-100	129	48	vervet	vervet	PROPN
ajlm-100	129	49	monkey	monkey	NOUN
ajlm-100	129	50	models	model	NOUN
ajlm-100	129	51	and	and	CCONJ
ajlm-100	129	52	human	human	ADJ
ajlm-100	129	53	cases	case	NOUN
ajlm-100	129	54	of	of	ADP
ajlm-100	129	55	sleeping	sleep	VERB
ajlm-100	129	56	sickness.23,24	sickness.23,24	NOUN
ajlm-100	129	57	similarly	similarly	ADV
ajlm-100	129	58	to	to	ADP
ajlm-100	129	59	t.	t.	PROPN
ajlm-100	129	60	b.	b.	PROPN
ajlm-100	129	61	rhodesiense	rhodesiense	PROPN
ajlm-100	129	62	infections	infection	NOUN
ajlm-100	129	63	in	in	ADP
ajlm-100	129	64	vervet	vervet	NOUN
ajlm-100	129	65	monkeys	monkey	NOUN
ajlm-100	129	66	,	,	PUNCT
ajlm-100	129	67	lymphocytopoenia	lymphocytopoenia	PROPN
ajlm-100	129	68	was	be	AUX
ajlm-100	129	69	noted	note	VERB
ajlm-100	129	70	in	in	ADP
ajlm-100	129	71	the	the	DET
ajlm-100	129	72	early	early	ADJ
ajlm-100	129	73	stage	stage	NOUN
ajlm-100	129	74	of	of	ADP
ajlm-100	129	75	the	the	DET
ajlm-100	129	76	disease	disease	NOUN
ajlm-100	129	77	and	and	CCONJ
ajlm-100	129	78	lymphocytosis	lymphocytosis	NOUN
ajlm-100	129	79	in	in	ADP
ajlm-100	129	80	the	the	DET
ajlm-100	129	81	late	late	ADJ
ajlm-100	129	82	stage.17	stage.17	PROPN
ajlm-100	129	83	limitations	limitation	NOUN
ajlm-100	129	84	of	of	ADP
ajlm-100	129	85	the	the	DET
ajlm-100	129	86	study	study	NOUN
ajlm-100	129	87	top	top	PROPN
ajlm-100	129	88	↑	↑	PROPN
ajlm-100	129	89	only	only	ADV
ajlm-100	129	90	three	three	NUM
ajlm-100	129	91	animals	animal	NOUN
ajlm-100	129	92	were	be	AUX
ajlm-100	129	93	used	use	VERB
ajlm-100	129	94	in	in	ADP
ajlm-100	129	95	this	this	DET
ajlm-100	129	96	study	study	NOUN
ajlm-100	129	97	;	;	PUNCT
ajlm-100	129	98	however	however	ADV
ajlm-100	129	99	an	an	DET
ajlm-100	129	100	extensive	extensive	ADJ
ajlm-100	129	101	amount	amount	NOUN
ajlm-100	129	102	of	of	ADP
ajlm-100	129	103	data	datum	NOUN
ajlm-100	129	104	was	be	AUX
ajlm-100	129	105	obtained	obtain	VERB
ajlm-100	129	106	.	.	PUNCT
ajlm-100	130	1	parasitaemia	parasitaemia	PROPN
ajlm-100	130	2	was	be	AUX
ajlm-100	130	3	limited	limit	VERB
ajlm-100	130	4	to	to	ADP
ajlm-100	130	5	the	the	DET
ajlm-100	130	6	wet	wet	ADJ
ajlm-100	130	7	smear	smear	NOUN
ajlm-100	130	8	microscopic	microscopic	ADJ
ajlm-100	130	9	observation	observation	NOUN
ajlm-100	130	10	method	method	NOUN
ajlm-100	130	11	only	only	ADV
ajlm-100	130	12	and	and	CCONJ
ajlm-100	130	13	,	,	PUNCT
ajlm-100	130	14	at	at	ADP
ajlm-100	130	15	very	very	ADV
ajlm-100	130	16	low	low	ADJ
ajlm-100	130	17	parasitaemia	parasitaemia	NOUN
ajlm-100	130	18	,	,	PUNCT
ajlm-100	130	19	the	the	DET
ajlm-100	130	20	method	method	NOUN
ajlm-100	130	21	could	could	AUX
ajlm-100	130	22	have	have	AUX
ajlm-100	130	23	missed	miss	VERB
ajlm-100	130	24	out	out	ADP
ajlm-100	130	25	early	early	ADJ
ajlm-100	130	26	relapses	relapse	NOUN
ajlm-100	130	27	.	.	PUNCT
ajlm-100	131	1	the	the	DET
ajlm-100	131	2	characterisation	characterisation	NOUN
ajlm-100	131	3	of	of	ADP
ajlm-100	131	4	the	the	DET
ajlm-100	131	5	model	model	NOUN
ajlm-100	131	6	was	be	AUX
ajlm-100	131	7	also	also	ADV
ajlm-100	131	8	limited	limit	VERB
ajlm-100	131	9	to	to	ADP
ajlm-100	131	10	haematological	haematological	ADJ
ajlm-100	131	11	profiles	profile	NOUN
ajlm-100	131	12	and	and	CCONJ
ajlm-100	131	13	clinical	clinical	ADJ
ajlm-100	131	14	examination	examination	NOUN
ajlm-100	131	15	.	.	PUNCT
ajlm-100	132	1	recommendations	recommendation	NOUN
ajlm-100	132	2	more	more	ADJ
ajlm-100	132	3	extensive	extensive	ADJ
ajlm-100	132	4	studies	study	NOUN
ajlm-100	132	5	are	be	AUX
ajlm-100	132	6	needed	need	VERB
ajlm-100	132	7	to	to	PART
ajlm-100	132	8	establish	establish	VERB
ajlm-100	132	9	baseline	baseline	ADJ
ajlm-100	132	10	levels	level	NOUN
ajlm-100	132	11	of	of	ADP
ajlm-100	132	12	various	various	ADJ
ajlm-100	132	13	biochemical	biochemical	ADJ
ajlm-100	132	14	parameters	parameter	NOUN
ajlm-100	132	15	in	in	ADP
ajlm-100	132	16	vervet	vervet	PROPN
ajlm-100	132	17	monkeys	monkey	NOUN
ajlm-100	132	18	to	to	PART
ajlm-100	132	19	aid	aid	VERB
ajlm-100	132	20	in	in	ADP
ajlm-100	132	21	the	the	DET
ajlm-100	132	22	determination	determination	NOUN
ajlm-100	132	23	of	of	ADP
ajlm-100	132	24	significant	significant	ADJ
ajlm-100	132	25	variations	variation	NOUN
ajlm-100	132	26	during	during	ADP
ajlm-100	132	27	infection	infection	NOUN
ajlm-100	132	28	/	/	SYM
ajlm-100	132	29	disease	disease	NOUN
ajlm-100	132	30	.	.	PUNCT
ajlm-100	133	1	haematological	haematological	ADJ
ajlm-100	133	2	profiles	profile	NOUN
ajlm-100	133	3	need	need	VERB
ajlm-100	133	4	to	to	PART
ajlm-100	133	5	be	be	AUX
ajlm-100	133	6	studied	study	VERB
ajlm-100	133	7	in	in	ADP
ajlm-100	133	8	shorter	short	ADJ
ajlm-100	133	9	sampling	sampling	NOUN
ajlm-100	133	10	intervals	interval	NOUN
ajlm-100	133	11	(	(	PUNCT
ajlm-100	133	12	e.g.	e.g.	ADV
ajlm-100	133	13	daily	daily	ADJ
ajlm-100	133	14	sampling	sample	VERB
ajlm-100	133	15	for	for	ADP
ajlm-100	133	16	the	the	DET
ajlm-100	133	17	first	first	ADJ
ajlm-100	133	18	week	week	NOUN
ajlm-100	133	19	of	of	ADP
ajlm-100	133	20	infection	infection	NOUN
ajlm-100	133	21	)	)	PUNCT
ajlm-100	133	22	in	in	ADP
ajlm-100	133	23	order	order	NOUN
ajlm-100	133	24	to	to	PART
ajlm-100	133	25	discern	discern	VERB
ajlm-100	133	26	properly	properly	ADV
ajlm-100	133	27	any	any	DET
ajlm-100	133	28	changes	change	NOUN
ajlm-100	133	29	during	during	ADP
ajlm-100	133	30	the	the	DET
ajlm-100	133	31	acute	acute	ADJ
ajlm-100	133	32	disease	disease	NOUN
ajlm-100	133	33	phase	phase	NOUN
ajlm-100	133	34	.	.	PUNCT
ajlm-100	134	1	conclusion	conclusion	NOUN
ajlm-100	134	2	top	top	PROPN
ajlm-100	134	3	↑	↑	PROPN
ajlm-100	134	4	the	the	DET
ajlm-100	134	5	clinical	clinical	ADJ
ajlm-100	134	6	,	,	PUNCT
ajlm-100	134	7	parasitological	parasitological	ADJ
ajlm-100	134	8	and	and	CCONJ
ajlm-100	134	9	haematological	haematological	ADJ
ajlm-100	134	10	observations	observation	NOUN
ajlm-100	134	11	obtained	obtain	VERB
ajlm-100	134	12	in	in	ADP
ajlm-100	134	13	this	this	DET
ajlm-100	134	14	study	study	NOUN
ajlm-100	134	15	compare	compare	VERB
ajlm-100	134	16	well	well	ADV
ajlm-100	134	17	with	with	ADP
ajlm-100	134	18	those	those	PRON
ajlm-100	134	19	arising	arise	VERB
ajlm-100	134	20	from	from	ADP
ajlm-100	134	21	t.	t.	PROPN
ajlm-100	134	22	b.	b.	PROPN
ajlm-100	134	23	rhodesiense	rhodesiense	PROPN
ajlm-100	134	24	;	;	PUNCT
ajlm-100	134	25	therefore	therefore	ADV
ajlm-100	134	26	,	,	PUNCT
ajlm-100	134	27	the	the	DET
ajlm-100	134	28	vervet	vervet	PROPN
ajlm-100	134	29	monkey	monkey	PROPN
ajlm-100	134	30	t.	t.	PROPN
ajlm-100	134	31	b.	b.	PROPN
ajlm-100	134	32	brucei	brucei	PROPN
ajlm-100	134	33	model	model	NOUN
ajlm-100	134	34	may	may	AUX
ajlm-100	134	35	be	be	AUX
ajlm-100	134	36	used	use	VERB
ajlm-100	134	37	as	as	ADP
ajlm-100	134	38	substitute	substitute	NOUN
ajlm-100	134	39	.	.	PUNCT
ajlm-100	135	1	this	this	DET
ajlm-100	135	2	animal	animal	NOUN
ajlm-100	135	3	model	model	NOUN
ajlm-100	135	4	may	may	AUX
ajlm-100	135	5	enable	enable	VERB
ajlm-100	135	6	researchers	researcher	NOUN
ajlm-100	135	7	and	and	CCONJ
ajlm-100	135	8	laboratory	laboratory	NOUN
ajlm-100	135	9	technicians	technician	NOUN
ajlm-100	135	10	to	to	PART
ajlm-100	135	11	study	study	VERB
ajlm-100	135	12	hat	hat	NOUN
ajlm-100	135	13	without	without	ADP
ajlm-100	135	14	the	the	DET
ajlm-100	135	15	high	high	ADJ
ajlm-100	135	16	risk	risk	NOUN
ajlm-100	135	17	of	of	ADP
ajlm-100	135	18	accidental	accidental	ADJ
ajlm-100	135	19	infection	infection	NOUN
ajlm-100	135	20	.	.	PUNCT
ajlm-100	136	1	acknowledgements	acknowledgement	NOUN
ajlm-100	136	2	top	top	PROPN
ajlm-100	136	3	↑	↑	PROPN
ajlm-100	136	4	this	this	DET
ajlm-100	136	5	project	project	NOUN
ajlm-100	136	6	was	be	AUX
ajlm-100	136	7	funded	fund	VERB
ajlm-100	136	8	jointly	jointly	ADV
ajlm-100	136	9	by	by	ADP
ajlm-100	136	10	the	the	DET
ajlm-100	136	11	institute	institute	PROPN
ajlm-100	136	12	of	of	ADP
ajlm-100	136	13	primate	primate	PROPN
ajlm-100	136	14	research	research	NOUN
ajlm-100	136	15	(	(	PUNCT
ajlm-100	136	16	ipr	ipr	PROPN
ajlm-100	136	17	)	)	PUNCT
ajlm-100	136	18	,	,	PUNCT
ajlm-100	136	19	jomo	jomo	PROPN
ajlm-100	136	20	kenyatta	kenyatta	PROPN
ajlm-100	136	21	university	university	PROPN
ajlm-100	136	22	of	of	ADP
ajlm-100	136	23	agriculture	agriculture	PROPN
ajlm-100	136	24	and	and	CCONJ
ajlm-100	136	25	technology	technology	NOUN
ajlm-100	136	26	-	-	PUNCT
ajlm-100	136	27	research	research	NOUN
ajlm-100	136	28	production	production	NOUN
ajlm-100	136	29	and	and	CCONJ
ajlm-100	136	30	extension	extension	NOUN
ajlm-100	136	31	and	and	CCONJ
ajlm-100	136	32	foundation	foundation	NOUN
ajlm-100	136	33	for	for	ADP
ajlm-100	136	34	innovative	innovative	ADJ
ajlm-100	136	35	new	new	ADJ
ajlm-100	136	36	diagnostics	diagnostic	NOUN
ajlm-100	136	37	(	(	PUNCT
ajlm-100	136	38	find	find	VERB
ajlm-100	136	39	)	)	PUNCT
ajlm-100	136	40	.	.	PUNCT
ajlm-100	137	1	we	we	PRON
ajlm-100	137	2	are	be	AUX
ajlm-100	137	3	grateful	grateful	ADJ
ajlm-100	137	4	to	to	ADP
ajlm-100	137	5	the	the	DET
ajlm-100	137	6	technical	technical	ADJ
ajlm-100	137	7	assistance	assistance	NOUN
ajlm-100	137	8	provided	provide	VERB
ajlm-100	137	9	by	by	ADP
ajlm-100	137	10	mr	mr	PROPN
ajlm-100	137	11	.	.	PROPN
ajlm-100	137	12	ken	ken	PROPN
ajlm-100	137	13	waititu	waititu	PROPN
ajlm-100	137	14	and	and	CCONJ
ajlm-100	137	15	mr	mr	PROPN
ajlm-100	137	16	tom	tom	PROPN
ajlm-100	137	17	adino	adino	PROPN
ajlm-100	137	18	of	of	ADP
ajlm-100	137	19	animal	animal	NOUN
ajlm-100	137	20	science	science	NOUN
ajlm-100	137	21	department	department	PROPN
ajlm-100	137	22	in	in	ADP
ajlm-100	137	23	institute	institute	PROPN
ajlm-100	137	24	of	of	ADP
ajlm-100	137	25	primate	primate	PROPN
ajlm-100	137	26	research	research	NOUN
ajlm-100	137	27	.	.	PUNCT
ajlm-100	138	1	competing	compete	VERB
ajlm-100	138	2	interests	interest	NOUN
ajlm-100	138	3	the	the	DET
ajlm-100	138	4	authors	author	NOUN
ajlm-100	138	5	declare	declare	VERB
ajlm-100	138	6	that	that	SCONJ
ajlm-100	138	7	they	they	PRON
ajlm-100	138	8	have	have	VERB
ajlm-100	138	9	no	no	DET
ajlm-100	138	10	financial	financial	ADJ
ajlm-100	138	11	or	or	CCONJ
ajlm-100	138	12	personal	personal	ADJ
ajlm-100	138	13	relationship(s	relationship(s	NOUN
ajlm-100	138	14	)	)	PUNCT
ajlm-100	138	15	that	that	PRON
ajlm-100	138	16	may	may	AUX
ajlm-100	138	17	have	have	AUX
ajlm-100	138	18	inappropriately	inappropriately	ADV
ajlm-100	138	19	influenced	influence	VERB
ajlm-100	138	20	them	they	PRON
ajlm-100	138	21	in	in	ADP
ajlm-100	138	22	writing	write	VERB
ajlm-100	138	23	this	this	DET
ajlm-100	138	24	article	article	NOUN
ajlm-100	138	25	.	.	PUNCT
ajlm-100	139	1	authors	author	NOUN
ajlm-100	139	2	’	’	PART
ajlm-100	139	3	contributions	contribution	NOUN
ajlm-100	139	4	n.m	n.m	PROPN
ajlm-100	139	5	.	.	PROPN
ajlm-100	139	6	(	(	PUNCT
ajlm-100	139	7	jomo	jomo	PROPN
ajlm-100	139	8	kenyatta	kenyatta	PROPN
ajlm-100	139	9	university	university	PROPN
ajlm-100	139	10	of	of	ADP
ajlm-100	139	11	agriculture	agriculture	PROPN
ajlm-100	139	12	and	and	CCONJ
ajlm-100	139	13	technology	technology	NOUN
ajlm-100	139	14	)	)	PUNCT
ajlm-100	139	15	was	be	AUX
ajlm-100	139	16	the	the	DET
ajlm-100	139	17	project	project	NOUN
ajlm-100	139	18	leader	leader	NOUN
ajlm-100	139	19	and	and	CCONJ
ajlm-100	139	20	in	in	ADP
ajlm-100	139	21	charge	charge	NOUN
ajlm-100	139	22	of	of	ADP
ajlm-100	139	23	animal	animal	NOUN
ajlm-100	139	24	welfare	welfare	NOUN
ajlm-100	139	25	.	.	PUNCT
ajlm-100	140	1	j.k	j.k	PROPN
ajlm-100	140	2	.	.	PUNCT
ajlm-100	141	1	(	(	PUNCT
ajlm-100	141	2	jomo	jomo	PROPN
ajlm-100	141	3	kenyatta	kenyatta	PROPN
ajlm-100	141	4	university	university	PROPN
ajlm-100	141	5	of	of	ADP
ajlm-100	141	6	agriculture	agriculture	NOUN
ajlm-100	141	7	and	and	CCONJ
ajlm-100	141	8	technology	technology	NOUN
ajlm-100	141	9	)	)	PUNCT
ajlm-100	141	10	and	and	CCONJ
ajlm-100	141	11	n.m	n.m	PROPN
ajlm-100	141	12	.	.	PROPN
ajlm-100	141	13	were	be	AUX
ajlm-100	141	14	responsible	responsible	ADJ
ajlm-100	141	15	for	for	ADP
ajlm-100	141	16	the	the	DET
ajlm-100	141	17	experimental	experimental	ADJ
ajlm-100	141	18	and	and	CCONJ
ajlm-100	141	19	project	project	NOUN
ajlm-100	141	20	design	design	NOUN
ajlm-100	141	21	.	.	PUNCT
ajlm-100	142	1	m.w	m.w	PROPN
ajlm-100	142	2	.	.	PUNCT
ajlm-100	143	1	(	(	PUNCT
ajlm-100	143	2	jomo	jomo	PROPN
ajlm-100	143	3	kenyatta	kenyatta	PROPN
ajlm-100	143	4	university	university	PROPN
ajlm-100	143	5	of	of	ADP
ajlm-100	143	6	agriculture	agriculture	NOUN
ajlm-100	143	7	and	and	CCONJ
ajlm-100	143	8	technology	technology	NOUN
ajlm-100	143	9	)	)	PUNCT
ajlm-100	143	10	,	,	PUNCT
ajlm-100	143	11	k.j	k.j	PROPN
ajlm-100	143	12	.	.	PROPN
ajlm-100	143	13	,	,	PUNCT
ajlm-100	143	14	n.m	n.m	PROPN
ajlm-100	143	15	.	.	PROPN
ajlm-100	143	16	,	,	PUNCT
ajlm-100	143	17	s.k	s.k	PROPN
ajlm-100	143	18	.	.	PUNCT
ajlm-100	144	1	(	(	PUNCT
ajlm-100	144	2	jomo	jomo	PROPN
ajlm-100	144	3	kenyatta	kenyatta	PROPN
ajlm-100	144	4	university	university	PROPN
ajlm-100	144	5	of	of	ADP
ajlm-100	144	6	agriculture	agriculture	NOUN
ajlm-100	144	7	and	and	CCONJ
ajlm-100	144	8	technology	technology	NOUN
ajlm-100	144	9	)	)	PUNCT
ajlm-100	144	10	and	and	CCONJ
ajlm-100	144	11	b.g	b.g	PROPN
ajlm-100	144	12	.	.	PROPN
ajlm-100	145	1	(	(	PUNCT
ajlm-100	145	2	institute	institute	NOUN
ajlm-100	145	3	of	of	ADP
ajlm-100	145	4	primate	primate	PROPN
ajlm-100	145	5	research	research	NOUN
ajlm-100	145	6	)	)	PUNCT
ajlm-100	145	7	performed	perform	VERB
ajlm-100	145	8	the	the	DET
ajlm-100	145	9	experiments	experiment	NOUN
ajlm-100	145	10	,	,	PUNCT
ajlm-100	145	11	whilst	whilst	SCONJ
ajlm-100	145	12	m.w	m.w	PROPN
ajlm-100	145	13	.	.	PROPN
ajlm-100	145	14	and	and	CCONJ
ajlm-100	145	15	s.k	s.k	PROPN
ajlm-100	145	16	.	.	PROPN
ajlm-100	145	17	performed	perform	VERB
ajlm-100	145	18	the	the	DET
ajlm-100	145	19	data	datum	NOUN
ajlm-100	145	20	analysis	analysis	NOUN
ajlm-100	145	21	.	.	PUNCT
ajlm-100	146	1	all	all	DET
ajlm-100	146	2	the	the	DET
ajlm-100	146	3	authors	author	NOUN
ajlm-100	146	4	participated	participate	VERB
ajlm-100	146	5	in	in	ADP
ajlm-100	146	6	the	the	DET
ajlm-100	146	7	writing	writing	NOUN
ajlm-100	146	8	of	of	ADP
ajlm-100	146	9	the	the	DET
ajlm-100	146	10	manuscript	manuscript	NOUN
ajlm-100	146	11	.	.	PUNCT
ajlm-100	147	1	references	reference	NOUN
ajlm-100	147	2	top	top	VERB
ajlm-100	147	3	↑	↑	NOUN
ajlm-100	147	4	1	1	NUM
ajlm-100	147	5	.	.	PUNCT
ajlm-100	147	6	world	world	PROPN
ajlm-100	147	7	health	health	PROPN
ajlm-100	147	8	organization	organization	PROPN
ajlm-100	147	9	.	.	PUNCT
ajlm-100	148	1	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	148	2	,	,	PUNCT
ajlm-100	148	3	human	human	ADJ
ajlm-100	148	4	african	african	NOUN
ajlm-100	148	5	(	(	PUNCT
ajlm-100	148	6	sleeping	sleep	VERB
ajlm-100	148	7	sickness	sickness	NOUN
ajlm-100	148	8	)	)	PUNCT
ajlm-100	148	9	.	.	PUNCT
ajlm-100	149	1	fact	fact	NOUN
ajlm-100	149	2	sheet	sheet	NOUN
ajlm-100	149	3	259	259	NUM
ajlm-100	149	4	.	.	PUNCT
ajlm-100	150	1	geneva	geneva	PROPN
ajlm-100	150	2	,	,	PUNCT
ajlm-100	150	3	switzerland	switzerland	PROPN
ajlm-100	150	4	:	:	PUNCT
ajlm-100	150	5	world	world	PROPN
ajlm-100	150	6	health	health	PROPN
ajlm-100	150	7	organization	organization	NOUN
ajlm-100	150	8	;	;	PUNCT
ajlm-100	150	9	2006	2006	NUM
ajlm-100	150	10	.	.	PUNCT
ajlm-100	151	1	2	2	X
ajlm-100	151	2	.	.	X
ajlm-100	151	3	world	world	PROPN
ajlm-100	151	4	health	health	PROPN
ajlm-100	151	5	organization	organization	PROPN
ajlm-100	151	6	.	.	PUNCT
ajlm-100	152	1	african	african	ADJ
ajlm-100	152	2	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	152	3	.	.	PUNCT
ajlm-100	153	1	world	world	NOUN
ajlm-100	153	2	health	health	PROPN
ajlm-100	153	3	organization	organization	PROPN
ajlm-100	153	4	fact	fact	NOUN
ajlm-100	153	5	sheet	sheet	NOUN
ajlm-100	153	6	no.259	no.259	PROPN
ajlm-100	153	7	;	;	PUNCT
ajlm-100	153	8	2000	2000	NUM
ajlm-100	153	9	,	,	PUNCT
ajlm-100	153	10	revised	revise	VERB
ajlm-100	153	11	august	august	PROPN
ajlm-100	153	12	2006	2006	NUM
ajlm-100	153	13	.	.	PUNCT
ajlm-100	154	1	http://www.who.int/mediacentre/factsheets/fs259/en/	http://www.who.int/mediacentre/factsheets/fs259/en/	X
ajlm-100	154	2	3	3	X
ajlm-100	154	3	.	.	X
ajlm-100	154	4	herwaldt	herwaldt	PROPN
ajlm-100	154	5	bl	bl	PROPN
ajlm-100	154	6	.	.	PUNCT
ajlm-100	154	7	laboratory	laboratory	NOUN
ajlm-100	154	8	-	-	PUNCT
ajlm-100	154	9	acquired	acquire	VERB
ajlm-100	154	10	parasitic	parasitic	ADJ
ajlm-100	154	11	infections	infection	NOUN
ajlm-100	154	12	from	from	ADP
ajlm-100	154	13	accidental	accidental	ADJ
ajlm-100	154	14	exposures	exposure	NOUN
ajlm-100	154	15	.	.	PUNCT
ajlm-100	155	1	clin	clin	PROPN
ajlm-100	155	2	microbiol	microbiol	PROPN
ajlm-100	155	3	rev	rev	VERB
ajlm-100	155	4	.	.	PUNCT
ajlm-100	156	1	2001;14(4):659–688	2001;14(4):659–688	X
ajlm-100	156	2	.	.	PUNCT
ajlm-100	156	3	http://dx.doi.org/10.1128/cmr.14.3.659-688.2001	http://dx.doi.org/10.1128/cmr.14.3.659-688.2001	VERB
ajlm-100	156	4	4	4	NUM
ajlm-100	156	5	.	.	PUNCT
ajlm-100	157	1	robertson	robertson	PROPN
ajlm-100	157	2	dhh	dhh	PROPN
ajlm-100	157	3	,	,	PUNCT
ajlm-100	157	4	pickens	pickens	PROPN
ajlm-100	157	5	s	s	PART
ajlm-100	157	6	,	,	PUNCT
ajlm-100	157	7	lawson	lawson	PROPN
ajlm-100	157	8	jh	jh	PROPN
ajlm-100	157	9	,	,	PUNCT
ajlm-100	157	10	et	et	PROPN
ajlm-100	157	11	al	al	PROPN
ajlm-100	157	12	.	.	PUNCT
ajlm-100	158	1	an	an	DET
ajlm-100	158	2	accidental	accidental	ADJ
ajlm-100	158	3	laboratory	laboratory	NOUN
ajlm-100	158	4	infection	infection	NOUN
ajlm-100	158	5	with	with	ADP
ajlm-100	158	6	african	african	ADJ
ajlm-100	158	7	trypanosomes	trypanosome	NOUN
ajlm-100	158	8	of	of	ADP
ajlm-100	158	9	a	a	DET
ajlm-100	158	10	defined	define	VERB
ajlm-100	158	11	stock	stock	NOUN
ajlm-100	158	12	i.	i.	NOUN
ajlm-100	158	13	the	the	DET
ajlm-100	158	14	clinical	clinical	ADJ
ajlm-100	158	15	course	course	NOUN
ajlm-100	158	16	of	of	ADP
ajlm-100	158	17	the	the	DET
ajlm-100	158	18	infection	infection	NOUN
ajlm-100	158	19	.	.	PUNCT
ajlm-100	159	1	j	j	PROPN
ajlm-100	159	2	infect	infect	VERB
ajlm-100	159	3	.	.	PUNCT
ajlm-100	160	1	1980;2(2):105–112	1980;2(2):105–112	X
ajlm-100	160	2	.	.	PUNCT
ajlm-100	160	3	http://dx.doi.org/10.1016/s0163-4453(80)91084-1	http://dx.doi.org/10.1016/s0163-4453(80)91084-1	NUM
ajlm-100	160	4	5	5	NUM
ajlm-100	160	5	.	.	PUNCT
ajlm-100	160	6	herbert	herbert	PROPN
ajlm-100	160	7	wj	wj	PROPN
ajlm-100	160	8	,	,	PUNCT
ajlm-100	160	9	parratt	parratt	PROPN
ajlm-100	160	10	d	d	PROPN
ajlm-100	160	11	,	,	PUNCT
ajlm-100	160	12	van	van	PROPN
ajlm-100	160	13	meirvenne	meirvenne	NOUN
ajlm-100	160	14	n	n	CCONJ
ajlm-100	160	15	,	,	PUNCT
ajlm-100	160	16	et	et	PROPN
ajlm-100	160	17	al	al	PROPN
ajlm-100	160	18	.	.	PUNCT
ajlm-100	161	1	an	an	DET
ajlm-100	161	2	accidental	accidental	ADJ
ajlm-100	161	3	laboratory	laboratory	NOUN
ajlm-100	161	4	infection	infection	NOUN
ajlm-100	161	5	with	with	ADP
ajlm-100	161	6	trypanosomes	trypanosome	NOUN
ajlm-100	161	7	of	of	ADP
ajlm-100	161	8	a	a	DET
ajlm-100	161	9	defined	define	VERB
ajlm-100	161	10	stock	stock	NOUN
ajlm-100	161	11	ii	ii	PROPN
ajlm-100	161	12	.	.	PUNCT
ajlm-100	162	1	studies	study	NOUN
ajlm-100	162	2	on	on	ADP
ajlm-100	162	3	the	the	DET
ajlm-100	162	4	serological	serological	ADJ
ajlm-100	162	5	response	response	NOUN
ajlm-100	162	6	of	of	ADP
ajlm-100	162	7	the	the	DET
ajlm-100	162	8	patient	patient	NOUN
ajlm-100	162	9	and	and	CCONJ
ajlm-100	162	10	the	the	DET
ajlm-100	162	11	identity	identity	NOUN
ajlm-100	162	12	of	of	ADP
ajlm-100	162	13	the	the	DET
ajlm-100	162	14	infecting	infect	VERB
ajlm-100	162	15	organism	organism	NOUN
ajlm-100	162	16	.	.	PUNCT
ajlm-100	163	1	j	j	PROPN
ajlm-100	163	2	infect	infect	VERB
ajlm-100	163	3	.	.	PUNCT
ajlm-100	164	1	1980;2(2):113–124	1980;2(2):113–124	X
ajlm-100	164	2	.	.	PUNCT
ajlm-100	164	3	http://dx.doi.org/10.1016/s0163-4453(80)91109-3	http://dx.doi.org/10.1016/s0163-4453(80)91109-3	NOUN
ajlm-100	164	4	6.6	6.6	NUM
ajlm-100	164	5	.	.	PUNCT
ajlm-100	164	6	keita	keita	PROPN
ajlm-100	164	7	m	m	PROPN
ajlm-100	164	8	,	,	PUNCT
ajlm-100	164	9	bouteille	bouteille	PROPN
ajlm-100	164	10	b	b	NOUN
ajlm-100	164	11	,	,	PUNCT
ajlm-100	164	12	enanga	enanga	PROPN
ajlm-100	164	13	b	b	NUM
ajlm-100	164	14	,	,	PUNCT
ajlm-100	164	15	et	et	PROPN
ajlm-100	164	16	al	al	PROPN
ajlm-100	164	17	.	.	PROPN
ajlm-100	164	18	trypanosoma	trypanosoma	PROPN
ajlm-100	164	19	brucei	brucei	PROPN
ajlm-100	164	20	brucei	brucei	PROPN
ajlm-100	164	21	:	:	PUNCT
ajlm-100	164	22	a	a	DET
ajlm-100	164	23	long	long	ADJ
ajlm-100	164	24	-	-	PUNCT
ajlm-100	164	25	term	term	NOUN
ajlm-100	164	26	model	model	NOUN
ajlm-100	164	27	of	of	ADP
ajlm-100	164	28	human	human	ADJ
ajlm-100	164	29	african	african	ADJ
ajlm-100	164	30	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	164	31	in	in	ADP
ajlm-100	164	32	mice	mouse	NOUN
ajlm-100	164	33	,	,	PUNCT
ajlm-100	164	34	meningo	meningo	NOUN
ajlm-100	164	35	-	-	PUNCT
ajlm-100	164	36	encephalitis	encephalitis	ADJ
ajlm-100	164	37	,	,	PUNCT
ajlm-100	164	38	astrocytosis	astrocytosis	NOUN
ajlm-100	164	39	,	,	PUNCT
ajlm-100	164	40	and	and	CCONJ
ajlm-100	164	41	neurological	neurological	ADJ
ajlm-100	164	42	disorders	disorder	NOUN
ajlm-100	164	43	.	.	PUNCT
ajlm-100	165	1	exp	exp	NOUN
ajlm-100	165	2	parasitol	parasitol	NOUN
ajlm-100	165	3	.	.	PUNCT
ajlm-100	166	1	1997;85(2):183–192	1997;85(2):183–192	X
ajlm-100	166	2	.	.	X
ajlm-100	166	3	http://dx.doi.org/10.1006/expr.1996.4136	http://dx.doi.org/10.1006/expr.1996.4136	PROPN
ajlm-100	166	4	7	7	NUM
ajlm-100	166	5	.	.	PUNCT
ajlm-100	167	1	farah	farah	PROPN
ajlm-100	167	2	io	io	PROPN
ajlm-100	167	3	,	,	PUNCT
ajlm-100	167	4	ngotho	ngotho	PROPN
ajlm-100	167	5	m	m	PROPN
ajlm-100	167	6	,	,	PUNCT
ajlm-100	167	7	kariuki	kariuki	PROPN
ajlm-100	167	8	m	m	PROPN
ajlm-100	167	9	,	,	PUNCT
ajlm-100	167	10	et	et	PROPN
ajlm-100	167	11	al	al	PROPN
ajlm-100	167	12	.	.	PUNCT
ajlm-100	167	13	animal	animal	NOUN
ajlm-100	167	14	models	model	NOUN
ajlm-100	167	15	of	of	ADP
ajlm-100	167	16	tropical	tropical	ADJ
ajlm-100	167	17	human	human	ADJ
ajlm-100	167	18	diseases	disease	NOUN
ajlm-100	167	19	.	.	PUNCT
ajlm-100	168	1	in	in	ADP
ajlm-100	168	2	:	:	PUNCT
ajlm-100	168	3	j	j	PROPN
ajlm-100	168	4	hau	hau	PROPN
ajlm-100	168	5	,	,	PUNCT
ajlm-100	168	6	g	g	PROPN
ajlm-100	168	7	hoosier	hoosier	NOUN
ajlm-100	168	8	,	,	PUNCT
ajlm-100	168	9	editors	editor	NOUN
ajlm-100	168	10	.	.	PUNCT
ajlm-100	169	1	handbook	handbook	NOUN
ajlm-100	169	2	of	of	ADP
ajlm-100	169	3	laboratory	laboratory	NOUN
ajlm-100	169	4	animal	animal	NOUN
ajlm-100	169	5	science	science	NOUN
ajlm-100	169	6	,	,	PUNCT
ajlm-100	169	7	vol	vol	NOUN
ajlm-100	169	8	.	.	PUNCT
ajlm-100	169	9	iii	iii	PROPN
ajlm-100	169	10	.	.	PUNCT
ajlm-100	170	1	new	new	PROPN
ajlm-100	170	2	york	york	PROPN
ajlm-100	170	3	:	:	PUNCT
ajlm-100	170	4	crc	crc	PROPN
ajlm-100	170	5	press	press	PROPN
ajlm-100	170	6	,	,	PUNCT
ajlm-100	170	7	2005	2005	NUM
ajlm-100	170	8	;	;	PUNCT
ajlm-100	170	9	pp	pp	ADP
ajlm-100	170	10	.	.	PUNCT
ajlm-100	171	1	169–224	169–224	NUM
ajlm-100	171	2	.	.	NOUN
ajlm-100	171	3	8	8	NUM
ajlm-100	171	4	.	.	PUNCT
ajlm-100	171	5	herbert	herbert	PROPN
ajlm-100	171	6	wj	wj	PROPN
ajlm-100	171	7	,	,	PUNCT
ajlm-100	171	8	lumsden	lumsden	PROPN
ajlm-100	171	9	wh	wh	PROPN
ajlm-100	171	10	.	.	PROPN
ajlm-100	172	1	trypanosoma	trypanosoma	PROPN
ajlm-100	172	2	brucei	brucei	PROPN
ajlm-100	172	3	:	:	PUNCT
ajlm-100	172	4	a	a	DET
ajlm-100	172	5	rapid	rapid	ADJ
ajlm-100	172	6	‘	'	PUNCT
ajlm-100	172	7	matching	matching	NOUN
ajlm-100	172	8	’	'	PUNCT
ajlm-100	172	9	method	method	NOUN
ajlm-100	172	10	for	for	ADP
ajlm-100	172	11	estimating	estimate	VERB
ajlm-100	172	12	the	the	DET
ajlm-100	172	13	host	host	NOUN
ajlm-100	172	14	’s	’s	PART
ajlm-100	172	15	parasitemia	parasitemia	NOUN
ajlm-100	172	16	.	.	PUNCT
ajlm-100	173	1	exp	exp	NOUN
ajlm-100	173	2	parasitol	parasitol	NOUN
ajlm-100	173	3	.	.	PUNCT
ajlm-100	174	1	1976;40(3):427–431	1976;40(3):427–431	X
ajlm-100	174	2	.	.	X
ajlm-100	174	3	http://dx.doi.org/10.1016/0014-4894(76)90110-7	http://dx.doi.org/10.1016/0014-4894(76)90110-7	NOUN
ajlm-100	174	4	9	9	NUM
ajlm-100	174	5	.	.	X
ajlm-100	175	1	gould	gould	PROPN
ajlm-100	175	2	ss	ss	PROPN
ajlm-100	175	3	,	,	PUNCT
ajlm-100	175	4	sayer	sayer	PROPN
ajlm-100	175	5	pd	pd	PROPN
ajlm-100	175	6	.	.	PROPN
ajlm-100	176	1	a	a	DET
ajlm-100	176	2	simple	simple	ADJ
ajlm-100	176	3	concentration	concentration	NOUN
ajlm-100	176	4	technique	technique	NOUN
ajlm-100	176	5	for	for	ADP
ajlm-100	176	6	direct	direct	ADJ
ajlm-100	176	7	detection	detection	NOUN
ajlm-100	176	8	of	of	ADP
ajlm-100	176	9	trypanosomes	trypanosome	NOUN
ajlm-100	176	10	in	in	ADP
ajlm-100	176	11	the	the	DET
ajlm-100	176	12	cerebrospinal	cerebrospinal	ADJ
ajlm-100	176	13	fluid	fluid	NOUN
ajlm-100	176	14	of	of	ADP
ajlm-100	176	15	vervet	vervet	NOUN
ajlm-100	176	16	monkeys	monkey	NOUN
ajlm-100	176	17	,	,	PUNCT
ajlm-100	176	18	17th	17th	ADJ
ajlm-100	176	19	isctrc	isctrc	NOUN
ajlm-100	176	20	meeting	meeting	NOUN
ajlm-100	176	21	.	.	PUNCT
ajlm-100	177	1	in	in	ADP
ajlm-100	177	2	:	:	PUNCT
ajlm-100	177	3	proceedings	proceeding	NOUN
ajlm-100	177	4	of	of	ADP
ajlm-100	177	5	the	the	DET
ajlm-100	177	6	international	international	ADJ
ajlm-100	177	7	scientific	scientific	ADJ
ajlm-100	177	8	council	council	NOUN
ajlm-100	177	9	for	for	ADP
ajlm-100	177	10	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	177	11	research	research	NOUN
ajlm-100	177	12	and	and	CCONJ
ajlm-100	177	13	control	control	NOUN
ajlm-100	177	14	)	)	PUNCT
ajlm-100	177	15	(	(	PUNCT
ajlm-100	177	16	oau	oau	PROPN
ajlm-100	177	17	)	)	PUNCT
ajlm-100	177	18	arusha	arusha	PROPN
ajlm-100	177	19	,	,	PUNCT
ajlm-100	177	20	tanzania	tanzania	PROPN
ajlm-100	177	21	,	,	PUNCT
ajlm-100	177	22	1983	1983	NUM
ajlm-100	177	23	;	;	PUNCT
ajlm-100	177	24	p.	p.	PROPN
ajlm-100	177	25	259–260	259–260	NUM
ajlm-100	177	26	.	.	PUNCT
ajlm-100	178	1	10	10	NUM
ajlm-100	178	2	.	.	PUNCT
ajlm-100	179	1	kagira	kagira	PROPN
ajlm-100	179	2	jm	jm	PROPN
ajlm-100	179	3	,	,	PUNCT
ajlm-100	179	4	ngotho	ngotho	PROPN
ajlm-100	179	5	m	m	PROPN
ajlm-100	179	6	,	,	PUNCT
ajlm-100	179	7	thuita	thuita	PROPN
ajlm-100	179	8	jk	jk	PROPN
ajlm-100	179	9	,	,	PUNCT
ajlm-100	179	10	et	et	PROPN
ajlm-100	179	11	al	al	PROPN
ajlm-100	179	12	.	.	PUNCT
ajlm-100	180	1	hematological	hematological	ADJ
ajlm-100	180	2	changes	change	NOUN
ajlm-100	180	3	in	in	ADP
ajlm-100	180	4	vervet	vervet	NOUN
ajlm-100	180	5	monkeys	monkey	NOUN
ajlm-100	180	6	(	(	PUNCT
ajlm-100	180	7	chlorocebus	chlorocebus	NOUN
ajlm-100	180	8	aethiops	aethiop	NOUN
ajlm-100	180	9	)	)	PUNCT
ajlm-100	180	10	during	during	ADP
ajlm-100	180	11	eight	eight	NUM
ajlm-100	180	12	months	month	NOUN
ajlm-100	180	13	’	'	PUNCT
ajlm-100	180	14	adaptation	adaptation	NOUN
ajlm-100	180	15	to	to	ADP
ajlm-100	180	16	captivity	captivity	NOUN
ajlm-100	180	17	.	.	PUNCT
ajlm-100	181	1	amer	amer	PROPN
ajlm-100	181	2	j	j	PROPN
ajlm-100	181	3	primatol	primatol	NOUN
ajlm-100	181	4	.	.	PUNCT
ajlm-100	182	1	2007;69(9):1053–1063	2007;69(9):1053–1063	NUM
ajlm-100	182	2	.	.	PUNCT
ajlm-100	183	1	http://dx.doi.org/10.1002/ajp.20422	http://dx.doi.org/10.1002/ajp.20422	NOUN
ajlm-100	183	2	11	11	NUM
ajlm-100	183	3	.	.	PUNCT
ajlm-100	184	1	ngotho	ngotho	PROPN
ajlm-100	184	2	m	m	PROPN
ajlm-100	184	3	,	,	PUNCT
ajlm-100	184	4	kagira	kagira	PROPN
ajlm-100	184	5	jm	jm	PROPN
ajlm-100	184	6	,	,	PUNCT
ajlm-100	184	7	gaithuma	gaithuma	PROPN
ajlm-100	184	8	ak	ak	PROPN
ajlm-100	184	9	,	,	PUNCT
ajlm-100	184	10	et	et	PROPN
ajlm-100	184	11	al	al	PROPN
ajlm-100	184	12	.	.	PUNCT
ajlm-100	185	1	a	a	DET
ajlm-100	185	2	robust	robust	ADJ
ajlm-100	185	3	and	and	CCONJ
ajlm-100	185	4	improved	improved	ADJ
ajlm-100	185	5	monkey	monkey	NOUN
ajlm-100	185	6	model	model	NOUN
ajlm-100	185	7	of	of	ADP
ajlm-100	185	8	human	human	ADJ
ajlm-100	185	9	african	african	ADJ
ajlm-100	185	10	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	185	11	.	.	PUNCT
ajlm-100	186	1	in	in	ADP
ajlm-100	186	2	:	:	PUNCT
ajlm-100	186	3	proceedings	proceeding	NOUN
ajlm-100	186	4	of	of	ADP
ajlm-100	186	5	the	the	DET
ajlm-100	186	6	xii	xii	PROPN
ajlm-100	186	7	international	international	PROPN
ajlm-100	186	8	congress	congress	PROPN
ajlm-100	186	9	of	of	ADP
ajlm-100	186	10	parasitology	parasitology	NOUN
ajlm-100	186	11	melbourne	melbourne	NOUN
ajlm-100	186	12	(	(	PUNCT
ajlm-100	186	13	australia)august	australia)august	ADV
ajlm-100	186	14	15–20	15–20	NUM
ajlm-100	186	15	,	,	PUNCT
ajlm-100	186	16	2010	2010	NUM
ajlm-100	186	17	;	;	PUNCT
ajlm-100	186	18	p.	p.	NOUN
ajlm-100	186	19	39–46	39–46	NUM
ajlm-100	186	20	.	.	PUNCT
ajlm-100	187	1	12	12	NUM
ajlm-100	187	2	.	.	PUNCT
ajlm-100	188	1	clerinx	clerinx	PROPN
ajlm-100	188	2	j	j	PROPN
ajlm-100	188	3	,	,	PUNCT
ajlm-100	188	4	vlieghe	vlieghe	NOUN
ajlm-100	188	5	e	e	NOUN
ajlm-100	188	6	,	,	PUNCT
ajlm-100	188	7	asselman	asselman	NOUN
ajlm-100	188	8	v	v	NOUN
ajlm-100	188	9	,	,	PUNCT
ajlm-100	188	10	et	et	PROPN
ajlm-100	188	11	al	al	PROPN
ajlm-100	188	12	.	.	PUNCT
ajlm-100	189	1	human	human	ADJ
ajlm-100	189	2	african	african	ADJ
ajlm-100	189	3	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	189	4	in	in	ADP
ajlm-100	189	5	a	a	DET
ajlm-100	189	6	belgian	belgian	ADJ
ajlm-100	189	7	traveller	traveller	NOUN
ajlm-100	189	8	returning	return	VERB
ajlm-100	189	9	from	from	ADP
ajlm-100	189	10	the	the	DET
ajlm-100	189	11	masai	masai	PROPN
ajlm-100	189	12	mara	mara	PROPN
ajlm-100	189	13	area	area	PROPN
ajlm-100	189	14	,	,	PUNCT
ajlm-100	189	15	kenya	kenya	PROPN
ajlm-100	189	16	,	,	PUNCT
ajlm-100	189	17	february	february	PROPN
ajlm-100	189	18	2012	2012	NUM
ajlm-100	189	19	.	.	PUNCT
ajlm-100	190	1	euro	euro	NOUN
ajlm-100	190	2	surveill	surveill	NOUN
ajlm-100	190	3	.	.	PUNCT
ajlm-100	191	1	2012;17(10):pii=20111	2012;17(10):pii=20111	X
ajlm-100	191	2	.	.	PUNCT
ajlm-100	191	3	available	available	ADJ
ajlm-100	191	4	online	online	ADV
ajlm-100	191	5	:	:	PUNCT
ajlm-100	191	6	http://www.eurosurveillance.org/viewarticle.aspx?articleid=20111	http://www.eurosurveillance.org/viewarticle.aspx?articleid=20111	ADJ
ajlm-100	191	7	13	13	NUM
ajlm-100	191	8	.	.	PUNCT
ajlm-100	192	1	gillett	gillett	PROPN
ajlm-100	192	2	mp	mp	PROPN
ajlm-100	192	3	,	,	PUNCT
ajlm-100	192	4	owen	owen	PROPN
ajlm-100	192	5	js	js	PROPN
ajlm-100	192	6	.	.	PUNCT
ajlm-100	193	1	comparison	comparison	NOUN
ajlm-100	193	2	of	of	ADP
ajlm-100	193	3	the	the	DET
ajlm-100	193	4	cytolytic	cytolytic	ADJ
ajlm-100	193	5	effects	effect	NOUN
ajlm-100	193	6	in	in	ADP
ajlm-100	193	7	vitro	vitro	X
ajlm-100	193	8	on	on	ADP
ajlm-100	193	9	trypanosoma	trypanosoma	PROPN
ajlm-100	193	10	brucei	brucei	PROPN
ajlm-100	193	11	brucei	brucei	PROPN
ajlm-100	193	12	of	of	ADP
ajlm-100	193	13	plasma	plasma	NOUN
ajlm-100	193	14	,	,	PUNCT
ajlm-100	193	15	high	high	ADJ
ajlm-100	193	16	density	density	NOUN
ajlm-100	193	17	lipoproteins	lipoprotein	NOUN
ajlm-100	193	18	,	,	PUNCT
ajlm-100	193	19	and	and	CCONJ
ajlm-100	193	20	apolipoprotein	apolipoprotein	VERB
ajlm-100	193	21	a	a	PRON
ajlm-100	193	22	-	-	PUNCT
ajlm-100	193	23	i	i	PRON
ajlm-100	193	24	from	from	ADP
ajlm-100	193	25	hosts	host	NOUN
ajlm-100	193	26	both	both	CCONJ
ajlm-100	193	27	susceptible	susceptible	ADJ
ajlm-100	193	28	(	(	PUNCT
ajlm-100	193	29	cattle	cattle	NOUN
ajlm-100	193	30	and	and	CCONJ
ajlm-100	193	31	sheep	sheep	NOUN
ajlm-100	193	32	)	)	PUNCT
ajlm-100	193	33	and	and	CCONJ
ajlm-100	193	34	resistant	resistant	ADJ
ajlm-100	193	35	(	(	PUNCT
ajlm-100	193	36	human	human	NOUN
ajlm-100	193	37	and	and	CCONJ
ajlm-100	193	38	baboon	baboon	NOUN
ajlm-100	193	39	)	)	PUNCT
ajlm-100	193	40	to	to	ADP
ajlm-100	193	41	infection	infection	NOUN
ajlm-100	193	42	.	.	PUNCT
ajlm-100	194	1	j	j	PROPN
ajlm-100	194	2	lipid	lipid	PROPN
ajlm-100	194	3	res	re	NOUN
ajlm-100	194	4	.	.	PUNCT
ajlm-100	195	1	1992;33(4):513–523	1992;33(4):513–523	NUM
ajlm-100	195	2	.	.	PUNCT
ajlm-100	196	1	14	14	NUM
ajlm-100	196	2	.	.	PUNCT
ajlm-100	197	1	pays	pay	VERB
ajlm-100	197	2	e	e	PROPN
ajlm-100	197	3	,	,	PUNCT
ajlm-100	197	4	vanhollebeke	vanhollebeke	PROPN
ajlm-100	197	5	b.	b.	PROPN
ajlm-100	197	6	mutual	mutual	ADJ
ajlm-100	197	7	self	self	NOUN
ajlm-100	197	8	-	-	PUNCT
ajlm-100	197	9	defence	defence	NOUN
ajlm-100	197	10	:	:	PUNCT
ajlm-100	197	11	the	the	DET
ajlm-100	197	12	trypanolytic	trypanolytic	ADJ
ajlm-100	197	13	factor	factor	NOUN
ajlm-100	197	14	story	story	NOUN
ajlm-100	197	15	.	.	PUNCT
ajlm-100	198	1	microbes	microbe	NOUN
ajlm-100	198	2	infect	infect	VERB
ajlm-100	198	3	.	.	PUNCT
ajlm-100	199	1	2008;10(9):985–989	2008;10(9):985–989	X
ajlm-100	199	2	.	.	PUNCT
ajlm-100	200	1	http://dx.doi.org/10.1016/j.micinf.2008.07.020	http://dx.doi.org/10.1016/j.micinf.2008.07.020	PRON
ajlm-100	200	2	15	15	NUM
ajlm-100	200	3	.	.	PUNCT
ajlm-100	201	1	gaithuma	gaithuma	PROPN
ajlm-100	201	2	ak	ak	PROPN
ajlm-100	201	3	,	,	PUNCT
ajlm-100	201	4	karanja	karanja	PROPN
ajlm-100	201	5	sm	sm	PROPN
ajlm-100	201	6	,	,	PUNCT
ajlm-100	201	7	ngotho	ngotho	PROPN
ajlm-100	201	8	m	m	PROPN
ajlm-100	201	9	,	,	PUNCT
ajlm-100	201	10	et	et	PROPN
ajlm-100	201	11	al	al	PROPN
ajlm-100	201	12	.	.	PROPN
ajlm-100	201	13	lipid	lipid	PROPN
ajlm-100	201	14	metabolism	metabolism	NOUN
ajlm-100	201	15	and	and	CCONJ
ajlm-100	201	16	other	other	ADJ
ajlm-100	201	17	metabolic	metabolic	NOUN
ajlm-100	201	18	changes	change	NOUN
ajlm-100	201	19	in	in	ADP
ajlm-100	201	20	vervet	vervet	NOUN
ajlm-100	201	21	monkeys	monkey	NOUN
ajlm-100	201	22	experimentally	experimentally	ADV
ajlm-100	201	23	infected	infect	VERB
ajlm-100	201	24	with	with	ADP
ajlm-100	201	25	trypanosoma	trypanosoma	PROPN
ajlm-100	201	26	brucei	brucei	PROPN
ajlm-100	201	27	rhodesiense	rhodesiense	PROPN
ajlm-100	201	28	.	.	PUNCT
ajlm-100	202	1	j	j	PROPN
ajlm-100	202	2	med	med	ADJ
ajlm-100	202	3	primatol	primatol	NOUN
ajlm-100	202	4	.	.	PUNCT
ajlm-100	203	1	2011;41(2):75–81	2011;41(2):75–81	NUM
ajlm-100	203	2	.	.	PUNCT
ajlm-100	204	1	http://dx.doi.org/10.1111/j.1600-0684.2011.00523.x	http://dx.doi.org/10.1111/j.1600-0684.2011.00523.x	ADJ
ajlm-100	204	2	16	16	NUM
ajlm-100	204	3	.	.	PUNCT
ajlm-100	205	1	ngotho	ngotho	PROPN
ajlm-100	205	2	m	m	PROPN
ajlm-100	205	3	,	,	PUNCT
ajlm-100	205	4	maina	maina	PROPN
ajlm-100	205	5	n	n	PROPN
ajlm-100	205	6	,	,	PUNCT
ajlm-100	205	7	kagira	kagira	PROPN
ajlm-100	205	8	j	j	PROPN
ajlm-100	205	9	,	,	PUNCT
ajlm-100	205	10	et	et	PROPN
ajlm-100	205	11	al	al	PROPN
ajlm-100	205	12	.	.	PROPN
ajlm-100	205	13	il-10	il-10	PUNCT
ajlm-100	205	14	is	be	AUX
ajlm-100	205	15	up	up	ADV
ajlm-100	205	16	regulated	regulate	VERB
ajlm-100	205	17	in	in	ADP
ajlm-100	205	18	early	early	ADJ
ajlm-100	205	19	and	and	CCONJ
ajlm-100	205	20	transitional	transitional	ADJ
ajlm-100	205	21	stage	stage	NOUN
ajlm-100	205	22	in	in	ADP
ajlm-100	205	23	vervet	vervet	NOUN
ajlm-100	205	24	monkeys	monkey	NOUN
ajlm-100	205	25	experimentally	experimentally	ADV
ajlm-100	205	26	infected	infect	VERB
ajlm-100	205	27	with	with	ADP
ajlm-100	205	28	trypanosoma	trypanosoma	PROPN
ajlm-100	205	29	brucei	brucei	PROPN
ajlm-100	205	30	rhodesiense	rhodesiense	PROPN
ajlm-100	205	31	.	.	PUNCT
ajlm-100	206	1	parasitol	parasitol	NOUN
ajlm-100	206	2	int	int	NOUN
ajlm-100	206	3	.	.	PUNCT
ajlm-100	207	1	2006;55(4	2006;55(4	NUM
ajlm-100	207	2	)	)	PUNCT
ajlm-100	207	3	243–248	243–248	NUM
ajlm-100	207	4	.	.	PUNCT
ajlm-100	208	1	http://dx.doi.org/10.1016/j.parint.2006.06.004	http://dx.doi.org/10.1016/j.parint.2006.06.004	NOUN
ajlm-100	208	2	17	17	NUM
ajlm-100	208	3	.	.	PUNCT
ajlm-100	209	1	ngotho	ngotho	PROPN
ajlm-100	209	2	m	m	PROPN
ajlm-100	209	3	,	,	PUNCT
ajlm-100	209	4	kagira	kagira	PROPN
ajlm-100	209	5	jm	jm	PROPN
ajlm-100	209	6	,	,	PUNCT
ajlm-100	209	7	kariuki	kariuki	PROPN
ajlm-100	209	8	c	c	PROPN
ajlm-100	209	9	,	,	PUNCT
ajlm-100	209	10	et	et	PROPN
ajlm-100	209	11	al	al	PROPN
ajlm-100	209	12	.	.	PUNCT
ajlm-100	209	13	influence	influence	NOUN
ajlm-100	209	14	of	of	ADP
ajlm-100	209	15	trypanocidal	trypanocidal	NOUN
ajlm-100	209	16	therapy	therapy	NOUN
ajlm-100	209	17	on	on	ADP
ajlm-100	209	18	the	the	DET
ajlm-100	209	19	haematology	haematology	NOUN
ajlm-100	209	20	of	of	ADP
ajlm-100	209	21	vervet	vervet	NOUN
ajlm-100	209	22	monkeys	monkey	NOUN
ajlm-100	209	23	experimentally	experimentally	ADV
ajlm-100	209	24	infected	infect	VERB
ajlm-100	209	25	with	with	ADP
ajlm-100	209	26	trypanosoma	trypanosoma	PROPN
ajlm-100	209	27	brucei	brucei	PROPN
ajlm-100	209	28	rhodesiense	rhodesiense	PROPN
ajlm-100	209	29	.	.	PUNCT
ajlm-100	210	1	acta	acta	PROPN
ajlm-100	210	2	trop	trop	PROPN
ajlm-100	210	3	.	.	PUNCT
ajlm-100	211	1	2011;119(1):14–18	2011;119(1):14–18	NUM
ajlm-100	211	2	.	.	PUNCT
ajlm-100	212	1	http://dx.doi.org/10.1016/j.actatropica.2011.02.013	http://dx.doi.org/10.1016/j.actatropica.2011.02.013	PROPN
ajlm-100	212	2	18	18	NUM
ajlm-100	212	3	.	.	PUNCT
ajlm-100	213	1	dow	dow	PROPN
ajlm-100	213	2	rb	rb	PROPN
ajlm-100	213	3	.	.	PUNCT
ajlm-100	214	1	the	the	DET
ajlm-100	214	2	clinical	clinical	ADJ
ajlm-100	214	3	and	and	CCONJ
ajlm-100	214	4	laboratory	laboratory	NOUN
ajlm-100	214	5	utility	utility	NOUN
ajlm-100	214	6	of	of	ADP
ajlm-100	214	7	platelet	platelet	NOUN
ajlm-100	214	8	volume	volume	NOUN
ajlm-100	214	9	parameters	parameter	NOUN
ajlm-100	214	10	.	.	PUNCT
ajlm-100	215	1	australia	australia	PROPN
ajlm-100	215	2	journal	journal	PROPN
ajlm-100	215	3	of	of	ADP
ajlm-100	215	4	medical	medical	ADJ
ajlm-100	215	5	science.1994;15:1–8	science.1994;15:1–8	PROPN
ajlm-100	215	6	.	.	PROPN
ajlm-100	215	7	19	19	NUM
ajlm-100	215	8	.	.	PUNCT
ajlm-100	216	1	robins	robin	NOUN
ajlm-100	216	2	-	-	PUNCT
ajlm-100	216	3	browne	browne	PROPN
ajlm-100	216	4	rm	rm	PROPN
ajlm-100	216	5	,	,	PUNCT
ajlm-100	216	6	schneider	schneider	PROPN
ajlm-100	216	7	j	j	PROPN
ajlm-100	216	8	,	,	PUNCT
ajlm-100	216	9	metz	metz	PROPN
ajlm-100	216	10	j.	j.	PROPN
ajlm-100	216	11	thrombocytopenia	thrombocytopenia	PROPN
ajlm-100	216	12	in	in	ADP
ajlm-100	216	13	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	216	14	.	.	PUNCT
ajlm-100	217	1	am	be	AUX
ajlm-100	217	2	j	j	PROPN
ajlm-100	217	3	trop	trop	X
ajlm-100	217	4	med	med	PROPN
ajlm-100	217	5	hyg.1975;24(2):226–231	hyg.1975;24(2):226–231	PROPN
ajlm-100	217	6	.	.	PROPN
ajlm-100	218	1	20	20	NUM
ajlm-100	218	2	.	.	PUNCT
ajlm-100	219	1	kagira	kagira	PROPN
ajlm-100	219	2	jm	jm	PROPN
ajlm-100	219	3	,	,	PUNCT
ajlm-100	219	4	thuita	thuita	PROPN
ajlm-100	219	5	jk	jk	PROPN
ajlm-100	219	6	,	,	PUNCT
ajlm-100	219	7	ngotho	ngotho	PROPN
ajlm-100	219	8	m	m	PROPN
ajlm-100	219	9	,	,	PUNCT
ajlm-100	219	10	et	et	PROPN
ajlm-100	219	11	al	al	PROPN
ajlm-100	219	12	.	.	PUNCT
ajlm-100	219	13	haematology	haematology	NOUN
ajlm-100	219	14	of	of	ADP
ajlm-100	219	15	experimental	experimental	ADJ
ajlm-100	219	16	trypanosoma	trypanosoma	PROPN
ajlm-100	219	17	brucei	brucei	PROPN
ajlm-100	219	18	rhodesiense	rhodesiense	PROPN
ajlm-100	219	19	infection	infection	NOUN
ajlm-100	219	20	in	in	ADP
ajlm-100	219	21	vervet	vervet	PROPN
ajlm-100	219	22	monkeys	monkey	NOUN
ajlm-100	219	23	.	.	PUNCT
ajlm-100	220	1	afr	afr	PROPN
ajlm-100	220	2	j	j	PROPN
ajlm-100	220	3	health	health	PROPN
ajlm-100	220	4	sci	sci	PROPN
ajlm-100	220	5	.	.	PUNCT
ajlm-100	220	6	2006;13(3–4):59–65	2006;13(3–4):59–65	PROPN
ajlm-100	220	7	.	.	PUNCT
ajlm-100	221	1	21	21	NUM
ajlm-100	221	2	.	.	PUNCT
ajlm-100	222	1	egbe	egbe	NOUN
ajlm-100	222	2	-	-	PUNCT
ajlm-100	222	3	nwiyi	nwiyi	VERB
ajlm-100	222	4	tn	tn	NOUN
ajlm-100	222	5	,	,	PUNCT
ajlm-100	222	6	igbokwe	igbokwe	VERB
ajlm-100	222	7	io	io	PROPN
ajlm-100	222	8	,	,	PUNCT
ajlm-100	222	9	onyeiyili	onyeiyili	PROPN
ajlm-100	222	10	pa	pa	PROPN
ajlm-100	222	11	.	.	PUNCT
ajlm-100	223	1	the	the	DET
ajlm-100	223	2	pathogenicity	pathogenicity	NOUN
ajlm-100	223	3	of	of	ADP
ajlm-100	223	4	diminazene	diminazene	NOUN
ajlm-100	223	5	aceturate	aceturate	NOUN
ajlm-100	223	6	-	-	PUNCT
ajlm-100	223	7	resistant	resistant	ADJ
ajlm-100	223	8	trypanosoma	trypanosoma	NOUN
ajlm-100	223	9	brucei	brucei	NOUN
ajlm-100	223	10	in	in	ADP
ajlm-100	223	11	rats	rat	NOUN
ajlm-100	223	12	after	after	ADP
ajlm-100	223	13	treatment	treatment	NOUN
ajlm-100	223	14	with	with	ADP
ajlm-100	223	15	the	the	DET
ajlm-100	223	16	drug	drug	NOUN
ajlm-100	223	17	.	.	PUNCT
ajlm-100	224	1	j	j	PROPN
ajlm-100	224	2	comp	comp	PROPN
ajlm-100	224	3	pathol	pathol	NOUN
ajlm-100	224	4	.	.	PUNCT
ajlm-100	225	1	2003;128(2–3):188–191	2003;128(2–3):188–191	X
ajlm-100	225	2	.	.	PUNCT
ajlm-100	226	1	http://dx.doi.org/10.1053/jcpa.2002.0599	http://dx.doi.org/10.1053/jcpa.2002.0599	PROPN
ajlm-100	226	2	22	22	NUM
ajlm-100	226	3	.	.	PUNCT
ajlm-100	227	1	umar	umar	PROPN
ajlm-100	227	2	ia	ia	PROPN
ajlm-100	227	3	,	,	PUNCT
ajlm-100	227	4	ogenyi	ogenyi	ADJ
ajlm-100	227	5	e	e	NOUN
ajlm-100	227	6	,	,	PUNCT
ajlm-100	227	7	okodaso	okodaso	PROPN
ajlm-100	227	8	d	d	PROPN
ajlm-100	227	9	,	,	PUNCT
ajlm-100	227	10	et	et	PROPN
ajlm-100	227	11	al	al	PROPN
ajlm-100	227	12	.	.	PROPN
ajlm-100	227	13	amelioration	amelioration	NOUN
ajlm-100	227	14	of	of	ADP
ajlm-100	227	15	anaemia	anaemia	NOUN
ajlm-100	227	16	and	and	CCONJ
ajlm-100	227	17	organ	organ	NOUN
ajlm-100	227	18	damage	damage	NOUN
ajlm-100	227	19	by	by	ADP
ajlm-100	227	20	combined	combined	ADJ
ajlm-100	227	21	intraperitoneal	intraperitoneal	ADJ
ajlm-100	227	22	administration	administration	NOUN
ajlm-100	227	23	of	of	ADP
ajlm-100	227	24	vitamins	vitamin	NOUN
ajlm-100	227	25	a	a	PRON
ajlm-100	227	26	and	and	CCONJ
ajlm-100	227	27	c	c	NOUN
ajlm-100	227	28	to	to	ADP
ajlm-100	227	29	trypanosoma	trypanosoma	PROPN
ajlm-100	227	30	brucei	brucei	PROPN
ajlm-100	227	31	brucei	brucei	PROPN
ajlm-100	227	32	-	-	PUNCT
ajlm-100	227	33	infected	infect	VERB
ajlm-100	227	34	rats	rat	NOUN
ajlm-100	227	35	.	.	PUNCT
ajlm-100	228	1	afr	afr	PROPN
ajlm-100	228	2	j	j	PROPN
ajlm-100	228	3	biotechnol	biotechnol	PROPN
ajlm-100	228	4	.	.	PUNCT
ajlm-100	229	1	2007;6(18):2083–2086	2007;6(18):2083–2086	ADJ
ajlm-100	229	2	.	.	PUNCT
ajlm-100	230	1	23	23	NUM
ajlm-100	230	2	.	.	PUNCT
ajlm-100	230	3	thuita	thuita	PROPN
ajlm-100	230	4	jk	jk	PROPN
ajlm-100	230	5	,	,	PUNCT
ajlm-100	230	6	kagira	kagira	PROPN
ajlm-100	230	7	jm	jm	PROPN
ajlm-100	230	8	,	,	PUNCT
ajlm-100	230	9	mwangangi	mwangangi	PROPN
ajlm-100	230	10	d	d	PROPN
ajlm-100	230	11	,	,	PUNCT
ajlm-100	230	12	et	et	PROPN
ajlm-100	230	13	al	al	PROPN
ajlm-100	230	14	.	.	PROPN
ajlm-100	231	1	trypanosoma	trypanosoma	PROPN
ajlm-100	231	2	brucei	brucei	PROPN
ajlm-100	231	3	rhodesiense	rhodesiense	PROPN
ajlm-100	231	4	transmitted	transmit	VERB
ajlm-100	231	5	by	by	ADP
ajlm-100	231	6	a	a	DET
ajlm-100	231	7	single	single	ADJ
ajlm-100	231	8	tsetse	tsetse	NOUN
ajlm-100	231	9	fly	fly	NOUN
ajlm-100	231	10	bite	bite	NOUN
ajlm-100	231	11	in	in	ADP
ajlm-100	231	12	vervet	vervet	NOUN
ajlm-100	231	13	monkeys	monkey	NOUN
ajlm-100	231	14	as	as	ADP
ajlm-100	231	15	a	a	DET
ajlm-100	231	16	model	model	NOUN
ajlm-100	231	17	of	of	ADP
ajlm-100	231	18	human	human	ADJ
ajlm-100	231	19	african	african	ADJ
ajlm-100	231	20	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	231	21	.	.	PUNCT
ajlm-100	232	1	plos	plos	PROPN
ajlm-100	232	2	negl	negl	PROPN
ajlm-100	232	3	trop	trop	X
ajlm-100	232	4	dis	dis	PROPN
ajlm-100	232	5	.	.	PUNCT
ajlm-100	232	6	2008;2(5):e238	2008;2(5):e238	PROPN
ajlm-100	232	7	.	.	PUNCT
ajlm-100	233	1	http://dx.doi.org/10.1371/journal.pntd.0000238	http://dx.doi.org/10.1371/journal.pntd.0000238	PROPN
ajlm-100	233	2	24	24	NUM
ajlm-100	233	3	.	.	PUNCT
ajlm-100	233	4	chisi	chisi	VERB
ajlm-100	233	5	je	je	PROPN
ajlm-100	233	6	,	,	PUNCT
ajlm-100	233	7	misiri	misiri	PROPN
ajlm-100	233	8	h	h	NOUN
ajlm-100	233	9	,	,	PUNCT
ajlm-100	233	10	zverev	zverev	PROPN
ajlm-100	233	11	y	y	PROPN
ajlm-100	233	12	,	,	PUNCT
ajlm-100	233	13	et	et	PROPN
ajlm-100	233	14	al	al	PROPN
ajlm-100	233	15	.	.	PROPN
ajlm-100	233	16	anaemia	anaemia	PROPN
ajlm-100	233	17	in	in	ADP
ajlm-100	233	18	human	human	ADJ
ajlm-100	233	19	african	african	ADJ
ajlm-100	233	20	trypanosomiasis	trypanosomiasis	NOUN
ajlm-100	233	21	caused	cause	VERB
ajlm-100	233	22	by	by	ADP
ajlm-100	233	23	trypanosoma	trypanosoma	PROPN
ajlm-100	233	24	brucei	brucei	PROPN
ajlm-100	233	25	rhodesiense	rhodesiense	PROPN
ajlm-100	233	26	.	.	PUNCT
ajlm-100	234	1	east	east	PROPN
ajlm-100	234	2	afr	afr	PROPN
ajlm-100	234	3	med	med	PROPN
ajlm-100	234	4	j.	j.	PROPN
ajlm-100	234	5	2004;81(10):505–508	2004;81(10):505–508	PROPN
ajlm-100	234	6	.	.	PUNCT
ajlm-100	235	1	http://dx.doi.org/10.4314/eamj.v81i10.9232	http://dx.doi.org/10.4314/eamj.v81i10.9232	PROPN